NewzIntel.com

Category: Health

  • MIL-OSI United Kingdom: New report highlights key sources of air pollution in Oxford

    Source: City of Oxford

    A new report has been published by Oxford City Council, providing a breakdown of the key sources of air pollution in the city. 

    The Oxford Source Apportionment report, which was conducted by Ricardo Group, highlights that road transport remains the highest contributor to NOx emissions, while domestic wood burning is the largest contributor to particulate pollution (PM2.5) in the city. 

    The report examines the contributions of different sectors to air pollution in Oxford (transport, domestic combustion, point sources, other transport, and other emissions), focusing on nitrogen oxides (NOX – a combination of nitric oxide (NO) and nitrogen dioxide (NO2)) and fine particulate matter (PM2.5 and PM10).  

    The report is based on air pollution data measured in 2022, as well as modelling on the impact of the introduction of 159 electric buses in Oxford through the Government’s ZEBRA scheme. 

    The report found that while road transport remains the largest source of NOX pollution (32%), domestic combustion—particularly wood burning—is the leading cause of harmful PM2.5 emissions (24%). 

    Key findings of the report: 

    • Road transport remains the largest contributor to NOX pollution – accounting for 32% of total NOX emissions.
    • Domestic combustion accounts for 26% of total NOX emissions.
    • Point sources (emissions from sources at a known location that can be directly mapped such as industry or commercial buildings) contribute 20% of total NOX emissions.
    • Other road transport (including boats, and military aircraft) accounts for 9% of total NOX emissions.
    • Other emissions (including rail and aircrafts, non-road mobile machinery, industry, waste, solvents, agriculture, and production processes) accounts for 13% of total NOX emissions.
    • Domestic wood burning is the highest contributor to PM2.5 pollution, accounting for 24% of total PM2.5 emissions.
    • Buses contribute 4% to total NOX emissions, reflecting a significant (28%) reduction since the previous source apportionment study, due to Oxford’s transition to electric buses. 

    Road Transport 

    Road transport remains the largest single contributor to NOX pollution, with diesel vehicles dominating emissions: 

    • Cars (petrol and diesel) account for 48% of total NOX emissions.
    • Heavy Goods Vehicles (HGVs) account for 19%.
    • Light Goods Vehicles (LGVs) account for 26%.
    • Buses contribute 4% to total NOX emissions, reflecting a significant (28%) reduction since the previous source apportionment study, due to Oxford’s transition to electric buses. 
    • Private hire and Hackney taxis account for 2%. 

    Since the previous Source Apportionment Study, road transport NOX emissions have dropped from 40% to 32%, primarily due to the introduction of electric buses under the government’s ZEBRA scheme. Buses now contribute to 4% to total NOX emissions in the city. 

    Since the previous Source Apportionment Study, road transport NOX emissions have dropped from 40% to 32%, primarily due to the introduction of electric buses under the government’s ZEBRA scheme. Buses now contribute to 4% to total NOX emissions in the city. 

    Hotspot Locations 

    In addition to transport emissions across the whole city, the report also looked at pollution in three ‘hotspot’ locations – St Clement’s, Botley road and Worcester Street – which have historically seen high levels of air pollution and are key roads for vehicles to travel into and across the city.  

    The findings show: 

    • Cars are the biggest contributors to NOX across all three locations.
    • LGVs and HGVs follow as the next most significant contributors.
    • Buses have seen a reduction in their contribution to NOX emissions, following the transition to electric in 2024.
    • Private hire taxis contribute more to NOX emissions than Hackney Carriages – with both sources combined accounting for 2% of NOX. 

    Domestic Combustion 

    The report highlights that the domestic combustion sector (which includes emissions from burning wood, coal, and gas to heat homes) is responsible for 35% of total PM2.5 emissions citywide – with wood burning alone accounting for 25%.  

    When looking at the specific sources of PM2.5 within the domestic combustion sector: 

    • Wood burning accounts for 70% of all PM2.5 emissions relating to domestic combustion.
    • Commercial heating (in businesses and institutions) contributes 15%.
    • Gas and coal (domestic others) burning contributes 14%.
    • Smokeless fuels account for just 1%.

    Other sources of emissions 

    Other sources of NOX emissions in Oxford includes: 

    • Point sources (such as industry and commercial buildings) contribute 20% of total NOX emissions.
    • Other road transport (including boats, and military aircraft) accounts for 9% of total NOX emissions.
    • Other emissions (including rail and aircrafts, non-road mobile machinery, industry, waste, solvents, agriculture, and production processes) account for 13% of total NOX emissions. 

    There is no safe level of air pollution  

    In Oxford, the main pollutant of concern is nitrogen dioxide (NO2). Over the past few years, Oxford’s air quality has improved significantly, and since the introduction of the city’s current Air Quality Action Plan in 2021, NO2 levels across Oxford have seen a 18% average reduction.  

    Oxford is currently in compliance with the UK’s legal limit for NO2 in all areas of ‘relevant exposure’ within the city (40 µg/m³). However, there is ultimately no safe level of NO2 exposure.  

    In September 2021 the World Health Organization (WHO) recommended a much ‘safer’ annual mean level of NO2 of 10 µg/m³. Under its current Air Quality Action Plan, which was established in January 2021, Oxford has set its own voluntary annual mean target for NO2 of 30 µg/m³) to be achieved across the city by 2025.  

    Next Steps 

    The report will inform the Council’s upcoming Air Quality Action Plan, which will be updated in 2026 following public consultation later this year.

    An Air Quality Action Plan (AQAP) outlines the actions that the Council and its partners will take to improve air quality in Oxford within a certain period of time.The Council’s current Air Quality Action Plan can be read here. 

    For more information on air quality in Oxford, visit the Council’s Air Quality pages.  

    Comment 

    “This latest source apportionment study shows us to the key sources of toxic air pollution in Oxford, and what areas we need to focus on to improve air pollution across the city.  

    “We can see that there has been a significant reduction in the contribution of buses to NOX levels following the introduction of the 159 electric bus fleet. However, cars remain the largest contributor to this pollution.  

    “The report also highlights that we must address the growing issue of domestic wood burning, which is now the largest source of harmful PM2.5 pollution in Oxford. Many people may not realise that even modern wood stoves produce dangerous emissions. By reducing wood burning and supporting zero-emission transport, we can continue to improve Oxford’s air quality for everyone.” 

    Councillor Anna Railton, Deputy Leader and Cabinet Member for Zero Carbon Oxford, Oxford City Council

    “The modelled impact that the new fleet of electric buses is having on air quality in Oxford in such as short space of time is remarkable. We are incredibly proud to have put together the successful bid alongside the bus companies to bring them to the city, and this new report shows why it was such an important initiative in creating a cleaner, greener county.” 

    Councillor Andrew Gant, Oxfordshire County Council’s Cabinet Member for Transport Management

    “We’re proud of the massive step change in emissions buses have delivered in Oxford over the last decade to help provide radically cleaner air for the communities we serve. 

    “This has been sustained over several years with the move to ultra-low emission vehicles and more recently zero emission vehicles, following significant investment by both companies.  

    “However, overall Oxford’s air is not benefitting as much as it could be due to the steadily increasing proportion of car and van emissions. The data clearly demonstrates that it’s vital for Oxford’s health that suitable measures are introduced to help reduce the volume of private vehicles on the city’s roads to achieve even greater improvements in air quality.” 

    Luke Marion, Managing Director of Oxford Bus Company

    MIL OSI United Kingdom –

  • MIL-OSI China: China launches hotlines, awareness campaigns to bolster mental health services

    Source: People’s Republic of China – State Council News

    BEIJING, Feb. 13 — A total of 18 provincial-level regions in China, including Beijing, Shanghai and Zhejiang, have launched the 12356 mental health assistance hotline, aiming to provide the public with more accessible, high-quality mental health services, a Chinese health official said on Thursday.

    Other provinces are actively progressing with similar initiatives to ensure comprehensive mental health services coverage nationwide, Hu Qiangqiang, a spokesperson for the National Health Commission (NHC), said at a press conference.

    Hu noted that the NHC has designated 2025 to 2027 as “pediatrics and mental health service years,” and outlined other key measures such as promoting mental health knowledge among key groups and guaranteeing that every city-level region has at least one hospital with specialized psychological and sleep disorder clinics.

    During the period, over 5,000 lectures on mental health will be organized nationwide, according to Hu. 

    MIL OSI China News –

  • MIL-OSI Security: I Am Navy Medicine: Hospital Corpsman Third Class Cohwen Houchin

    Source: United States Navy (Medical)

    Naval Health Clinic Cherry Point bid Fair Winds and Following Seas to Hospital Corpsman Cohwen Houchin on Wednesday, February 12 and recognized him for his outstanding service.

    Houchin served aboard the facility from May 2023 to February 2025 in the Pharmacy and Materials Management Departments. During his time here, he processed over 6,200 prescriptions and facilitated the distribution of over $500,000 in supplies to support 24 departments.

    He was also a member of the facility’s Honor Guard and displayed exceptional military bearing and professionalism during 21 events. Cohwen received the Navy and Marine Corps Achievement Medal in recognition of his exceptional service.

    MIL Security OSI –

  • MIL-OSI: 1m Launches Risk Intelligence Network to Help Healthcare Providers Respond to Federal Policy Changes

    Source: GlobeNewswire (MIL-OSI)

    Initiative equips providers with critical data and intelligence to navigate shifting federal policies on healthcare funding, reimbursement and eligibility

    More than fifteen health systems engaged in the first week

    NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) — 1m, a data and analytics technology company serving the risk management needs of healthcare organizations, today announced the launch of a national standardized risk assessment to help healthcare providers stay ahead of critical changes in federal healthcare policy. The initiative will include leading healthcare providers across the country to provide an objective and data-based analysis of emerging risks and their potential impact. More than fifteen health systems are already engaged and preparing to participate.

    The assessment will be made available to participating healthcare providers. Interested parties can contact intelligence@1mplatform.com to inquire about participating.

    “Health systems are scrambling to assess the flurry of policy shifts and emerging risks independently,” said Chris Giuliano, co-CEO and CTO of 1m. “We’ve seen this reactive cycle before—in response to COVID-19, cybersecurity threats, and inflation. It’s time to break the cycle. This intelligence network will standardize risk assessments and help providers align on responsive strategies.”

    1m will survey a consortium of health systems to create an anonymized national healthcare risk dataset. That data will be used to create standardized reports and executive-ready guidance for risk managers, business leaders and boards. The initial assessments will focus on the recent policy changes proposed by Congress and the new administration, and their potential impact on providers, e.g.:

    • Medicaid funding cuts and eligibility requirements
    • Medicare funding cuts and drug pricing negotiations
    • Reductions related to the Affordable Care Act (ACA)
    • Inflationary pressures as a result of new tariffs
    • Cuts in funding for public health agencies
    • Impact of immigration policy on staffing

    All participating health systems will have access to the in-depth, data-driven outputs, including:

    • Consensus risk assessments
    • Information on risk quantification methods
    • Benchmarking insights showing the distribution of responses across peer organizations
    • A catalog of common mitigation strategies for each risk
    • Highlighted expert insights summarizing the most valuable qualitative feedback
    • Executive and Board-ready presentations summarizing results
    • The option for 1m to customize the results for their organization

    The initial survey will be conducted during the month of February, with results available to participating organizations in early March.  

    1m recently raised a Series A financing, announced in December 2024, which included participation from five leading healthcare systems.

    About 1m

    1m is a data and analytics technology company serving large healthcare organizations through a B2B SaaS model. Led by former Goldman Sachs healthcare investment bankers Jeff Ellis and Chris Giuliano, 1m is setting the standard for risk management in healthcare, with an end-to-end risk management solution designed for Enterprise Risk, Internal Audit, Compliance, and Finance teams. The platform leverages robust data, analytics and monitoring tools that integrate seamlessly into existing risk management workflows to deliver timely, high-ROI decision support.

    For more information, visit https://www.1mplatform.com/.

    The MIL Network –

  • MIL-OSI USA: Governor Newsom announces appointments 2.12.25

    Source: US State of California 2

    Feb 12, 2025

    Kate Hoit, of Sacramento, has been appointed Deputy Secretary of Communications at the California Department of Veterans Affairs. Hoit has been the PACT Act Enterprise Program Management Office Communications and Outreach Lead at the U.S. Department of Veterans Affairs since 2023. She was a Communications Lead in the Veteran Experience Office, U.S. Department of Veterans Affairs from 2021 to 2023. Hoit was the California State Director at the Vet Voice Foundation from 2018 to 2021. She was the Military Marketing Manager at National University from 2017 to 2018. Hoit was the Director of Content and Communications at Got Your 6 from 2014 to 2017. She was a Public Affairs Specialist at the U.S. Department of Veterans Affairs from 2011 to 2014. Hoit served in the U.S. Army Reserve from 2001 to 2009. She is a Pat Tillman Scholar and a member of the Truman National Security Project. She earned her Master of the Arts Degree in Non-Fiction Writing from Johns Hopkins University, and a Bachelor of the Arts in Journalism from the University at Albany, State University of New York. This position does not require Senate confirmation, and the compensation is $154,860. Hoit is a Democrat.

    Shaun Spillane, of Gold River, has been appointed Chief Deputy Inspector General at the Office of the Inspector General, where he has been Chief Counsel since 2023, and was Attorney IV from 2013 to 2023. Spillane was Labor Relations Counsel II at the California Department of Human Resources from 2009 to 2013. He was a Graduate Student Assistant in the Office of the Inspector General from 2007 to 2009. Spillane earned a Juris Doctor degree from the University of the Pacific, McGeorge School of Law and a Bachelor of Arts degree in Psychology from the University of Michigan. This position does not require Senate confirmation, and the compensation is $201,972. Spillane is registered without party preference.

    Michael “Mike” Detoy, of Hermosa Beach, has been appointed to the California Public Employees’ Retirement System Board of Administration. Detoy has been Councilmember and Mayor of the City of Hermosa Beach since 2019. He has been Fire Captain for the City of Riverside since 2011. Detoy is President of the Riverside City Firefighters Association. He earned a Master of Public Administration degree from California Baptist University and a Bachelor of Science degree in Finance from Santa Clara University. This position does not require Senate confirmation, and the compensation is $100 per diem. Detoy is a Democrat.

    Christopher Gonder, of Brawley, has been appointed to the Commission on Correctional Peace Officer Standards and Training. Gonder has been a Correctional Officer at the California Department of Corrections and Rehabilitation since 2016. He is the Vice President of the California Correctional Peace Officers Association, Calipatria Chapter and President of the Chicano Correctional Workers Association, Calipatria Chapter. This position does not require Senate confirmation, and there is no compensation. Gonder is registered without party preference.

    Hellen Hong, of Los Angeles, has been reappointed to the Civil Rights Council, where she has served since 2021. Hong has been Chief Executive Officer at CalBar Connect since 2020. She was the Director at the Office of Access and Inclusion at the State Bar of California from 2019 to 2020. Hong held multiple executive positions at First Place for Youth from 2014 to 2019. She was the Executive Director of the Los Angeles Center for Law and Justice from 2007 to 2014. Hong was a Public Interest Attorney from 2004 to 2007. She was Assistant Director of State Government Relations at the University of California from 2002 to 2004. Hong earned her Juris Doctor degree from Loyola Law School. This position requires Senate confirmation, and the compensation is $100 per diem. Hong is a Democrat

    Hugh Crooks, of Los Angeles, has been reappointed to the California Veterans Board, where he has served since 2017. Crooks was a Human Resources Operations Manager at the Los Angeles County Registrar-Recorder/County Clerk from 2000 to 2005. Crooks was Head of Administrative and Facility Services at the Los Angeles County Museum of Natural History from 1991 to 2000. He was Safety Police Chief III for the Protective Services Division at the Los Angeles County Safety Police from 1969 to 1991. Crooks was a Rifleman in the U.S. Army from 1967 to 1969. He is a member of the Veterans of Foreign Wars, 9th Infantry Division Society, and the Los Angeles County Sheriff’s Advisory Group. Crooks was a National Executive Committeeman and Chief Financial Officer of the American Legion, Department of California. This position requires Senate confirmation, and the compensation is $100 per diem. Crooks is a Democrat. 

    Press Releases, Recent News

    Recent news

    Feb 11, 2025

    News SACRAMENTO – Governor Gavin Newsom today announced the following appointments:Karen Morrison, of Sacramento, has been appointed Director at the California Department of Pesticide Regulation. Morrison has held multiple positions at the Department of Pesticide…

    Feb 11, 2025

    News What you need to know: Across all of state government, highly-specialized personnel and response equipment are on the ground working to protect communities statewide from storm impacts.  Los Angeles, California – With another significant winter storm system…

    Feb 11, 2025

    News What you need to know: Governor Gavin Newsom issued an executive order today ordering the state to ensure that childcare providers impacted by the recent wildfires in Los Angeles are aware of their potential eligibility for Disaster Unemployment Assistance and…

    MIL OSI USA News –

  • MIL-OSI USA: Researchers Unlock New Potential Porcine Virus Treatment

    Source: US State of Connecticut

    UConn researchers have identified a novel small molecule for the development of preventative treatment for a serious and costly disease in pigs.

    Porcine reproductive and respiratory syndrome virus (PRRSV) costs an estimated $1.2 billion annually in the U.S. In Europe, the estimated yearly loss is €1.5 billion. The virus causes respiratory disease in piglets, and miscarriages or stillbirths in sows.

    There is currently no effective vaccine or treatment for PRRSV. Some scientists are working on genetically modified pigs to block viral infection, but this strategy will take decades to have a measurable impact.

    Researchers from the College of Agriculture, Health and Natural Resources have identified a small molecule that can successfully disable the virus’ mechanisms for reproducing and evading the host organism’s immune system.

    They published these findings in the Journal of Virology. Jiaqi Zhu ‘23 (CAHNR), is the first author on this paper. UConn collaborators include Xiuchun “Cindy” Tian, professor of animal science; Antonio Garmendia, professor of pathobiology and veterinary science; Neha Mishra, associate professor of pathobiology and veterinary science, and Kyle Hadden, professor of pharmaceutical science.

    This work is a collaboration between UConn and Northwest A&F University in China, where Young Tang, former UConn associate professor, is currently faculty.

    The researchers began this work by using artificial intelligence to screen a bank of small molecules to identify which ones might be good candidates. The algorithm compared the structure of the viral protein the researchers wanted to target against those of the small molecules.

    They then narrowed their results down to a single chemical that could inhibit the virus without producing toxic effects.

    The researchers targeted a protein called NendoU. This protein is highly conserved, meaning that when the virus mutates, this protein will likely stay the same because it plays such an essential role in the virus’ ability to reproduce.

    The researchers found that the number of viral particles in cells treated with the small molecule was more than 1,000 times fewer than the untreated control group.

    “Basically, the virus comes into the untreated cell and uses the cell’s machinery to amplify and create more viruses,” Tian says. “So, if you treat the cells with this particular chemical, compared to untreated cells, it’s going to reduce it by 1,000 times in terms of viral number.”

    NendoU is also common across other closely related viruses.

    “We were thinking this [chemical] could also work on other viruses in this order,” Zhu says. “So, we tested it on another virus called chicken infectious bronchitis virus and it also worked very well.”

    COVID-19 belongs to the same viral family as PRRSV. This means that even though PRRSV is not a risk to human health, this research could have applications for human anti-viral drug development.

    These findings build on previous work from this group in which, in collaboration with technology enabled pharmaceutical company, Atomwise Inc., they identified a different chemical that disrupts the virus’ ability to enter the host cell.

    “By shutting the door for viral entry and inhibiting those that are already in the cells, we could combine these two small molecules in the future, and potentially have a stronger, and synergistic effect on disease control,” says Tian.

    The researchers are working with UConn’s Technology Commercialization Services (TCS) to advance the development and commercialization of this technology. Engaging with TCS early on, they protected their intellectual property and developed a strategic commercialization plan. As part of these efforts, TCS facilitated one-on-one meetings with five of the world’s ten largest animal healthcare companies, along with multiple other organizations interested in the technology.

    “We have received amazing interest from industry, and the feedback has been extremely helpful, setting up the development path of the technology,” says Ana Fidantsef, industry liaison with TCS. “We hope these interactions will lead to collaborations that will immensely help the swine market and industry.”

    This work relates to CAHNR’s Strategic Vision area focused on Ensuring a Vibrant and Sustainable Agricultural Industry and Food Supply.

    Follow UConn CAHNR on social media

    MIL OSI USA News –

  • MIL-OSI Security: U.S. Naval Hospital Yokosuka and ASBBC Okinawa Successfully Complete Groundbreaking Blood Drive

    Source: United States Navy (Medical)

    YOKOSUKA, Japan – U.S. Naval Hospital (USNH) Yokosuka, in partnership with the Armed Services Blood Bank Center (ASBBC) Okinawa, successfully hosted a groundbreaking two-day blood drive, marking the first-ever mobilization of the ASBBC Okinawa team to Yokosuka, Jan. 29 and 30.

    The event saw more than 200 potential donors, resulting in 110 successful whole blood donations. This initiative plays a critical role in strengthening blood sustainment efforts within the IndoPacific region at far forward military treatment facilities (MTF).

    “All the hard work, meticulous planning, and collaborative coordination from all teams and partners were truly worthwhile,’ said USNH Yokosuka’s Laboratory department head Lt. Sheryll Tagura. “Our ultimate goal is to support not only our warfighters at sea, on land, and in the air but also their families at the home front.”

    Extensive Planning and Coordination

    The success of the blood drive was made possible through six months of meticulous planning and coordination. The USNH Yokosuka laboratory team, with essential support from the 374th Medical Group’s lab team at Yokota Air Base team, was responsible for the logistics of hosting the ASBBC Okinawa team. More than 33 personnel, including American Red Cross Yokosuka volunteers, dedicated over 500 man-hours to execute the event.

    During the drive, the hospital’s laboratory staff processed over 600 blood samples and managed the storage of 110 whole blood units. Additionally, the team facilitated training and education for the hospital’s Walking Blood Bank team. A Walking Blood Bank (WBB) is a system where pre-
    screened individuals, usually military personnel or members of a community, can donate fresh whole blood in emergency situations. While screening samples during the blood drive, the WBB program added 37 successful prescreens to their inventory.

    “I want to thank our partners: ASBBC, Yokota AFB Laboratory, 613TH Air Operations Center, Yokota Air Base, Commander Fleet Activities Yokosuka, Yokosuka’s Officers’ Club, American Red Cross, Navy Commissary, Commander, Fleet Air Western Pacific, and most especially our blood donors,” said Tagura. “If our efforts save even one life, then it was all worth it.”

    Collaboration with ASBBC Okinawa

    The collaboration with ASBBC Okinawa proved to be an exceptional experience for the USNH Yokosuka team. “We had the opportunity to observe their extensive expertise and professionalism in action,” said Hospital Corpsman 1st Class David Sisto. “Their team is highly trained and operates with remarkable efficiency. We look forward to future opportunities to work together.”

    The ASBBC Okinawa team consisted of 14 personnel, including 12 enlisted members from the Air Force, Army, and Navy, one officer from the Air Force, and one civilian technical supervisor. Their involvement was crucial in executing the drive effectively.

    Strategic Importance of Mainland Blood Drives

    The ASBBC Okinawa team emphasized the significance of conducting blood drives in mainland Japan, as they provide an underutilized resource for sustaining blood supply in the Indo-Pacific region. This effort follows a previous mainland blood drive at Yokota Air Base, further expanding the reach and capabilities of ASBBC.

    “Executing this blood drive in Yokosuka has provided us with invaluable knowledge on mobilizing off-island and within mainland Japan,” said U.S. Indo-Pacific ASBBC Deputy Director Air Force Capt. Yessenia Greene. “This experience has strengthened our ability to operate in emergency and contested environments while building a joint network across military services for large-scale blood drives.”

    Looking Ahead

    Given the success of this inaugural event, ASBBC Okinawa anticipates conducting more blood drives on mainland Japan in the future.
    “We had a great experience working with USNH Yokosuka,” Greene added. “The team was phenomenal, and leadership was incredibly supportive. This initiative has set the stage for future mobilizations, and we hope to return to Yokosuka for another blood drive soon.”

    ASBBC Okinawa is the sole source of fresh blood in support of the U.S. 7th Fleet and all Defense Health Agency military treatment facilities in the U.S. Indo-Pacific Command area of operations.

    MIL Security OSI –

  • MIL-OSI Asia-Pac: Union Minister Shri George Kurian inaugurates symposium on “Aquatic Animal Diseases – Addressing emerging challenges and preparedness”

    Source: Government of India

    Union Minister Shri George Kurian inaugurates symposium on “Aquatic Animal Diseases – Addressing emerging challenges and preparedness”

    Union Minister underlines the importance of nutrition and biosecurity in aquaculture

    Shri Kurian emphasizes the need for continuous research and innovation in aquatic animal health management

    Posted On: 13 FEB 2025 4:43PM by PIB Delhi

    Union Minister of State for Fisheries, Animal Husbandry and Dairying Shri George Kurian has inaugurated the symposium on ‘Aquatic Animal Diseases: Emerging Challenges and Preparedness’ organised at the ICAR Convention Centre, Pusa Campus, New Delhi today. The symposium was organised as part of the 14th Asian Fisheries and Aquaculture Forum (14AFAF) meet being held here from 12-15 February, 2025 with the theme “Greening the Blue Growth in Asia-Pacific.

    Speaking on the occasion, Shri George Kurien said appreciated ICAR for its initiative in organizing the symposium and emphasized the “One Earth – One Family” approach, stressing the importance of nutrition and biosecurity in aquaculture. He highlighted that sustainable aquaculture practices are key to ensuring food security, livelihoods, and economic growth in India. He acknowledged the efforts made under various government initiatives such as PMMSY and emphasized the need for continuous research and innovation in aquatic animal health management. He called for a multi-stakeholder approach, involving government agencies, research institutions, and industry players, to work together towards strengthening disease surveillance, enhancing biosecurity protocols, and improving diagnostic and therapeutic measures.

     

    Dr. J.K. Jena, DDG (Fisheries Science), ICAR, and Convener of the symposium, provided an overview of the event, thanking the Government of India and Network of Aquaculture Centers in the Asia Pacific for their support. He emphasized about the need of strong biosecurity measures and discussed the ongoing NSPAAD Phase II and INFAR project, which aim to develop strategies for better disease control in aquaculture. He emphasized the Network project on Fish Health as a crucial initiative for advancing disease research and control in aquaculture. which focuses on disease management and early response mechanisms to mitigate potential risks in fish farming. Furthermore, he stressed that disease management will be critically important for the future in light of the diversification of aquaculture with introduction of new species, new systems, and the expansion of aquaculture. He also highlighted the importance of diagnostics, therapeutics, and vaccines for effective disease management in aquaculture.

    Shri Sagar Mehra, Joint Secretary, Department of Fisheries, Ministry of Fisheries and Animal Husbandry and Dairying in his address, highlighted the vital role of fisheries in supporting livelihoods and the economy. He stressed the importance of national, regional, and local-level strategies to combat disease outbreaks effectively. He underscored the need for proactive response mechanisms, recognizing that disease transmission is often linked to live animal movement. He called for enhanced biosecurity measures and early detection systems to safeguard the sustainability and economic viability of the aquaculture industry.

    Dr B.K. Behera, Chief Executive, NFDB emphasized the need to institutionalize fish disease surveillance programs in India to ensure systematic disease monitoring, early detection, and effective control. He highlighted the importance of establishing disease-free zones in key aquaculture areas to prevent the spread of infections and enhance biosecurity measures. Institutionalizing surveillance would require integrating it into national aquaculture policies, strengthening regulatory frameworks, and ensuring sustained funding and implementation across states.

    Dr. Eduardo Leano, NACA, Thailand provided insights into NACA’s mission since 1990, operating in 20 countries and spearheading five key disease surveillance programs. He highlighted the growing risk of antimicrobial resistance (AMR) in aquaculture and stressed the urgent need for a sustainable, internationally coordinated approach to aquatic biosecurity.

    Earlier Dr. B.K. Das, Director of ICAR-CIFRI, delivered the welcome address, highlighting aquaculture advancements and the importance of strengthening disease management. He emphasized the Network project on fish health under National Surveillance Programme for Aquatic Animal Diseases (NSPAAD) as a key initiative for improving disease surveillance and fostering innovation in aquatic health solutions.

    Dr. P.K. Sahoo, Director, ICAR-CIFA, delivered the Vote of thanks, acknowledging the contributions of all dignitaries and participants.

    The Asian Fisheries and Aquaculture Forum (AFAF) is a triennial event of the Asian Fisheries Society with its Headquarters in Kuala Lumpur, Malaysia. This 14AFAF is being jointly organized by the Asian Fisheries Society (AFS), Kuala Lumpur; Indian Council of Agricultural Research (ICAR), New Delhi; the Department of Fisheries (DoF), Government of India; and the Asian Fisheries Society Indian Branch (AFSIB), Mangalore. This prestigious event is being hosted in India for the 2nd time after the 8AFAF held at Kochi in 2007.

                                                                ****

    MG/RN/KSR

    (Release ID: 2102768) Visitor Counter : 36

    MIL OSI Asia Pacific News –

  • MIL-OSI Asia-Pac: Union MoS for Health and Family Welfare, Shri Prataprao Jadhav Inaugurates First National Stakeholder Consultation by FSSAI on pesticide residues; advocates good agricultural practices & collaborative efforts

    Source: Government of India

    Union MoS for Health and Family Welfare, Shri Prataprao Jadhav Inaugurates First National Stakeholder Consultation by FSSAI on pesticide residues; advocates good agricultural practices & collaborative efforts

    Collective efforts key to addressing pesticide concerns: Shri Prataprao Jadhav

    Posted On: 13 FEB 2025 5:30PM by PIB Delhi

    Union Minister of State for Health and Family Welfare, Shri Prataprao Ganpatrao Jadhav inaugurated the National Stakeholder Consultation on Challenges in Monitoring Pesticide Residues in Food Commodities organized by Food Safety and Standards Authority of India (FSSAI), Ministry of Health & Family Welfare, here today. Emphasizing the need for a nationwide strategy for stricter monitoring of pesticide residues in food, Shri Jadhav urged all stakeholders to work collectively in promoting best practices for food safety and sustainability.

    This stakeholder consultation on pesticides is first in the series of such consultations with stakeholders on emerging issues like sustainable packaging, nutraceuticals, antimicrobial resistance etc. Addressing stakeholders, the Union Minister appreciated the initiative of FSSAI and stressed on the need to review existing practices in pesticide monitoring and to create a robust mechanism to address the challenges of pesticide residue. He also emphasized the importance of agriculture in sustaining millions of livelihoods and ensuring food security. Shri Jadhav added that today’s farmers are more adaptive towards use of new technology so it is easier to educate them on use of pesticides and about Good Agricultural Practices (GAPs). He also advocated for collaborative efforts from all the stakeholders to devise a concrete action plan to minimize pesticide residues in food commodities.

    Shri Jadhav also stated that the consultation would prove instrumental in identification of gaps, which can then be focused and deliberated upon to develop a robust mechanism of food safety and make food commodities free of pesticide residue. He also commended FSSAI’s efforts in strengthening food safety frameworks.

    Union Health Secretary, Ms. Punya Salila Srivastava, shared her valuable insights on the issue, emphasizing that the indiscriminate use of pesticides poses significant risks to public health. She stressed the importance of strengthening monitoring systems and raising public awareness about pesticide use, ensuring that every person has access to safe food. She advocated for the development of actionable strategies aimed at protecting public health, underscoring that the primary goal of this consultation is to ensure that everyone can enjoy safe and healthy food.

    Shri Devesh Chaturvedi, Secretary, Ministry of Agriculture and Farmers’ Welfare delivered a special address wherein he highlighted the issue of spurious pesticide in the market and also advocated judicious use of pesticides to protect consumer health.

    Shri Subrata Gupta, Secretary, Ministry of Food Processing Industries emphasized the need for all stakeholders in the food value chain to collaborate to address challenges related to pesticides. “Pesticides causes not only bad health but also bad commerce.”

    Shri G Kamala Vardhana Rao, CEO, FSSAI in his concluding remarks reiterated the FSSAI’s commitment to ensuring food safety through stringent monitoring and regulatory measures. He concluded that “By ensuring the safety of food, we protect not only public health but also our environment, the livelihoods of our farmers, and the future of international trade. The outcomes of this consultation will form the foundation for more effective policies and regulations that reflect the complexities of today’s agricultural and food safety landscape” He added that the insights and recommendations from this consultation will contribute to the development of more robust policies and action plans for improving pesticide residue monitoring and ensuring food safety across India.

    The National Stakeholder Consultation on Pesticide Residues marks a crucial step in strengthening food safety by addressing challenges in monitoring pesticide use and ensuring regulatory compliance. Recognizing the need for a coordinated approach, FSSAI convened this consultation to enhance surveillance, enforce safety standards, and mitigate health risks associated with chemical residues in food. By bringing together key stakeholders, the consultation fosters collaboration on best practices, emerging risks, and innovative solutions like bio-pesticides and precision application. As India aligns with global safety standards, this discussion is pivotal in safeguarding public health and promoting sustainable agriculture.

    The event brought together key stakeholders, including government officials, scientific experts, regulatory bodies, National Institutes, representatives from Industry Association, farmer organizations, consumer associations & pesticide manufacturer associations to deliberate on strategies and exchange valuable insights, which will help to devise concrete action plans.

    The consultation featured a technical session followed by a panel discussion on “Global Regulatory Frameworks and National-Level Challenges in Monitoring Pesticide Residues in Food Commodities. The panel featured experts from the Joint FAO/WHO Meeting on Pesticide Residues (JMPR), FAO, ICAR, CIB&RC, and FSSAI’s Scientific Panel on Pesticide Residues.

    Key discussions focused on emphasizing the importance of expanding national surveillance programs, enhancing laboratory capacities, discussions on aligning India’s Maximum Residue Limits (MRLs) with international standards like Codex Alimentarius while considering India’s unique agricultural and environmental conditions.

    The post-lunch session featured an open forum stakeholder interaction involving stakeholders from agriculture, food processing, and consumer organizations to voice their concerns and recommendations. Key issues raised during the consultation included the challenges in implementing effective pesticide residue monitoring, the need for harmonizing India’s Maximum Residue Limits (MRLs) with international standards, and concerns over off-label and excessive pesticide use. There was also a strong emphasis on enhancing farmer education and awareness, introducing digital traceability solutions, and promoting sustainable alternatives such as bio-pesticides and Integrated Pest Management (IPM) to minimize health risks and trade barrier.

    ****

    MV

    HFW/FSSAI National Stakeholder Consultation/13Feb2025/1

    (Release ID: 2102807) Visitor Counter : 50

    MIL OSI Asia Pacific News –

  • MIL-OSI Asia-Pac: Parliament Question: New Employment Opportunities In The Public Sector And Government-Aided PSUs

    Source: Government of India

    Posted On: 13 FEB 2025 3:51PM by PIB Delhi

    Employment generation coupled with improving employability is the highest priority of the Government. Accordingly, the Government of India has taken various steps to provide opportunities of employment to the youth of the nation.

    There is substantial investment in schemes like Production Linked Incentive (PLI) scheme, Prime Minister’s Employment Generation Programme (PMEGP), Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS), Pt. Deen Dayal Upadhyaya Grameen Kaushalya Yojana (DDU-GKY), Deendayal Antodaya Yojana – National Rural Livelihoods Mission (DAY-NRLM), Deendayal Antodaya Yojana – National Urban Livelihoods Mission (DAY-NULM), Make in India, Start-up India, Stand-up India, Digital India, PM Street Vendor’s AtmaNirbhar Nidhi (PM-SVANidhi) Scheme, Pradhan Mantri MUDRA Yojana (PMMY), etc. for employment generation. Major step up in infrastructure viz. Roads, Railways, Airports, Ports, Waterways etc. has also boosted job opportunities in related sectors.

    Further, Government of India is running the National Career Service (NCS) Portal which is a one-stop solution for providing career related services including jobs from private and government sectors, information on online & offline job fairs, job search & matching career counseling, vocational guidance, information on skill development courses, skill/training programmes etc. through a digital platform [www.ncs.gov.inIn the Union Budget 2024-2025, the Government announced the Prime Minister’s package of 5 schemes and initiatives to facilitate employment, skilling and other opportunities for 4.1 crore youth over a 5-year period with a central outlay of Rs.2 lakh crore. The Union Budget 2025-2026 also aims to create multiple employment generation opportunities across various sectors such as tourism, manufacturing, fisheries, etc., and also includes various measures to support entrepreneurship and skilling for youth.

    The occurrence and filling of vacant posts in various Ministries/Departments is a continuous process. As part of Rozgar Melas, organized by the Government of India, vacant posts are being filled in mission mode, which will act as a catalyst in further employment generation across the Central Government Ministries/Departments, Central Public Sector Undertakings (CPUs) /Autonomous Bodies/Educational and Health Institutions etc. in a time bound manner. So far 14 Rozgar Melas have been held at central level in 45-50 cities across various State/Union Territories. Several lakh appointment letters have been issued during Rozgar Melas by the participating Ministries/Departments.

    This information was given by Union Minister of State (Independent Charge) for Personnel, Public Grievances and Pensions, Dr. Jitendra Singh in a written reply in the Rajya Sabha today.

    ****

    NKR/PSM

    (RS US Q NO. 1080)

    (Release ID: 2102738) Visitor Counter : 18

    MIL OSI Asia Pacific News –

  • MIL-OSI Asia-Pac: Towards a Cancer-Free India

    Source: Government of India

    Towards a Cancer-Free India

    Commitment to Prevention, Treatment & Innovation

    Posted On: 13 FEB 2025 3:31PM by PIB Delhi

    “In Cancer Care, collaboration is essential for cure. An integrated approach encompassing prevention, screening, diagnosis, and treatment is essential to reduce the burden of cancer.”

    • Prime Minister Shri Narendra Modi

     

    Introduction

    Cancer is one of the leading causes of death worldwide. In 2022, about 20 million new cancer cases were reported, and 9.7 million people died from the disease globally. Cancer also remains a critical public health challenge in India, with cases projected to rise significantly. In India, around 100 out of every 1 lakh people are diagnosed with cancer. According to the Indian Council of Medical Research (ICMR), the estimated number of incidences of cancer cases was more than 14 lakhs in 2023 in India.

    The National Cancer Registry Programme (NCRP) under ICMR has been tracking cancer incidence, burden, and trends since 1982, playing a vital role in gathering and analyzing data, enabling evidence-based policy decisions. The National Institute of Cancer Prevention & Research (NICPR) is the nodal agency research and screening guidelines under NPCDCS.

    The Government of India has introduced robust policies, strategic interventions, and financial assistance schemes to enhance prevention, early detection, treatment, and patient care nationwide. This article outlines cancer prevalence, government efforts, financial aid, research, and budget commitments to strengthen cancer care in India.

    Union Budget 2025-26: Prioritizing Cancer Care

    The Ministry of Health and Family Welfare has been allocated a total of Rs.99,858.56 crore, with Rs. 95,957.87 crore designated for the Department of Health and Family Welfare and Rs. 3,900.69 crore for the Department of Health Research.

    The Union Budget 2025-26 underscores the Government of India’s dedication to enhancing cancer care through several key initiatives:

    • Day Care Cancer Centres: The government plans to establish Day Care Cancer Centres in all district hospitals over the next three years, with 200 centres slated for 2025-26.
    • Customs Duty Exemptions:
    • To alleviate treatment costs, 36 lifesaving drugs and medicines for treating cancer, rare diseases and chronic diseases fully exempted from Basic Customs Duty (BCD)
    • Six lifesaving medicines to attract concessional customs duty of 5%
    • Furthermore, specified drugs and medicines under Patient Assistance Programmes run by pharmaceutical companies fully exempted from BCD.

    Holistic Cancer Control: A Policy-Driven Approach

    1. National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) – The NPCDCS is a flagship initiative under the National Health Mission (NHM) focuses on controlling non-communicable diseases (NCDs), including cancer. Three most common types of cancers (oral cancer, breast cancer and cervical cancer) are an integral part of NPCDCS. It is aimed at strengthening cancer control efforts, focusing on health promotion, early detection, and treatment infrastructure for cancer.

    Components

    • Cancer screening: For oral, breast, and cervical cancers at the community level.
    • Early detection & awareness: Through health workers and digital platforms.
    • Strengthening infrastructure: Establishment of tertiary cancer centers (TCCs) and state cancer institutes (SCIs).

    Under this program, the government has established

    • 770 District NCD Clinics
    • 233 Cardiac Care Units
    • 372 District Day Care Centres
    • 6,410 Community Health Centre NCD Clinics

    These facilities provide accessible and affordable cancer screenings, particularly for oral, breast, and cervical cancers.

    2.  Strengthening of Tertiary Care for Cancer Scheme

    It enhances specialized cancer care facilities with aims to decentralize cancer treatment, making services more accessible across states.

    Tertiary Cancer Care Network Strengthening

    • India has significantly expanded its cancer treatment ecosystem, with the establishment of:
      19 State Cancer Institutes (SCIs)
    • 20 Tertiary Care Cancer Centres (TCCCs)

    The National Cancer Institute (NCI) in Jhajjar, Haryana, and the second campus of Chittaranjan National Cancer Institute (CNCI) in Kolkata are playing a pivotal role in providing cutting-edge cancer treatment and research opportunities.

    3. Ayushman Bharat Yojana – Launched in 2018, Ayushman Bharat is a landmark health initiative designed to provide universal health coverage, particularly for rural and vulnerable populations. The scheme plays an important role in ensuring timely treatment of cancer patients within 30 days. The scheme covers chemotherapy, radiotherapy, and surgical oncology for cancer treatment for economically vulnerable families. Till 2024, over 90% of registered cancer patients have commenced treatment under this scheme, reducing out-of-pocket expenses and ensuring financial protection for millions.

    4. The Health Minister’s Cancer Patient Fund (HMCPF): The Health Minister’s Cancer Patient Fund under Rashtriya Arogya Nidhi (RAN) provides financial aid up to ₹5 lakh for cancer treatment to patients below the poverty line. The maximum financial assistance admissible under the Scheme will be ₹15 Lakh. It covers treatment at 27 Regional Cancer Centres (RCCs), with ₹50 lakh revolving funds allocated to each center. Established in 2009, the scheme ensures accessible and affordable cancer care for underprivileged patients.

    5. National Cancer Grid (NCG): The National Cancer Grid (NCG) was established in 2012 to ensure high-quality, standardized cancer care across India. Eight years later, it has grown into the world’s largest cancer network with 287 members, comprising cancer centres, research institutes, patient advocacy groups, charitable organizations and professional societies. Between the member organizations of the NCG, the network treats over 750,000 new patients with cancer annually, which is over 60% of all of India’s cancer burden. The NCG also works closely with Ayushman Bharat – PMJAY to provide affordable, evidence-based cancer treatment and streamline costs under the scheme. It has also played a key role in shaping the National Digital Health Mission (NDHM) by contributing to the development of electronic patient health records.

    Advancing Cancer Research and Treatment

    1. India’s First Indigenous CAR-T Cell Therapy: NexCAR19 – A Breakthrough in Cancer Treatment

    In April 2024, India achieved a historic milestone in cancer care with the launch of NexCAR19, the nation’s first indigenously developed CAR-T cell therapy, created through a groundbreaking collaboration between IIT Bombay, Tata Memorial Centre, and ImmunoACT. This cutting-edge innovation offers a highly effective, next-generation treatment for blood cancers, bringing hope to thousands of patients. Designed to be affordable and accessible, NexCAR19 marks a critical step towards self-reliance in oncology care, reducing dependence on expensive imported therapies and strengthening India’s position in advanced cancer treatment and biotechnology research.

    2. Quad Cancer Moonshot Initiative

    In Sep 2024, India, in partnership with the US, Australia, and Japan, has launched the Quad Cancer Moonshot to eliminate cervical cancer across the Indo-Pacific region. This initiative aims to scale up screening and vaccination programs, advance cutting-edge research, and strengthen global collaboration to ensure early detection, effective treatment, and improved survival rates.

    3. Expansion of ACTREC

    In January 2025, the Advanced Centre for Treatment, Research, and Education in Cancer (ACTREC), a key arm of Tata Memorial Centre (TMC), embarked on a major expansion to revolutionize cancer research, treatment, and patient care. This initiative aims to accelerate clinical breakthroughs, enhance oncology care, and establish cutting-edge therapeutic facilities, reinforcing India’s leadership in advanced cancer treatment and innovation.

    Awareness Generation

    The Indian government is working to raise awareness about cancer prevention and treatment in several ways:

    1. Community Awareness – Preventive aspect of Cancer is strengthened under Comprehensive Primary Health Care through Ayushman Aarogya Mandir by promotion of wellness activities and targeted communication at the community level.
    2. Media Campaigns – Print, electronic and social media are used to increase public awareness. Healthy lifestyle is promoted through observation of National Cancer Awareness Day and World Cancer Day.               
    3. Government Support – The National Programme for Non-Communicable Diseases (NP-NCD) provides funds to states for awareness programs under the National Health Mission (NHM).
    4. Healthy Eating Promotion – The Eat Right India campaign by the Food Safety and Standards Authority of India (FSSAI) encourages nutritious food choices.
    5. Fitness Initiatives – The Fit India Movement by the Ministry of Youth Affairs and Sports promotes physical activity, while the Ministry of AYUSH conducts yoga programs for better health.

    These efforts aim to educate people on leading a healthy lifestyle, preventing cancer, and seeking timely medical care.

    Conclusion

    India has made significant strides in cancer prevention, treatment, and research through policy reforms, expanded healthcare infrastructure, and financial assistance schemes. The Union Budget 2025-26 emphasizes strengthening cancer care with initiatives like Day Care Cancer Centres and customs duty exemptions on life-saving drugs. Programs such as NPCDCS, PMJAY, and HMCPF ensure affordable treatment and early detection, while research initiatives like NexCAR19 and the National Cancer Grid are advancing oncology care.  Despite progress, challenges remain in equitable access, early detection, and rising cancer cases. Greater investment in awareness, lifestyle interventions, and technology-driven solutions is crucial. With a multi-sectoral approach and sustained government efforts, India aims to build a comprehensive and inclusive cancer care system, improving patient outcomes nationwide.

    References

    Kindly find the pdf file 

    ***

    Santosh Kumar/ Sarla Meena / Vatsla Srivastava

    (Release ID: 2102729) Visitor Counter : 40

    MIL OSI Asia Pacific News –

  • MIL-OSI Asia-Pac: “Specific plans/projects in North Eastern Region”

    Source: Government of India (2)

    Posted On: 13 FEB 2025 2:02PM by PIB Delhi

    The Government of India is implementing various flagship and other schemes for the development of the North Eastern Region through the respective Line Ministries/Departments.

    Under 10% GBS, an expenditure of Rs.5.74 lakh crores has been incurred by these Central Ministries/Departments since financial year 2014-15, the year–wise details are at Annexure-I.

    The Ministry of DoNER is also implementing five schemes under which development projects are posed by the  State Governments of NER as well as by the Central Ministries/Agencies for implementation in the region. The timeline for the implementation of projects sanctioned under the schemes varies from project to project depending on the sector, geographical location, cost etc. The list of the schemes of MDoNER, the budget outlay and the sectors covered under these schemes are at Annexure- II.

    This information was given by the Minister of State of the Ministry of Development of North Eastern Region Dr. Sukanta Majumdar in a written reply to a question in Rajya Sabha today.

    *****

    Samrat/Dheeraj/Allen: donerpib[at]gmail[dot]com 

     

    Annexure-I

    Year-wise summary of allocation and utilization of budgets under 10% GBS (2014-15 to 2024-25)

    (Figures in Rs. Crore)

    Sl.

    Financial Year

    Budget Estimate (BE)*

    Revised Estimate (RE)

    Actual Expenditure (AE)

    1

    2014-15

    36,108

    27,359

    24,819

    2

    2015-16

    29,088

    29,669

    28,674

    3

    2016-17

    29,125

    32,180

    29,368

    4

    2017-18

    43,245

    40,972

    39,753

    5

    2018-19

    47,995

    47,088

    46,055

    6

    2019-20

    59,370

    53,374

    48,534

    7

    2020-21

    60,112

    51,271

    48,564

    8

    2021-22

    68,020

    68,440

    70,874

    9

    2022-23

    76,040

    72,540

    82,690

    10

    2023-24

    94,680

    91,802

    1,02,749

    11

    2024-25

    100893.23

    87735.96

    52357.74

     

    Total

    6,44,676

    6,02,431

    5,74,438

    ****

     

    Annexure- II

    List of the schemes of MDoNER, the budget outlay and the sectors covered

    S.No.

    Scheme

    Outlay for sanction of new projects till 31.03.2026

    RE for 2024-25

    Sectors

    1

    PM-DevINE

    6600.0

    1394
    • Agriculture & Allied
    • Livelihood
    • Education
    • Healthcare
    • Irrigation, Flood Control & Watershed Management
    • Tourism & Culture
    • Science and Technology
    • Information, Public Relation and Culture
    • Industries
    • Power
    • Water supply
    • Civil Aviation Infrastructure
    • Telecommunication
    • Sports

    2

    NESIDS(Roads)

    2718.00

    850

    3

    NESIDS(OTRI)

    3795.91

    650
    • Primary and Secondary Education
    • Primary and Secondary Healthcare
    • Industries
    • Power
    • Water supply
    • Civil Aviation Infrastructure
    • Telecommunication
    • Sports

    4

    Schemes of NEC

    1978.77

    800
    • Agriculture & Allied
    • Livelihood
    • Higher Education
    • Tertiary Healthcare
    • Irrigation, Flood Control & Watershed Management
    • Tourism & Culture
    • Science and Technology
    • Information, Public Relation and Culture

    5

    Special Packages

    1250.0

    202

    As per Memorandum of Settlement of Government of India with the Territorial Councils

    ****

    (Release ID: 2102675) Visitor Counter : 16

    MIL OSI Asia Pacific News –

  • MIL-OSI Asia-Pac: Collaboration between India and Indonesia milestone for quality assurance in Traditional Medicine: Shri Prataprao Jadhav, Union Minister of State (IC) Ministry of Ayush

    Source: Government of India (2)

    Posted On: 13 FEB 2025 1:51PM by PIB Delhi

    The Prime Minister of India, Shri Narendra Modi and the President of Indonesia, Mr. Prabowo Subianto witnessed Exchange of Memorandum of Understanding (MoU) between India and Indonesia on January 25, 2025 at Hyderabad House, in New Delhi. One of the MoU exchanged between India and Indonesia is in the Field of Traditional Medicine Quality Assurance between Pharmacopoeia Commission for Indian Medicine & Homeopathy, Ministry of Ayush and Indonesian Food and Drug Authority.

    Highlighting the importance of the MoU exchanged between India and Indonesia in the Field of Traditional Medicine Quality Assurance between Pharmacopoeia Commission for Indian Medicine & Homeopathy, Ministry of Ayush and Indonesian Food and Drug Authority on 25.01.2025, the Union Minister of State (Independent Charge), Ministry of Ayush, Shri Prataprao Jadhav said that the MoU is set to elevate global standards.

    PM Shri Narendra Modi and the President of Indonesia, Mr. Prabowo Subianto witnessing the Exchange of MoUs between India and Indonesia at Hyderabad House, in New Delhi, on January 25, 2025

    Further highlighting the significance of the MoU, the Shri Prataprao Jadhav stated “This collaboration will play a crucial role in ensuring the safety, efficacy, and quality of traditional medicines, setting the stage for a more integrated and scientifically-regulated approach to this valuable healthcare system.”

    Underlining the key features of the MoU, Secretary, Ministry of Ayush, Vaidya Rajesh Kotecha stated, “Through this strategic collaboration, we are fostering greater knowledge exchange, capacity building, and strengthening the role of traditional medicine in global healthcare. Pharmacopoeia Commission for Indian Medicine & Homeopathy (PCIM&H) is an IS/ISO 9001:2015 certified institution for Quality Management Systems (QMS) dedicated to establishing and maintaining standards for Indian medicine and homoeopathy. This partnership between the premier institutions will significantly benefit all stakeholders.

    This strategic partnership focuses on fostering collaboration in traditional medicine quality assurance, with both parties committing to various forms of cooperation. Key provisions of the MoU include:

    • Exchange of information and expertise on regulatory provisions for traditional medicine.

    • Capacity-building initiatives such as seminars, workshops, and training programs aimed at enhancing professional knowledge and skills.

    • Technical visits to facilitate familiarisation with the regulatory processes of both countries.

    • Joint participation in international events related to traditional medicine.

    • Collaboration on joint training programs for industries or entities involved in the traditional medicine sector.

    • Expansion of cooperation into other mutually agreed areas.

    This collaboration reflects the growing global recognition of traditional medicine’s importance in healthcare and wellness. With its deep-rooted cultural and medicinal heritage, India and Indonesia are committed to advancing the standards and quality of traditional medicine.

    The MoU also signifies a shared vision for ensuring the safety, efficacy, and accessibility of traditional medicine, paving the way for further collaboration between India and Indonesia and setting an example for other nations in embracing the integration of traditional systems of medicine within modern healthcare frameworks.

    Notably, the MoU exchanged on 25.01.2025 in the presence of the Prime Minister of India and the President of Indonesia by the Minister of External Affairs, Government of India, and the Ministry of External Affairs, Republic of Indonesia, marks a historic milestone in the bilateral relations between the two nations.

    This partnership between India and Indonesia highlights the importance of both nations working together to preserve and innovate within their rich medicinal traditions, contributing to the growing recognition and acceptance of traditional medicine globally.

    ****

    MV/AKS

    (Release ID: 2102672) Visitor Counter : 100

    MIL OSI Asia Pacific News –

  • MIL-OSI Europe: Minutes – Wednesday, 12 February 2025 – Strasbourg – Final edition

    Source: European Parliament

    PV-10-2025-02-12

    EN

    EN

    iPlPv_Sit

    Minutes
    Wednesday, 12 February 2025 – Strasbourg

    IN THE CHAIR: Roberta METSOLA
    President

    1. Opening of the sitting

    The sitting opened at 09:04.


    2. Negotiations ahead of Parliament’s first reading (Rule 72) (action taken)

    The decision of the AFET and BUDG committees to enter into interinstitutional negotiations had been announced on 10 February 2025 (minutes of 10.2.2025, item 7).

    As no request for a vote pursuant to Rule 72(2) had been made, the committees responsible had been able to enter into negotiations upon expiry of the deadline.


    3. Commission Work Programme 2025 (debate)

    Commission statement: Commission Work Programme 2025 (2025/2500(RSP))

    The President gave explanations on the conduct of the debate, as a new format was being tested.

    The following spoke: Gerben-Jan Gerbrandy, on the presence of the Commission at the debate.

    Maroš Šefčovič (Member of the Commission) made the statement.

    The following spoke: Jeroen Lenaers, on behalf of the PPE Group, Iratxe García Pérez, on behalf of the S&D Group, Jordan Bardella, on behalf of the PfE Group, Nicola Procaccini, on behalf of the ECR Group, Valérie Hayer, on behalf of the Renew Group, Bas Eickhout, on behalf of the Verts/ALE Group, Martin Schirdewan, on behalf of The Left Group, René Aust, on behalf of the ESN Group, Tomas Tobé, Camilla Laureti, Sebastiaan Stöteler, who also answered a blue-card question from Gerben-Jan Gerbrandy, Patryk Jaki, who also answered a blue-card question from Yvan Verougstraete, Billy Kelleher, Kira Marie Peter-Hansen, who also answered a blue-card question from Tomáš Zdechovský, Pasquale Tridico, Christine Anderson, Kateřina Konečná, who also answered a blue-card question from Tomáš Zdechovský, Dolors Montserrat, Mohammed Chahim, Tamás Deutsch, who also answered a blue-card question from Martin Hojsík, Lídia Pereira, who also answered a blue-card question from João Oliveira, Gabriele Bischoff, Charlie Weimers, who also answered a blue-card question from Petras Gražulis, Gerben-Jan Gerbrandy, who also answered a blue-card question from Sander Smit, Željana Zovko, Damian Boeselager, Andrey Novakov, Yannis Maniatis, Jorge Buxadé Villalba, Adrian-George Axinia, Gordan Bosanac, Tomislav Sokol, Ana Catarina Mendes, Irene Montero, Monika Beňová, Lena Düpont, Alex Agius Saliba, Karlo Ressler, Paolo Borchia, Assita Kanko, Martin Hojsík, Angelika Niebler, Anna Bryłka, Zsuzsanna Borvendég, Elissavet Vozemberg-Vrionidi, Heléne Fritzon, Harald Vilimsky, Beata Szydło, Paulo Cunha, who also answered a blue-card question from João Oliveira, Mario Mantovani, Hannah Neumann, Li Andersson, Thomas Geisel, Nikolina Brnjac, Kathleen Van Brempt, Gilles Pennelle, Ioan-Rareş Bogdan and Marion Maréchal.

    The following spoke under the catch-the-eye procedure: Michał Wawrykiewicz, Juan Fernando López Aguilar, Sebastian Tynkkynen, Hilde Vautmans, Tilly Metz, Lynn Boylan, Lukas Sieper, Sunčana Glavak, Maria Grapini, Bert-Jan Ruissen, Seán Kelly, Vytenis Povilas Andriukaitis, Thomas Bajada, Cristina Maestre and Jean-Marc Germain.

    The following spoke: Maroš Šefčovič.

    The following spoke: Jeroen Lenaers, who referred to the presence of the Commission at the debate.

    The debate closed.


    4. One year after the murder of Alexei Navalny and the continued repression of the democratic opposition in Russia (debate)

    Statements by Parliament: One year after the murder of Alexei Navalny and the continued repression of the democratic opposition in Russia (2024/2526(RSP))

    The President made an introductory address.

    The following spoke: Sandra Kalniete, on behalf of the PPE Group, Andreas Schieder, on behalf of the S&D Group, Pierre-Romain Thionnet, on behalf of the PfE Group, Nicola Procaccini, on behalf of the ECR Group, Bernard Guetta, on behalf of the Renew Group, Sergey Lagodinsky, on behalf of the Verts/ALE Group, Martin Schirdewan, on behalf of The Left Group, and Petar Volgin, on behalf of the ESN Group.

    The debate closed.

    (The sitting was suspended for a few moments.)


    IN THE CHAIR: Sophie WILMÈS
    Vice-President

    5. Resumption of the sitting

    The sitting resumed at 12:05.


    6. Voting time

    For detailed results of the votes, see also ‘Results of votes’ and ‘Results of roll-call votes’.


    6.1. VAT: rules for the digital age * (vote)

    Report on the draft Council directive amending Directive 2006/112/EC as regards VAT rules for the digital age [15159/2024 – C10-0170/2024 – 2022/0407(CNS)] – Committee on Economic and Monetary Affairs. Rapporteur: Ľudovít Ódor (A10-0001/2025)

    (Majority of the votes cast)

    COUNCIL DRAFT

    Approved by single vote (P10_TA(2025)0012)

    The following had spoken:

    Before the vote, Ľudovít Ódor (rapporteur) to make a statement on the basis of Rule 165(4).

    (‘Results of votes’, item 1)


    6.2. Administrative cooperation in the field of taxation * (vote)

    Report on the proposal for a Council directive amending Directive 2011/16/EU on administrative cooperation in the field of taxation [COM(2024)0497 – C10-0169/2024 – 2024/0276(CNS)] – Committee on Economic and Monetary Affairs. Rapporteur: Aurore Lalucq (A10-0002/2025)

    (Majority of the votes cast)

    COMMISSION PROPOSAL AU CONSEIL

    Approved by single vote (P10_TA(2025)0013)

    (‘Results of votes’, item 2)


    6.3. Objection pursuant to Rule 115(2) and (3): Genetically modified maize DP910521 (vote)

    Motion for a resolution tabled by the ENVI Committee, in accordance with Rule 115(2) and 115(3), (B10-0061/2025) – Members responsible: Martin Häusling, Biljana Borzan, Anja Hazekamp

    (Majority of the votes cast)

    MOTION FOR A RESOLUTION

    Adopted (P10_TA(2025)0014)

    (‘Results of votes’, item 3)


    6.4. Objection pursuant to Rule 115(2) and (3): Genetically modified maize MON 95275 (vote)

    Motion for a resolution tabled by the ENVI Committee, in accordance with Rule 115(2) and 115(3), on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 95275 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (D102172/03 – 2024/3011(RSP)) (B10-0060/2025) – Members responsible: Martin Häusling, Biljana Borzan, Anja Hazekamp

    (Majority of the votes cast)

    MOTION FOR A RESOLUTION

    Adopted (P10_TA(2025)0015)

    (‘Results of votes’, item 4)

    (The sitting was suspended at 12:11.)


    IN THE CHAIR: Martin HOJSÍK
    Vice-President

    7. Resumption of the sitting

    The sitting resumed at 12:15.


    8. Approval of the minutes of the previous sitting

    The minutes of the previous sitting were approved.


    9. Collaboration between conservatives and the far right as a threat to competitiveness in the EU (topical debate)

    The following spoke: René Repasi to open the debate proposed by the S&D Group.

    The following spoke: Adam Szłapka (President-in-Office of the Council) and Stéphane Séjourné (Executive Vice-President of the Commission).

    The following spoke: Daniel Caspary, on behalf of the PPE Group, Javi López, on behalf of the S&D Group, António Tânger Corrêa, on behalf of the PfE Group, Carlo Fidanza, on behalf of the ECR Group, Billy Kelleher, on behalf of the Renew Group, Daniel Freund, on behalf of the Verts/ALE Group, Martin Schirdewan, on behalf of The Left Group, Ivan David, on behalf of the ESN Group, Lukas Mandl, Heléne Fritzon, Klara Dostalova, Jadwiga Wiśniewska, Sandro Gozi, Maria Ohisalo, Marina Mesure, Markus Buchheit, Lukas Sieper, Angelika Niebler, Katarina Barley, Anders Vistisen, Charlie Weimers, Charles Goerens, Thomas Waitz, Jussi Saramo, Erik Kaliňák, Alma Ezcurra Almansa, Mohammed Chahim, Paolo Borchia, Assita Kanko, Moritz Körner, Reinier Van Lanschot, Luis-Vicențiu Lazarus, Riho Terras, Alessandra Moretti, Ondřej Knotek, Stefano Cavedagna, Anna Stürgkh, Majdouline Sbai, François-Xavier Bellamy, Andreas Schieder, Jorge Buxadé Villalba, Cristian Terheş, Stefan Berger, Vasile Dîncu, Afroditi Latinopoulou, Thomas Pellerin-Carlin, Csaba Dömötör, Estelle Ceulemans, Jean-Paul Garraud, Tiemo Wölken and Marc Angel.

    The following spoke: Stéphane Séjourné and Adam Szłapka.

    The debate closed.


    10. Competitiveness Compass (debate)

    Council and Commission statements: Competitiveness Compass (2025/2531(RSP))

    Adam Szłapka (President-in-Office of the Council) and Stéphane Séjourné (Executive Vice-President of the Commission) made the statements.

    The following spoke: Christian Ehler, on behalf of the PPE Group.

    IN THE CHAIR: Roberts ZĪLE
    Vice-President

    The following spoke: Mohammed Chahim, on behalf of the S&D Group, Tom Vandendriessche, on behalf of the PfE Group, Johan Van Overtveldt, on behalf of the ECR Group, Morten Løkkegaard, on behalf of the Renew Group, Marie Toussaint, on behalf of the Verts/ALE Group, Hanna Gedin, on behalf of The Left Group, Sarah Knafo, on behalf of the ESN Group, Markus Ferber, Gabriele Bischoff, who also answered a blue-card question from Bogdan Rzońca, Anders Vistisen, Piotr Müller, João Cotrim De Figueiredo, Ville Niinistö, Anthony Smith, Lefteris Nikolaou-Alavanos, Peter Liese, Alex Agius Saliba, Julie Rechagneux, who also answered a blue-card question from Anthony Smith, Elena Donazzan, Pascal Canfin, Sara Matthieu, Per Clausen, who also answered a blue-card question from Jadwiga Wiśniewska, Andreas Schwab, Irene Tinagli, who also answered a blue-card question from Diana Iovanovici Şoşoacă, András Gyürk, Gheorghe Piperea, Svenja Hahn, João Oliveira, Lídia Pereira, Aurore Lalucq, Jana Nagyová, Giovanni Crosetto, Anna-Maja Henriksson, Rudi Kennes, Massimiliano Salini, Ana Catarina Mendes, who also answered blue-card questions from João Oliveira and Lídia Pereira, Margarita de la Pisa Carrión, who also answered a blue-card question from Dario Nardella, Kosma Złotowski, Anna Stürgkh, Fernando Navarrete Rojas, Estelle Ceulemans, Sebastian Kruis, Dick Erixon, Jeannette Baljeu, Jens Gieseke, Jonás Fernández, Tomasz Buczek, Antonella Sberna, Oihane Agirregoitia Martínez, Tom Berendsen, Laura Ballarín Cereza, Pascale Piera, Nora Junco García, Cynthia Ní Mhurchú, Pilar del Castillo Vera, Dario Nardella, Ľudovít Ódor, Eszter Lakos and Carla Tavares.

    IN THE CHAIR: Christel SCHALDEMOSE
    Vice-President

    The following spoke: Virgil-Daniel Popescu, Lara Wolters, Jessica Polfjärd, Delara Burkhardt, Eero Heinäluoma, Victor Negrescu and Marcos Ros Sempere.

    The following spoke under the catch-the-eye procedure: Hélder Sousa Silva, Nina Carberry, Maria Zacharia, Maria Grapini and Sebastian Tynkkynen.

    The following spoke: Stéphane Séjourné and Adam Szłapka.

    The debate closed.


    11. Composition of committees and delegations

    The ECR Group had notified the President of the following decisions changing the composition of the committees and delegations:

    – ITRE Committee: Diego Solier to replace Carlo Ciccioli

    – PETI Committee: Chiara Gemma

    The decisions took effect as of that day.


    12. Need for targeted support to EU regions bordering Russia, Belarus and Ukraine (debate)

    Council and Commission statements: Need for targeted support to EU regions bordering Russia, Belarus and Ukraine (2025/2532(RSP))

    Adam Szłapka (President-in-Office of the Council) and Raffaele Fitto (Executive Vice-President of the Commission) made the statements.

    The following spoke: Andrzej Halicki, on behalf of the PPE Group, Marcos Ros Sempere, on behalf of the S&D Group, Sebastian Tynkkynen, on behalf of the ECR Group, Ľubica Karvašová, on behalf of the Renew Group, Mārtiņš Staķis, on behalf of the Verts/ALE Group, Marcin Sypniewski, on behalf of the ESN Group, Ioan-Rareş Bogdan, Marina Kaljurand, Tobiasz Bocheński, Elsi Katainen, Michael von der Schulenburg, Andrey Novakov, Eero Heinäluoma, Georgiana Teodorescu, Eugen Tomac, Mika Aaltola, Carla Tavares, Aurelijus Veryga, Petras Auštrevičius, Riho Terras, Reinis Pozņaks, Christophe Gomart and Maciej Wąsik.

    The following spoke under the catch-the-eye procedure: Seán Kelly, Juan Fernando López Aguilar, Liudas Mažylis, Vilija Blinkevičiūtė and Diana Iovanovici Şoşoacă.

    The following spoke: Raffaele Fitto and Adam Szłapka.

    The debate closed.


    13. US withdrawal from the Paris Climate Agreement and the World Health Organisation, and the suspension of US development and humanitarian aid (debate)

    Commission statement: US withdrawal from the Paris Climate Agreement and the World Health Organisation, and the suspension of US development and humanitarian aid (2025/2527(RSP))

    Hadja Lahbib (Member of the Commission) made the statement.

    The following spoke: Michał Szczerba, on behalf of the PPE Group, Mohammed Chahim, on behalf of the S&D Group, Ondřej Knotek, on behalf of the PfE Group, Alexandr Vondra, on behalf of the ECR Group, Barry Andrews, on behalf of the Renew Group, Michael Bloss, on behalf of the Verts/ALE Group, Jonas Sjöstedt, on behalf of The Left Group, Christine Anderson, on behalf of the ESN Group, Udo Bullmann, who also declined to take a blue-card question from Alexander Sell, António Tânger Corrêa, Anna Zalewska, Dan Barna, Ignazio Roberto Marino, Isabel Serra Sánchez, Alexander Sell, Ondřej Dostál, Tomislav Sokol, Vytenis Povilas Andriukaitis, Gerolf Annemans, Francesco Torselli, Charles Goerens, Lena Schilling, Marc Botenga, Anja Arndt, David McAllister, Tiemo Wölken, who also answered a blue-card question from Alexander Sell, Julien Sanchez, Laurence Trochu, Sigrid Friis and Isabella Lövin.

    IN THE CHAIR: Antonella SBERNA
    Vice-President

    The following spoke: Catarina Martins, who also answered a blue-card question from Diana Iovanovici Şoşoacă, Stanislav Stoyanov, Radan Kanev, Nicola Zingaretti, Juan Carlos Girauta Vidal, Sergio Berlato, who also answered a blue-card question from Radan Kanev, Michal Wiezik, Rasmus Nordqvist, Valentina Palmisano, Milan Mazurek, Lídia Pereira, Marta Temido, who also answered a blue-card question from João Oliveira, Marieke Ehlers, who also answered a blue-card question from Nicolae Ştefănuță, Lukas Sieper on some of the remarks made by the previous speaker, Nikolas Farantouris, Sander Smit, who also answered a blue-card question from Anna Strolenberg, Antonio Decaro, Hermann Tertsch, Murielle Laurent, Roman Haider, Leire Pajín, Virginie Joron, Heléne Fritzon, Gerald Hauser, Robert Biedroń, Anne-Sophie Frigout and Aleksandar Nikolic.

    The following spoke under the catch-the-eye procedure: Seán Kelly, Marit Maij, Alexander Jungbluth, Lukas Sieper, Nikolina Brnjac and Michał Wawrykiewicz.

    The following spoke: Hadja Lahbib.

    The debate closed.


    14. Honouring the memory of Ján Kuciak and Martina Kušnírová: advancing media freedom, strengthening the rule of law and protecting journalists across the EU (debate)

    Commission statement: Honouring the memory of Ján Kuciak and Martina Kušnírová: advancing media freedom, strengthening the rule of law and protecting journalists across the EU (2025/2556(RSP))

    Michael McGrath (Member of the Commission) made the statement.

    The following spoke: Miriam Lexmann, on behalf of the PPE Group, Ana Catarina Mendes, on behalf of the S&D Group, Juan Carlos Girauta Vidal, on behalf of the PfE Group, Małgorzata Gosiewska, on behalf of the ECR Group, Veronika Cifrová Ostrihoňová, on behalf of the Renew Group, Tineke Strik, on behalf of the Verts/ALE Group, Konstantinos Arvanitis, on behalf of The Left Group, Milan Uhrík, on behalf of the ESN Group, David Casa, Emma Rafowicz, Irena Joveva, Katarína Roth Neveďalová, Magdalena Adamowicz, Sophie Wilmès, Hristo Petrov and Laurence Farreng.

    IN THE CHAIR: Esteban GONZÁLEZ PONS
    Vice-President

    The following spoke under the catch-the-eye procedure: Juan Fernando López Aguilar, Maria Zacharia and Lukas Sieper.

    The following spoke: Michael McGrath.

    The debate closed.


    15. Debate on cases of breaches of human rights, democracy and the rule of law (debate)

    (For the titles and authors of the motions for resolutions, see minutes of 12.2.2025, item I.)


    15.1. Recent dismissals and arrests of mayors in Türkiye

    Motions for resolutions B10-0100/2025, B10-0103/2025, B10-0110/2025, B10-0115/2025, B10-0119/2025, B10-0121/2025 and B10-0124/2025 (2025/2546(RSP))

    Michalis Hadjipantela, Evin Incir, Malik Azmani, Vladimir Prebilič, Isabel Serra Sánchez and Sebastiaan Stöteler introduced their groups’ motions for resolutions.

    The following spoke: Reinhold Lopatka, on behalf of the PPE Group, Nacho Sánchez Amor, on behalf of the S&D Group, Arkadiusz Mularczyk, on behalf of the ECR Group, Mélissa Camara, on behalf of the Verts/ALE Group, Giorgos Georgiou, on behalf of The Left Group, Nikos Papandreou and Per Clausen.

    The following spoke under the catch-the-eye procedure: Geadis Geadi and Maria Zacharia.

    The following spoke: Glenn Micallef (Member of the Commission).

    The debate closed.

    Vote: 13 February 2025.


    15.2. Repression by the Ortega-Murillo regime in Nicaragua, targeting human rights defenders, political opponents and religious communities in particular

    Motions for resolutions B10-0126/2025, B10-0128/2025, B10-0130/2025, B10-0131/2025, B10-0132/2025, B10-0134/2025 and B10-0135/2025 (2025/2547(RSP))

    Željana Zovko, Leire Pajín, Carlo Fidanza, Oihane Agirregoitia Martínez, Diana Riba i Giner and Tomasz Froelich introduced their groups’ motions for resolutions.

    The following spoke: Antonio López-Istúriz White, on behalf of the PPE Group, Francisco Assis, on behalf of the S&D Group, Davor Ivo Stier, Gabriel Mato and Francisco José Millán Mon.

    The following spoke: Glenn Micallef (Member of the Commission).

    The debate closed.

    Vote: 13 February 2025.


    15.3. Continuing detention and risk of the death penalty for individuals in Nigeria charged with blasphemy, notably the case of Yahaya Sharif-Aminu

    Motions for resolutions B10-0101/2025, B10-0104/2025, B10-0111/2025, B10-0113/2025, B10-0117/2025, B10-0120/2025, B10-0122/2025 and B10-0123/2025 (2025/2548(RSP))

    Miriam Lexmann, Hannes Heide, Bert-Jan Ruissen, Catarina Vieira, Merja Kyllönen, Susanna Ceccardi and Tomasz Froelich introduced their groups’ motions for resolutions.

    The following spoke: Arkadiusz Mularczyk, on behalf of the ECR Group.

    The following spoke: Glenn Micallef (Member of the Commission).

    The debate closed.

    Vote: 13 February 2025.


    16. Silent crisis: the mental health of Europe’s youth (debate)

    Commission statement: Silent crisis: the mental health of Europe’s youth (2025/2552(RSP))

    Glenn Micallef (Member of the Commission) made the statement.

    The following spoke: Tomislav Sokol, on behalf of the PPE Group, Alex Agius Saliba, on behalf of the S&D Group, Aurelijus Veryga, on behalf of the ECR Group, Veronika Cifrová Ostrihoňová, on behalf of the Renew Group, Ignazio Roberto Marino, on behalf of the Verts/ALE Group, Catarina Martins, on behalf of The Left Group, Milan Mazurek, on behalf of the ESN Group, Adam Jarubas, Nikos Papandreou, Michele Picaro and Nicolae Ştefănuță.

    IN THE CHAIR: Victor NEGRESCU
    Vice-President

    The following spoke: Emma Fourreau, Alvise Pérez, András Tivadar Kulja, Romana Jerković, Kim Van Sparrentak, Elena Nevado del Campo, Nicolás González Casares, Peter Agius, Maria Walsh and Jessika Van Leeuwen.

    The following spoke under the catch-the-eye procedure: Martine Kemp, Ana Miranda Paz, João Oliveira and Sunčana Glavak.

    The following spoke: Glenn Micallef.

    The debate closed.


    17. Explanations of vote

    Written explanations of vote

    Explanations of vote submitted in writing under Rule 201 appear on the Members’ pages on Parliament’s website.


    18. Agenda of the next sitting

    The next sitting would be held the following day, 13 February 2025, starting at 09:00. The agenda was available on Parliament’s website.


    19. Approval of the minutes of the sitting

    In accordance with Rule 208(3), the minutes of the sitting would be put to the House for approval at the beginning of the afternoon of the next sitting.


    20. Closure of the sitting

    The sitting closed at 21:26.


    LIST OF DOCUMENTS SERVING AS A BASIS FOR THE DEBATES AND DECISIONS OF PARLIAMENT


    I. Motions for resolutions tabled

    Recent dismissals and arrests of mayors in Türkiye

    The following Members or political groups had requested that a debate be held, in accordance with Rule 150, on the following motions for resolutions:

    on the recent dismissals and arrests of mayors in Türkiye (B10-0100/2025)
    Isabel Serra Sánchez, Özlem Demirel
    on behalf of The Left Group

    on the recent dismissals and arrests of mayors in Türkiye (B10-0103/2025)
    Vladimir Prebilič, Mélissa Camara, Mounir Satouri, Vicent Marzà Ibáñez, Catarina Vieira, Maria Ohisalo, Erik Marquardt, Nicolae Ştefănuță, Ville Niinistö, Villy Søvndal
    on behalf of the Verts/ALE Group

    on the recent dismissals and arrests of mayors in Türkiye (B10-0110/2025)
    Malik Azmani, Oihane Agirregoitia Martínez, Petras Auštrevičius, Dan Barna, Benoit Cassart, Olivier Chastel, Veronika Cifrová Ostrihoňová, Karin Karlsbro, Ľubica Karvašová, Jan-Christoph Oetjen, Marie-Agnes Strack-Zimmermann, Hilde Vautmans, Sophie Wilmès, Lucia Yar
    on behalf of the Renew Group

    on the recent dismissals and arrests of mayors in Türkiye (B10-0115/2025)
    Sebastiaan Stöteler, Marieke Ehlers, Jaroslav Bžoch, Roberto Vannacci, Susanna Ceccardi
    on behalf of the PfE Group

    on the recent dismissals and arrests of mayors in Türkiye (B10-0119/2025)
    Yannis Maniatis, Francisco Assis, Nacho Sánchez Amor, Evin Incir, Nikos Papandreou, Pina Picierno
    on behalf of the S&D Group

    on the recent dismissals and arrests of mayors in Türkiye (B10-0121/2025)
    Sebastião Bugalho, Vangelis Meimarakis, Željana Zovko, Wouter Beke, Antonio López Istúriz White, Isabel Wiseler Lima, Ingeborg Ter Laak, Tomáš Zdechovský, Mirosława Nykiel, Jessica Polfjärd, Luděk Niedermayer, Jan Farský, Inese Vaidere
    on behalf of the PPE Group

    on the recent dismissals and arrests of mayors in Türkiye (B10-0124/2025)
    Joachim Stanisław Brudziński, Sebastian Tynkkynen, Małgorzata Gosiewska, Waldemar Tomaszewski, Veronika Vrecionová, Ondřej Krutílek, Assita Kanko, Alexandr Vondra
    on behalf of the ECR Group

    Repression by the Ortega-Murillo regime in Nicaragua, targeting human rights defenders, political opponents and religious communities in particular

    The following Members or political groups had requested that a debate be held, in accordance with Rule 150, on the following motions for resolutions:

    on the repression by the Ortega-Murillo regime in Nicaragua, targeting human rights defenders, political opponents and religious communities in particular (B10-0126/2025)
    Sebastião Bugalho, Željana Zovko, Antonio López-Istúriz White, Gabriel Mato, David McAllister, Vangelis Meimarakis, Wouter Beke, Isabel Wiseler-Lima, Ingeborg Ter Laak, Tomáš Zdechovský, Mirosława Nykiel, Jessica Polfjärd, Luděk Niedermayer, Jan Farský, Andrey Kovatchev, Inese Vaidere
    on behalf of the PPE Group

    on the repression by the Ortega-Murillo regime in Nicaragua, targeting human rights defenders, political opponents and religious communities in particular (B10-0128/2025)
    Diana Riba i Giner, Catarina Vieira, Maria Ohisalo, Nicolae Ştefănuță, Ville Niinistö
    on behalf of the Verts/ALE Group

    on the repression by the Ortega-Murillo regime in Nicaragua, targeting human rights defenders, political opponents and religious communities in particular (B10-0130/2025)
    Tomasz Froelich
    on behalf of the ESN Group

    on the repression by the Ortega-Murillo regime in Nicaragua, targeting human rights defenders, political opponents and religious communities in particular (B10-0131/2025)
    Bernard Guetta, Oihane Agirregoitia Martínez, Petras Auštrevičius, Malik Azmani, Dan Barna, Benoit Cassart, Olivier Chastel, Engin Eroglu, Karin Karlsbro, Ľubica Karvašová, Ilhan Kyuchyuk, Urmas Paet, Marie-Agnes Strack-Zimmermann, Hilde Vautmans, Lucia Yar
    on behalf of the Renew Group

    on the repression by the Ortega-Murillo regime in Nicaragua, targeting human rights defenders, political opponents and religious communities in particular (B10-0132/2025)
    Hermann Tertsch, Jorge Martín Frías, Gerolf Annemans, Nikola Bartůšek, Roberto Vannacci, Susanna Ceccardi
    on behalf of the PfE Group

    on the repression by the Ortega-Murillo regime in Nicaragua, targeting human rights defenders, political opponents and religious communities in particular (B10-0134/2025)
    Yannis Maniatis, Francisco Assis, Leire Pajín
    on behalf of the S&D Group

    on the repression by the Ortega-Murillo regime in Nicaragua, targeting human rights defenders, political opponents and religious communities in particular (B10-0135/2025)
    Adam Bielan, Jadwiga Wiśniewska, Mariusz Kamiński, Ondřej Krutílek, Veronika Vrecionová, Joachim Stanisław Brudziński, Małgorzata Gosiewska, Waldemar Tomaszewski, Sebastian Tynkkynen, Assita Kanko, Ivaylo Valchev, Alexandr Vondra, Aurelijus Veryga, Alberico Gambino
    on behalf of the ECR Group

    Continuing detention and risk of the death penalty for individuals in Nigeria charged with blasphemy, notably the case of Yahaya Sharif-Aminu

    The following Members or political groups had requested that a debate be held, in accordance with Rule 150, on the following motions for resolutions:

    on continuing detention and risk of the death penalty for individuals in Nigeria charged with blasphemy, notably the case of Yahaya Sharif-Aminu (B10-0101/2025)
    Merja Kyllönen
    on behalf of The Left Group

    on continuing detention and risk of the death penalty for individuals in Nigeria charged with blasphemy, notably the case of Yahaya Sharif-Aminu (B10-0104/2025)
    Catarina Vieira, Maria Ohisalo, Nicolae Ştefănuță
    on behalf of the Verts/ALE Group

    on continuing detention and risk of the death penalty for individuals in Nigeria charged with blasphemy, notably the case of Yahaya Sharif-Aminu (B10-0111/2025)
    Susanna Ceccardi, Nikola Bartůšek
    on behalf of the PfE Group

    on continuing detention and risk of the death penalty for individuals in Nigeria charged with blasphemy, notably the case of Yahaya Sharif-Aminu (B10-0113/2025)
    Tomasz Froelich
    on behalf of the ESN Group

    on continuing detention and risk of the death penalty for individuals in Nigeria charged with blasphemy, notably the case of Yahaya Sharif-Aminu (B10-0117/2025)
    Jan Christoph Oetjen, Oihane Agirregoitia Martínez, Petras Auštrevičius, Malik Azmani, Dan Barna, Benoit Cassart, Olivier Chastel, Engin Eroglu, Karin Karlsbro, Ilhan Kyuchyuk, Urmas Paet, Marie Agnes Strack Zimmermann, Hilde Vautmans, Lucia Yar
    on behalf of the Renew Group

    on continuing detention and risk of the death penalty for individuals in Nigeria charged with blasphemy, notably the case of Yahaya Sharif-Aminu (B10-0120/2025)
    Yannis Maniatis, Francisco Assis, Hannes Heide
    on behalf of the S&D Group

    on continuing detention and risk of the death penalty for individuals in Nigeria charged with blasphemy, notably the case of Yahaya Sharif-Aminu (B10-0122/2025)
    Sebastião Bugalho, Vangelis Meimarakis, Željana Zovko, Wouter Beke, Isabel Wiseler Lima, Ingeborg Ter Laak, Tomáš Zdechovský, Mirosława Nykiel, Jessica Polfjärd, Luděk Niedermayer, Jan Farský, Inese Vaidere, Andrey Kovatchev
    on behalf of the PPE Group

    on continuing detention and risk of the death penalty for individuals in Nigeria charged with blasphemy, notably the case of Yahaya Sharif-Aminu (B10-0123/2025)
    Bert Jan Ruissen, Jadwiga Wiśniewska, Ondřej Krutílek, Veronika Vrecionová, Bogdan Rzońca, Joachim Stanisław Brudziński, Małgorzata Gosiewska, Waldemar Tomaszewski, Michał Dworczyk, Sebastian Tynkkynen, Assita Kanko, Alexandr Vondra, Alberico Gambino
    on behalf of the ECR Group


    II. Delegated acts (Rule 114(2))

    Draft delegated acts forwarded to Parliament

    – Commission Delegated Regulation supplementing Regulation (EU) 600/2014 of the European Parliament and of the Council as regards OTC derivatives identifying reference data to be used for the purposes of the transparency requirements laid down in Article 8a(2) and Articles 10 and 21 (C(2025)00417 – 2025/2534(DEA))

    Deadline for raising objections: 3 months from the date of receipt of 24 January 2025

    referred to committee responsible: ECON

    – Commission Delegated Regulation amending the regulatory technical standards laid down in Delegated Regulation (EU) 2021/931 as regards the specification of the formula for calculating the supervisory delta of call and put options mapped to the commodity risk category (C(2025)00459 – 2025/2537(DEA))

    Deadline for raising objections: 3 months from the date of receipt of 28 January 2025

    referred to committee responsible: ECON

    – Commission Delegated Regulation amending Delegated Regulation (EU) 2019/624 as regards ante-mortem inspections in slaughterhouses, ante-mortem inspections at the holding of provenance and post-mortem inspections (C(2025)00539 – 2025/2540(DEA))

    Deadline for raising objections: 2 months from the date of receipt of 30 January 2025

    referred to committee responsible: ENVI
    opinion: AGRI

    – Commission Delegated Regulation amending the regulatory technical standards laid down in Delegated Regulation (EU) 2022/2059, Delegated Regulation (EU) 2022/2060 and Delegated Regulation (EU) 2023/1577 as regards the technical details of back-testing and profit and loss attribution requirements, the criteria for assessing the modellability of risk factors, and the treatment of foreign-exchange risk and commodity risk in the non-trading book (C(2025)00595 – 2025/2543(DEA))

    Deadline for raising objections: 3 months from the date of receipt of 3 February 2025

    referred to committee responsible: ECON

    – Commission Delegated Regulation supplementing Directive 2003/87/EC of the European Parliament and of the Council by laying down detailed rules for the yearly calculation of price differences between eligible aviation fuels and fossil kerosene and for the EU ETS allocation of allowances for the use of eligible aviation fuels (C(2025)00681 – 2025/2559(DEA))

    Deadline for raising objections: 2 months from the date of receipt of 6 February 2025

    referred to committee responsible: ENVI
    opinion: ITRE

    – Commission Delegated Regulation amending Regulation (EU) 2023/2053 of the European Parliament and of the Council as regards the management of bluefin tuna in the eastern Atlantic and in the Mediterranean (C(2025)00748 – 2025/2560(DEA))

    Deadline for raising objections: 2 months from the date of receipt of 7 February 2025

    referred to committee responsible: PECH


    III. Implementing measures (Rule 115)

    Draft implementing measures falling under the regulatory procedure with scrutiny forwarded to Parliament

    – Commission Regulation amending Regulation (EU) 2023/1803 as regards International Financial Reporting Standard 9 and International Financial Reporting Standard 7 (Text with EEA relevance) (D103844/01 – 2025/2525(RPS) – deadline: 21 April 2025)
    referred to committee responsible: ECON
    opinion: JURI

    – Commission Regulation amending and correcting Regulation (EU) No 142/2011 as regards certain requirements for the placing on the market and imports of animal by-products and derived products not intended for human consumption (D103880/01 – 2025/2535(RPS) – deadline: 28 April 2025)
    referred to committee responsible: ENVI


    IV. Transfers of appropriations and budgetary decisions

    In accordance with Article 29 of the Financial Regulation, the Committee on Budgets had decided to approve transfer of appropriations No 1/2025 – Section IX – European Data Protection Supervisor.

    In accordance with Article 31(1) of the Financial Regulation, the Committee on Budgets had decided to approve the Commission’s transfer of appropriations DEC 01/2025 – Section III – Commission.

    In accordance with Article 31(6) of the Financial Regulation, the Council of the European Union had decided to approve the Commission’s transfer of appropriations DEC 01/2025 – Section III – Commission.


    ATTENDANCE REGISTER

    Present:

    Aaltola Mika, Abadía Jover Maravillas, Adamowicz Magdalena, Aftias Georgios, Agirregoitia Martínez Oihane, Agius Peter, Agius Saliba Alex, Alexandraki Galato, Allione Grégory, Al-Sahlani Abir, Anadiotis Nikolaos, Anderson Christine, Andersson Li, Andresen Rasmus, Andrews Barry, Andriukaitis Vytenis Povilas, Androuët Mathilde, Angel Marc, Annemans Gerolf, Annunziata Lucia, Antoci Giuseppe, Arias Echeverría Pablo, Arimont Pascal, Arłukowicz Bartosz, Arnaoutoglou Sakis, Arndt Anja, Arvanitis Konstantinos, Asens Llodrà Jaume, Assis Francisco, Attard Daniel, Aubry Manon, Auštrevičius Petras, Axinia Adrian-George, Azmani Malik, Bajada Thomas, Baljeu Jeannette, Ballarín Cereza Laura, Bardella Jordan, Barley Katarina, Barna Dan, Barrena Arza Pernando, Bartulica Stephen Nikola, Bartůšek Nikola, Bausemer Arno, Bay Nicolas, Bay Christophe, Beke Wouter, Beleris Fredis, Bellamy François-Xavier, Benea Adrian-Dragoş, Benifei Brando, Benjumea Benjumea Isabel, Beňová Monika, Bentele Hildegard, Berendsen Tom, Berger Stefan, Berg Sibylle, Berlato Sergio, Bernhuber Alexander, Biedroń Robert, Bielan Adam, Bischoff Gabriele, Blaha Ľuboš, Blinkevičiūtė Vilija, Blom Rachel, Bloss Michael, Bocheński Tobiasz, Boeselager Damian, Bogdan Ioan-Rareş, Bonaccini Stefano, Bonte Barbara, Borchia Paolo, Borrás Pabón Mireia, Borvendég Zsuzsanna, Borzan Biljana, Bosanac Gordan, Bosse Stine, Botenga Marc, Boyer Gilles, Boylan Lynn, Brandstätter Helmut, Brasier-Clain Marie-Luce, Braun Grzegorz, Brejza Krzysztof, Bricmont Saskia, Brnjac Nikolina, Brudziński Joachim Stanisław, Bryłka Anna, Buchheit Markus, Buczek Tomasz, Buda Daniel, Budka Borys, Bugalho Sebastião, Buła Andrzej, Bullmann Udo, Burkhardt Delara, Buxadé Villalba Jorge, Bystron Petr, Bžoch Jaroslav, Camara Mélissa, Canfin Pascal, Carberry Nina, Cârciu Gheorghe, Carême Damien, Casa David, Caspary Daniel, Cassart Benoit, Castillo Laurent, del Castillo Vera Pilar, Cavazzini Anna, Cavedagna Stefano, Ceccardi Susanna, Cepeda José, Ceulemans Estelle, Chahim Mohammed, Chaibi Leila, Chastel Olivier, Chinnici Caterina, Cifrová Ostrihoňová Veronika, Ciriani Alessandro, Cisint Anna Maria, Clausen Per, Cormand David, Corrado Annalisa, Costanzo Vivien, Cotrim De Figueiredo João, Cowen Barry, Cremer Tobias, Crespo Díaz Carmen, Cristea Andi, Crosetto Giovanni, Cunha Paulo, Dahl Henrik, Danielsson Johan, Dauchy Marie, Dávid Dóra, David Ivan, Decaro Antonio, de la Hoz Quintano Raúl, Della Valle Danilo, Deloge Valérie, De Masi Fabio, De Meo Salvatore, Deutsch Tamás, Dibrani Adnan, Diepeveen Ton, Dieringer Elisabeth, Dîncu Vasile, Disdier Mélanie, Dobrev Klára, Doherty Regina, Doleschal Christian, Dömötör Csaba, Do Nascimento Cabral Paulo, Donazzan Elena, Dorfmann Herbert, Dostalova Klara, Dostál Ondřej, Düpont Lena, Dworczyk Michał, Ecke Matthias, Ehler Christian, Ehlers Marieke, Eriksson Sofie, Erixon Dick, Eroglu Engin, Estaràs Ferragut Rosa, Ezcurra Almansa Alma, Falcă Gheorghe, Farantouris Nikolas, Farreng Laurence, Farský Jan, Ferber Markus, Ferenc Viktória, Fernández Jonás, Fidanza Carlo, Firea Gabriela, Firmenich Ruth, Fita Claire, Flanagan Luke Ming, Fourlas Loucas, Fourreau Emma, Fragkos Emmanouil, Freund Daniel, Frigout Anne-Sophie, Friis Sigrid, Fritzon Heléne, Froelich Tomasz, Funchion Kathleen, Furet Angéline, Furore Mario, Gahler Michael, Gál Kinga, Gálvez Lina, Gambino Alberico, García Hermida-Van Der Walle Raquel, Garraud Jean-Paul, Gasiuk-Pihowicz Kamila, Geadi Geadis, Gedin Hanna, Geese Alexandra, Geier Jens, Geisel Thomas, Gemma Chiara, Georgiou Giorgos, Gerbrandy Gerben-Jan, Germain Jean-Marc, Gerzsenyi Gabriella, Geuking Niels, Gieseke Jens, Giménez Larraz Borja, Girauta Vidal Juan Carlos, Glavak Sunčana, Glucksmann Raphaël, Goerens Charles, Gomart Christophe, Gomes Isilda, Gómez López Sandra, Gonçalves Bruno, Gonçalves Sérgio, González Casares Nicolás, González Pons Esteban, Gori Giorgio, Gosiewska Małgorzata, Gotink Dirk, Gozi Sandro, Grapini Maria, Gražulis Petras, Gregorová Markéta, Grims Branko, Griset Catherine, Gronkiewicz-Waltz Hanna, Groothuis Bart, Grossmann Elisabeth, Gualmini Elisabetta, Guarda Cristina, Guetta Bernard, Guzenina Maria, Győri Enikő, Gyürk András, Hadjipantela Michalis, Hahn Svenja, Haider Roman, Halicki Andrzej, Hansen Niels Flemming, Hassan Rima, Hauser Gerald, Häusling Martin, Hava Mircea-Gheorghe, Hazekamp Anja, Heide Hannes, Heinäluoma Eero, Henriksson Anna-Maja, Herbst Niclas, Herranz García Esther, Hetman Krzysztof, Hohlmeier Monika, Hojsík Martin, Holmgren Pär, Hölvényi György, Homs Ginel Alicia, Humberto Sérgio, Ijabs Ivars, Imart Céline, Inselvini Paolo, Iovanovici Şoşoacă Diana, Jaki Patryk, Jalloul Muro Hana, Jamet France, Jarubas Adam, Jerković Romana, Joński Dariusz, Joron Virginie, Jouvet Pierre, Joveva Irena, Juknevičienė Rasa, Junco García Nora, Jungbluth Alexander, Kabilov Taner, Kalfon François, Kaliňák Erik, Kaljurand Marina, Kalniete Sandra, Kamiński Mariusz, Kanev Radan, Kanko Assita, Karlsbro Karin, Kartheiser Fernand, Karvašová Ľubica, Katainen Elsi, Kefalogiannis Emmanouil, Kelleher Billy, Keller Fabienne, Kelly Seán, Kemp Martine, Kennes Rudi, Knafo Sarah, Knotek Ondřej, Kobosko Michał, Köhler Stefan, Kohut Łukasz, Kokalari Arba, Kolář Ondřej, Kollár Kinga, Kols Rihards, Konečná Kateřina, Kopacz Ewa, Körner Moritz, Kountoura Elena, Kovatchev Andrey, Krah Maximilian, Krištopans Vilis, Kruis Sebastian, Krutílek Ondřej, Kubín Tomáš, Kuhnke Alice, Kulja András Tivadar, Kulmuni Katri, Kyllönen Merja, Kyuchyuk Ilhan, Lagodinsky Sergey, Lakos Eszter, Lalucq Aurore, Lange Bernd, Langensiepen Katrin, Laššáková Judita, László András, Latinopoulou Afroditi, Laurent Murielle, Laureti Camilla, Laykova Rada, Lazarov Ilia, Lazarus Luis-Vicențiu, Le Callennec Isabelle, Leggeri Fabrice, Lenaers Jeroen, Lewandowski Janusz, Lexmann Miriam, Liese Peter, Lins Norbert, Løkkegaard Morten, Lopatka Reinhold, López Javi, López Aguilar Juan Fernando, López-Istúriz White Antonio, Lövin Isabella, Luena César, Lupo Giuseppe, McAllister David, Madison Jaak, Maestre Cristina, Magoni Lara, Magyar Péter, Maij Marit, Maląg Marlena, Manda Claudiu, Mandl Lukas, Maniatis Yannis, Mantovani Mario, Maran Pierfrancesco, Marczułajtis-Walczak Jagna, Maréchal Marion, Mariani Thierry, Marino Ignazio Roberto, Marquardt Erik, Martín Frías Jorge, Martins Catarina, Martusciello Fulvio, Mato Gabriel, Matthieu Sara, Mavrides Costas, Mayer Georg, Mazurek Milan, Mažylis Liudas, McNamara Michael, Mebarek Nora, Mehnert Alexandra, Meimarakis Vangelis, Meleti Eleonora, Mendes Ana Catarina, Mendia Idoia, Mertens Verena, Mesure Marina, Metsola Roberta, Metz Tilly, Mikser Sven, Milazzo Giuseppe, Millán Mon Francisco José, Minchev Nikola, Miranda Paz Ana, Montero Irene, Montserrat Dolors, Morace Carolina, Moreira de Sá Tiago, Moreno Sánchez Javier, Moretti Alessandra, Motreanu Dan-Ştefan, Mularczyk Arkadiusz, Müller Piotr, Mureşan Siegfried, Nagyová Jana, Nardella Dario, Navarrete Rojas Fernando, Negrescu Victor, Nemec Matjaž, Nesci Denis, Neuhoff Hans, Neumann Hannah, Nevado del Campo Elena, Niebler Angelika, Niedermayer Luděk, Niinistö Ville, Nikolaou-Alavanos Lefteris, Nikolic Aleksandar, Ní Mhurchú Cynthia, Noichl Maria, Nordqvist Rasmus, Novakov Andrey, Nykiel Mirosława, Obajtek Daniel, Ódor Ľudovít, Oetjen Jan-Christoph, Ohisalo Maria, Oliveira João, Olivier Philippe, Omarjee Younous, Ó Ríordáin Aodhán, Ozdoba Jacek, Paet Urmas, Pajín Leire, Palmisano Valentina, Panayiotou Fidias, Papadakis Kostas, Papandreou Nikos, Pappas Nikos, Pascual de la Parte Nicolás, Patriciello Aldo, Paulus Jutta, Pedro Ana Miguel, Pedulla’ Gaetano, Pellerin-Carlin Thomas, Peltier Guillaume, Penkova Tsvetelina, Pennelle Gilles, Pereira Lídia, Pérez Alvise, Peter-Hansen Kira Marie, Petrov Hristo, Picaro Michele, Picierno Pina, Picula Tonino, Piera Pascale, Pimpie Pierre, Piperea Gheorghe, de la Pisa Carrión Margarita, Pokorná Jermanová Jaroslava, Polato Daniele, Polfjärd Jessica, Popescu Virgil-Daniel, Pozņaks Reinis, Prebilič Vladimir, Princi Giusi, Pürner Friedrich, Rackete Carola, Radev Emil, Radtke Dennis, Rafowicz Emma, Ratas Jüri, Razza Ruggero, Rechagneux Julie, Regner Evelyn, Repasi René, Repp Sabrina, Ressler Karlo, Reuten Thijs, Riba i Giner Diana, Ricci Matteo, Ridel Chloé, Riehl Nela, Ripa Manuela, Ros Sempere Marcos, Roth Neveďalová Katarína, Rougé André, Ruissen Bert-Jan, Ruotolo Sandro, Rzońca Bogdan, Saeidi Arash, Salini Massimiliano, Salis Ilaria, Salla Aura, Sánchez Amor Nacho, Sanchez Julien, Sancho Murillo Elena, Sardone Silvia, Šarec Marjan, Sargiacomo Eric, Satouri Mounir, Saudargas Paulius, Sbai Majdouline, Sberna Antonella, Schaldemose Christel, Schaller-Baross Ernő, Schenk Oliver, Scheuring-Wielgus Joanna, Schieder Andreas, Schilling Lena, Schwab Andreas, Scuderi Benedetta, Seekatz Ralf, Sell Alexander, Serrano Sierra Rosa, Serra Sánchez Isabel, Sidl Günther, Sienkiewicz Bartłomiej, Sieper Lukas, Simon Sven, Singer Christine, Sinkevičius Virginijus, Sippel Birgit, Sjöstedt Jonas, Śmiszek Krzysztof, Smith Anthony, Smit Sander, Sokol Tomislav, Solier Diego, Solís Pérez Susana, Sommen Liesbet, Sonneborn Martin, Sorel Malika, Sousa Silva Hélder, Søvndal Villy, Staķis Mārtiņš, Stancanelli Raffaele, Ştefănuță Nicolae, Steger Petra, Stier Davor Ivo, Storm Kristoffer, Stöteler Sebastiaan, Stoyanov Stanislav, Strack-Zimmermann Marie-Agnes, Strada Cecilia, Streit Joachim, Strik Tineke, Strolenberg Anna, Sturdza Şerban Dimitrie, Stürgkh Anna, Sypniewski Marcin, Szczerba Michał, Szekeres Pál, Szydło Beata, Tamburrano Dario, Tânger Corrêa António, Tarczyński Dominik, Tarquinio Marco, Tarr Zoltán, Târziu Claudiu-Richard, Tavares Carla, Tegethoff Kai, Temido Marta, Teodorescu Georgiana, Teodorescu Måwe Alice, Terheş Cristian, Ter Laak Ingeborg, Terras Riho, Tertsch Hermann, Thionnet Pierre-Romain, Timgren Beatrice, Tinagli Irene, Tobé Tomas, Tolassy Rody, Tomac Eugen, Tomašič Zala, Tomaszewski Waldemar, Tomc Romana, Tonin Matej, Toom Jana, Topo Raffaele, Torselli Francesco, Tosi Flavio, Toussaint Marie, Tovaglieri Isabella, Toveri Pekka, Tridico Pasquale, Trochu Laurence, Tsiodras Dimitris, Tudose Mihai, Turek Filip, Tynkkynen Sebastian, Uhrík Milan, Vaidere Inese, Valchev Ivaylo, Vălean Adina, Valet Matthieu, Van Brempt Kathleen, Van Brug Anouk, van den Berg Brigitte, Vandendriessche Tom, Van Dijck Kris, Van Lanschot Reinier, Van Leeuwen Jessika, Vannacci Roberto, Van Overtveldt Johan, Van Sparrentak Kim, Varaut Alexandre, Vasconcelos Ana, Vasile-Voiculescu Vlad, Vautmans Hilde, Vedrenne Marie-Pierre, Ventola Francesco, Verougstraete Yvan, Veryga Aurelijus, Vešligaj Marko, Vicsek Annamária, Vieira Catarina, Vilimsky Harald, Vincze Loránt, Vind Marianne, Vistisen Anders, Vivaldini Mariateresa, Volgin Petar, von der Schulenburg Michael, Vondra Alexandr, Voss Axel, Vozemberg-Vrionidi Elissavet, Vrecionová Veronika, Vázquez Lázara Adrián, Waitz Thomas, Walsh Maria, Walsmann Marion, Warborn Jörgen, Warnke Jan-Peter, Wąsik Maciej, Wawrykiewicz Michał, Wcisło Marta, Wechsler Andrea, Weimers Charlie, Werbrouck Séverine, Wiesner Emma, Wiezik Michal, Wilmès Sophie, Winkler Iuliu, Winzig Angelika, Wiseler-Lima Isabel, Wiśniewska Jadwiga, Wölken Tiemo, Wolters Lara, Yar Lucia, Yon-Courtin Stéphanie, Yoncheva Elena, Zacharia Maria, Zalewska Anna, Žalimas Dainius, Zan Alessandro, Zdechovský Tomáš, Zdrojewski Bogdan Andrzej, Zijlstra Auke, Zīle Roberts, Zingaretti Nicola, Złotowski Kosma, Zoido Álvarez Juan Ignacio, Zovko Željana, Zver Milan

    Excused:

    Morano Nadine, Zarzalejos Javier

    MIL OSI Europe News –

  • MIL-OSI United Nations: Safeguarding the Historic Naval Hospital of Port Royal

    Source: United Nations

    The Historic Naval Hospital of Port Royal in Jamaica, a vital heritage site surrounded by a 19th-century sea wall, is threatened by coastal erosion, storm surges, and ship traffic. At the request of Jamaican national authorities and with the generous support of the Netherlands Funds-in-Trust, a new project has been launched to address these challenges.

    The Historic Naval Hospital of Port Royal, a vital heritage site surrounded by a 19th-century sea wall, is threatened by coastal erosion, storm surges, and ship traffic. As a key component of the heritage site “Archaeological Landscape of 17th Century Port Royal” submitted by Jamaica for the inscription to the UNESCO’s World Heritage List, the hospital and its surrounding archaeological grounds are at risk of significant deterioration.

    A 2022 Heritage Impact Assessment highlighted that continued erosion of the sea wall could severely impact the structural integrity of the Naval Hospital and the 17th-century streets that lie beneath the complex, jeopardizing the preservation of this iconic historic site. At the request of Jamaican national authorities and with the generous support of the Netherlands Funds-in-Trust, a new project has been launched.

    Such project aims to bolster the protection of the Naval Hospital and its archaeological grounds. The initiative will focus on reinforcing the sea wall, enhancing the site’s resilience to coastal erosion, and mitigating the effects of climate change. The project will also support the capacity-building of national institutions responsible for heritage conservation.

    Port Royal was once one of the most prosperous and notorious cities in the Caribbean during the 17th century, earning its infamous reputation as the “wickedest city on Earth.” Today, much of Port Royal lies submerged beneath the sea, with the Historic Naval Hospital serving as a key reminder of the city’s storied past.

    Key objectives of the project include:

    • Improving protection: Strengthening the protection of the Historic Naval Hospital of Port Royal from coastal erosion, climate change, and human activity.
    • Community engagement: Involving the local community in rehabilitation efforts and raising awareness about the vulnerability of cultural heritage.
    • Sustainable management: Ensuring the long-term conservation and daily management of the site by the Jamaica National Heritage Trust, with community participation.

    Expected project outcomes include:

    • Structural reinforcement: Identification and consolidation of the most vulnerable sections of the sea wall.
    • Capacity building: Strengthening the capacities of national institutions to manage and conserve cultural heritage.
    • Improved cooperation: Fostering better collaboration between heritage management stakeholders, tourism development organizations, and local communities.

    This project is part of a broader effort to safeguard Port Royal’s rich cultural legacy, ensuring its preservation for future generations. Jamaica’s initiative to propose Port Royal for inclusion on UNESCO’s World Heritage List marks a crucial step in recognizing and safeguarding its rich archaeological heritage, with the World Heritage Committee reviewing the nomination later this year. This endeavor reflects the country’s commitment to ensure that the stories and achievements of past generations endure for those to come.

    MIL OSI United Nations News –

  • MIL-OSI: Beneficient Reports Results for Third Quarter Fiscal 2025

    Source: GlobeNewswire (MIL-OSI)

     

    Announced Proposed Transaction to Increase Tangible Book Value to Ben Public Company Stockholders by $9 Million on 8.4 Million Shares Outstanding, Permanent Equity Increased by $35 Million

    Completed First Primary Capital Transaction as Part of Ongoing Business Development Activities

    Announced Proposed International Bank Acquisition to Expand Alternative and Digital Asset Markets Capabilities

    DALLAS, Feb. 13, 2025 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform, AltAccess, today reported its financial results for the fiscal 2025 third quarter, which ended December 31, 2024.

    Commenting on the fiscal 2025 third quarter results, Beneficient management said: “Our fiscal third quarter was focused on key steps that we believe will ready Ben for significant new activities in delivering liquidity, primary capital and digital asset markets solutions – which we believe are all opportunities to disrupt and enhance the solutions available to large financial audiences. During the fiscal third quarter, we also closed our first primary capital transaction and are seeking additional opportunities.

    “A complementary part of our plan is the proposed acquisition of Mercantile Bank International Corp. (“Mercantile Bank”), a Puerto Rico-based International Financial Entity, which is expected to enable Ben to offer an expanded range of digital asset market solutions and companion custody, clearing and control account fee-based services. We intend to drive new growth opportunities in calendar 2025, which we believe have the potential to generate above market fee rates. These efforts are expected to further build out our expansive model and enable the Company to benefit from a growing range of trust, custody and other services we provide as well as the underlying performance of the private equity assets held in trust.

    “Additionally, we are pleased to have continued to strengthen our capital structure, increasing our permanent equity by $35 million through a re-designation of certain preferred equity. Furthermore, we executed an agreement to complete additional transactions designed to revise the liquidation priority of Beneficient Company Holdings, L.P. (“BCH”) and deliver other benefits to our public company stockholders provided by entities controlled by our founders, which are expected to become increasingly visible as the Company enters into more liquidity and primary capital transactions.”

    Third Quarter Fiscal 2025 and Recent Highlights (for the quarter ended December 31, 2024 or as noted):

    • Reported investments with a fair value of $334.3 million, increased from $329.1 million at the end of our prior fiscal year, served as collateral for Ben Liquidity’s net loan portfolio of $260.6 million and $256.2 million, respectively. Reported investments include our first primary capital transaction with a closing of $1.4 million on December 31, 2024.
    • Revenues increased to $4.4 million in the third quarter of fiscal 2025 as compared to $(10.2) million in the same quarter of fiscal 2024. For the nine months ended December 31, 2024, revenues for fiscal 2025 were $23.0 million as compared to $(55.7) million for fiscal 2024.
    • Operating expenses declined 98% to $13.9 million in the third quarter of fiscal 2025, as compared to $905.7 million in the third quarter of fiscal 2024, which included a non-cash goodwill impairment of $883.2 million. For the nine months ended December 31, 2024, operating expenses for fiscal 2025 were $1.9 million, which included the release of a loss contingency accrual of $55.0 million and non-cash goodwill impairment of $3.7 million, as compared to $2.4 billion in fiscal 2024, which included non-cash goodwill impairment of $2.3 billion.
    • Excluding the non-cash goodwill impairment in the prior comparable period, operating expenses declined 38% to $13.9 million in the third quarter of fiscal 2025 as compared to $22.5 million in the same period of fiscal 2024. For the nine months ended December 31, 2024, excluding the non-cash goodwill impairment and the loss contingency release in each period, as applicable, operating expenses were $53.2 million in fiscal 2025 as compared to $111.7 million in fiscal 2024.
    • Improved permanent equity from a deficit of $148.3 million as of June 30, 2024 to a positive $14.3 million as of December 31, 2024 through a combination of redesignating approximately $160.5 million of temporary equity to permanent equity and additional capital from equity sales and liquidity transactions offset by net loss allocable to permanent equity classified securities of $6.9 million during the applicable period.
    • Announced proposed transaction on December 23, 2024 to revise the liquidation priority of BCH and provide other benefits to our public company shareholders, which on a proforma basis, amounts to $9.2 million of tangible book value to Ben’s public company stockholders(1) using December 31, 2024 financial information, as compared to no book value to Ben’s public company stockholders absent the transaction.
    • Announced an agreement to acquire Mercantile Bank in exchange for an aggregate purchase price of $1.5 million, subject to certain closing conditions, which is expected to enable Ben to offer an expanded range of digital asset markets solutions and companion custody, clearing and control account fee-based services that generate additional cash flow in calendar 2025, including additional alternative asset custody services with the potential to generate higher fee rates than are generally available for traditional custody services.

    Loan Portfolio

    As a result of executing on our business plan of providing financing for liquidity, or early investment exits, for alternative asset marketplace participants, Ben organically develops a balance sheet comprised largely of loans collateralized by a well- diversified alternative asset portfolio that is expected to grow as Ben successfully executes on its core business.

    Ben’s balance sheet strategy for ExAlt Loan origination is built on the theory of the portfolio endowment model for the fiduciary financings we make by utilizing our patent-pending computer implemented technologies branded as OptimumAlt. Our OptimumAlt endowment model balance sheet approach guides diversification of our fiduciary financings across seven asset classes of alternative assets, over 11 industry sectors in which alternative asset managers invest, and at least six countrywide exposures and multiple vintages of dates of investment into the private funds and companies.

    As of December 31, 2024, Ben’s loan portfolio was supported by a highly diversified alternative asset collateral portfolio providing diversification across approximately 220 private market funds and approximately 750 investments across various asset classes, industry sectors and geographies. This portfolio includes exposure to some of the most exciting, sought after private company names worldwide, such as the largest private space exploration company, an innovative software and payment systems provider, a venture capital firm investing in waste-to-energy and clean energy technologies, a technology company providing Net Zero solutions in the production of advanced biofuels, a designer and manufacturer of shaving products, a large online store for women’s clothes and other fashionable accessories that has announced intentions to go public, a mobile banking services provider, and others.

    Figure 1: Portfolio Diversification

    Diversification Using Principal Loan Balance, Net of Allowance for Credit Losses

    As of December 31, 2024, the charts below present the ExAlt Loan portfolio’s relative exposure by certain characteristics (percentages determined by aggregate fiduciary ExAlt Loan portfolio principal balance net of allowance for credit losses, which includes the exposure to interests in certain of our former affiliates composing part of the Fiduciary Loan Portfolio).

    As of December 31, 2024. Represents the characteristics of professionally managed funds and investments in the Collateral (defined as follows) portfolio. The Collateral for the ExAlt Loans in the loan portfolio is comprised of a diverse portfolio of direct and indirect interests (through various investment vehicles, including, limited partnership interests and private and public equity and debt securities, which include our and our affiliates’ or our former affiliates’ securities), primarily in third-party, professionally managed private funds and investments. Loan balances usedto calculate the percentages reported in the pie charts are loan balances net of any allowance for credit losses, and as ofDecember 31, 2024, the total allowance for credit losses was$325 million, for a total gross loan balance of$586 millionand a loan balance net of allowance for credit losses of$261 million.

    Business Segments: Third Quarter Fiscal 2025

    Ben Liquidity

    Ben Liquidity offers simple, rapid and cost-effective liquidity products through the use of our proprietary financing and trust structure, or the “Customer ExAlt Trusts,” which facilitate the exchange of a customer’s alternative assets for consideration.

    • Ben Liquidity recognized $11.3 million of interest income for the fiscal third quarter, a decrease of 5.7% from the quarter ended September 30, 2024, primarily due to a higher percentage loans being placed on nonaccrual status, partially offset by the effects of compounding interest on the remaining loans.
    • Operating loss for the fiscal third quarter was $2.9 million, a decline from operating income of $2.9 million for the quarter ended September 30, 2024. The decline in operating performance was due to higher intersegment credit losses in the current fiscal period as compared to the quarter ended September 30, 2024 due to slightly lower collateral values while the amortized cost basis increased principally due to interest capitalizing at a higher rate than loan payments.

    Ben Custody

    Ben Custody provides full-service trust and custody administration services to the trustees of certain of the Customer ExAlt Trusts, which own the exchanged alternative assets following liquidity transactions in exchange for fees payable quarterly calculated as a percentage of assets in custody.

    • NAV of alternative assets and other securities held in custody by Ben Custody during the fiscal third quarter increased to $385.1 million as of December 31, 2024, compared to $381.2 million as of March 31, 2024. The increase was driven by $1.4 million of new originations and unrealized gains on existing assets, principally related adjustments to the relative share held in custody of the respective fund’s NAV based on updated financial information received from the funds’ investment manager or sponsor during the period, offset by distributions during the period.
    • Revenues applicable to Ben Custody were $5.4 million for the fiscal third quarter, compared to $5.4 million for the quarter ended September 30, 2024. The similar amount of revenues for these periods was a result of stable NAV of alternative assets and other securities held in custody at the beginning of each applicable period, when such fees are calculated.
    • Operating income for the fiscal third quarter decreased to $3.5 million, from $4.3 million for the quarter ended September 30, 2024. The decrease was primarily due to credit losses related to certain fees collateralized by securities of our former parent company. Additionally, there was no non-cash goodwill impairment in the third fiscal quarter as compared to non-cash goodwill impairment of $0.3 million for the quarter ended September 30, 2024.
    • Adjusted operating income(1) for the fiscal third quarter was $4.8 million, compared to adjusted operating income(1) of $4.6 million for the quarter ended September 30, 2024. The increase was due to slightly lower operating expenses, principally related to lower employee compensation due to lower headcount.

    Business Segments: Through Nine Months Ended Fiscal 2025

    Ben Liquidity

    • Ben Liquidity recognized $34.1 million of interest income for the nine months ended December 31, 2024, down 6.0% compared to the prior year period, primarily due to lower loans, net of the allowance for credit losses, resulting from higher levels of non-accrual loans and loan prepayments, partially offset by new loans originated.
    • Operating loss was $0.5 million for the nine months ended December 31, 2024, improving from an operating loss of $1.8 billion in the prior year period. The prior period loss was driven by non-cash goodwill impairment totaling $1.7 billion and credit losses largely related to securities of our former parent company.
    • Adjusted operating loss(1) was $0.5 million for the nine months ended December 31, 2024 compared to adjusted operating loss(1) of $11.8 million in the prior year period with the improvement in adjusted operating loss(1) primarily related to lower credit loss adjustments recognized in the current fiscal year and lower employee compensation costs due to lower headcount.

    Ben Custody

    • Ben Custody revenues were $16.2 million for the nine months ended December 31, 2024, down 14.7%, compared to the prior year period, primarily due to lower NAV of alternative assets and other securities held in custody.
    • Operating income was $9.1 million for the nine months ended December 31, 2024 compared to operating loss of $538.8 million in the prior year period, with the increase in operating income principally related to a significantly larger non-cash goodwill impairment in the prior year period of $554.6 million as compared to $3.4 million in the current fiscal year.
    • Adjusted operating income(1) for the nine months ended December 31, 2024 was $13.9 million, compared to adjusted operating income(1) of $15.8 million in the prior year period with the decrease in adjusted operating income(1) primarily due to lower revenue related to lower NAV of alternative assets and other securities held in custody partially offset by slightly lower operating expenses during the current fiscal year period.

    Capital and Liquidity

    • As of December 31, 2024, the Company had cash and cash equivalents of $4.1 million and total debt of $122.9 million.
    • Distributions received from alternative assets and other securities held in custody totaled $19.3 million for the nine months ended December 31, 2024, compared to $38.4 million for the same period of fiscal 2024.
    • Total investments (at fair value) of $334.3 million at December 31, 2024 supported Ben Liquidity’s loan portfolio.

    (1) Represents a non-GAAP financial measure. For reconciliations of our non-GAAP measures to the most directly comparable GAAP financial measures and for the reasons we believe the non-GAAP measures provide useful information, see Non-GAAP Reconciliations.

    Board Update

    On November 21, 2024, Karen Wendel was appointed to the Board as an independent director and a member of various committees, including the Audit committee of the Board, bringing substantial additional expertise in Cyber Security, Identity Solutions, Security Regulations, ISO Global Standards, e-Commerce, e-Healthcare, PKI Digital Certificates and Blockchain to Beneficient. Ms. Wendel serves as Founder and Chief Executive Officer of Trust Chains, a cybersecurity consulting firm, and previously served as the Chief Executive Officer and board member of IdenTrust, a global identity solutions company, from May 2003 to February 2016. Ms. Wendel has also served as Chief Executive Officer and a board member for eFinance Corporation, as a board member and audit committee member of Level Field Capital, a Nasdaq-traded special purpose acquisition company, as a partner at the Capital Markets Company (CAPCO), a Belgium-based consulting firm, and is the former head of the U.S. Financial Services Practice at Gemini Consulting. Ms. Wendel is an author on financial management, payments and supply chain integration; an advisor to U.S. government agencies and the European Union on emerging technologies for payments and transaction processing; and a keynote speaker at major international banking conferences.

    Consolidated Fiscal Third Quarter Results

    Table 1 below presents a summary of selected unaudited consolidated operating financial information.

    Consolidated Fiscal Third Quarter Results
    ($ in thousands, except share and per share amounts)    		 Fiscal 3Q25
    December 31,
    2024    		 Fiscal 2Q25
    September 30,
    2024    		 Fiscal 3Q24
    December 31,
    2023    		 Change %
    vs. Prior
    Quarter    		   YTD Fiscal
     2025    		 YTD Fiscal
     2024    		 Change %
    vs. Prior
    YTD
    GAAP Revenues $ 4,419   $ 8,561   $ (10,235 ) (48.4)%   $ 23,026   $ (55,739 ) NM
    Adjusted Revenues(1)   4,427     8,734     8,456   (49.3)%     23,572     8,478   NM
    GAAP Operating Income (Loss)   (9,513 )   (13,715 )   (915,951 ) 30.6%     21,110     (2,453,685 ) NM
    Adjusted Operating Loss(1)   (7,301 )   (6,611 )   (11,684 ) (10.4)%     (18,638 )   (57,374 ) 67.5%
    Basic Class A EPS $ (1.32 ) $ 2.98   $ (158.36 ) NM   $ 10.30   $ (668.31 ) NM
    Diluted Class A EPS $ (1.32 ) $ 0.03   $ (158.36 ) NM   $ 0.12   $ (668.31 ) NM
    Segment Revenues attributable to Ben’s Equity Holders(2)   16,621     16,626     17,961   —%     49,482     53,715   (7.9)%
    Adjusted Segment Revenues attributable to Ben’s Equity Holders (1)(2)   16,621     16,626     18,146   —%     49,489     55,059   (10.1)%
    Segment Operating Income (Loss) attributable to Ben’s Equity Holders   (8,281 )   (9,192 )   (894,617 ) 9.9%     27,391     (2,414,893 ) NM
    Adjusted Segment Operating Loss attributable to Ben’s Equity Holders(1)(2) $ (4,737 ) $ (2,261 ) $ (4,594 ) NM   $ (11,551 ) $ (37,583 ) 69.3%

    NM – Not meaningful.

    (1) Adjusted Revenues, Adjusted Operating Loss, Adjusted Segment Revenues attributable to Ben’s Equity Holders and Adjusted Segment Operating Loss attributable to Ben’s Equity Holders are non-GAAP financial measures. For reconciliations of our non-GAAP measures to the most directly comparable GAAP financial measures and for the reasons we believe the non-GAAP measures provide useful information, see Non-GAAP Reconciliations.

    (2) Segment financial information attributable to Ben’s equity holders is presented to provide users of our financial information an understanding and visual aide of the segment information (revenues, operating income (loss), and adjusted operating income (loss)) that impacts Ben’s Equity Holders. “Ben’s Equity Holders” refers to the holders of Beneficient Class A and Class B common stock and Series B Preferred Stock as well as holders of interests in BCH which represent noncontrolling interests. For a description of noncontrolling interests, see Item 2 of our Quarterly Report on Form 10-Q for the nine months ended December 31, 2024, and Reconciliation of Business Segment Information Attributable to Ben’s Equity Holders to Net Income Attributable to Ben Common Holders. Such information is computed as the sum of the Ben Liquidity, Ben Custody and Corp/Other segments since it is the operating results of those segments that determine the net income (loss) attributable to Ben’s Equity Holders. See further information in table 5 and Non-GAAP Reconciliations.

    Table 2 below presents a summary of selected unaudited consolidated balance sheet information.

    Consolidated Fiscal Third Quarter Results
    ($ in thousands)    		 Fiscal 3Q25
    As of
    December 31, 2024    		   Fiscal 4Q24
    As of
    March 31, 2024    		   Change %
    Investments, at Fair Value $ 334,278   $ 329,119   1.6%
    All Other Assets   52,720     22,676   132.5%
    Goodwill and Intangible Assets, Net   13,014     16,706   (22.1)%
    Total Assets $ 400,012   $ 368,501   8.6%


    Business Segment Information Attributable to Ben’s Equity Holders    (1)

    Table 3 below presents unaudited segment revenues and segment operating income (loss) for business segments attributable to Ben’s equity holders.

    Segment Revenues Attributable to Ben’s Equity Holders(1)
    ($ in thousands)    		 Fiscal 3Q25
    December 31,
    2024    		 Fiscal 2Q25
    September 30,
    2024    		 Fiscal 3Q24
    December 31,
    2023    		 Change %
    vs. Prior
    Quarter    		   YTD Fiscal
     2025    		 YTD Fiscal
     2024    		 Change %
    vs. Prior
    YTD
    Ben Liquidity $ 11,297   $ 11,978   $ 11,275 (5.7)%   $ 34,124   $ 36,303   (6.0)%
    Ben Custody   5,410     5,386     5,897 0.4%     16,178     18,961   (14.7)%
    Corporate & Other   (86 )   (738 )   789 88.3%     (820 )   (1,549 ) 47.1%
    Total Segment Revenues Attributable to Ben’s Equity Holders(1) $ 16,621   $ 16,626   $ 17,961 —%   $ 49,482   $ 53,715   (7.9)%
    Segment Operating Income (Loss) Attributable to Ben’s Equity Holders(1)
    ($ in thousands)    		 Fiscal 3Q25
    December 31,
    2024    		 Fiscal 2Q25
    September 30,
    2024    		 Fiscal 3Q24
    December 31,
    2023    		 Change %
    vs. Prior
    Quarter    		   YTD Fiscal
     2025    		 YTD Fiscal
     2024    		 Change %
    vs. Prior
    YTD
    Ben Liquidity $ (2,853 ) $ 2,905   $ (606,405 ) NM   $ (462 ) $ (1,781,521 ) 100.0%
    Ben Custody   3,507     4,329     (267,995 ) (19.0)%     9,123     (538,840 ) NM
    Corporate & Other   (8,935 )   (16,426 )   (20,217 ) 45.6%     18,730     (94,532 ) NM
    Total Segment Operating Income (Loss) Attributable to Ben’s Equity Holders(1) $ (8,281 ) $ (9,192 ) $ (894,617 ) 9.9%   $ 27,391   $ (2,414,893 ) NM

    NM – Not meaningful.

    (1) Segment financial information attributable to Ben’s equity holders is presented to provide users of our financial information an understanding and visual aide of the segment information (revenues, operating income (loss), and adjusted operating income (loss)) that impacts Ben’s Equity Holders. “Ben’s Equity Holders” refers to the holders of Beneficient Class A and Class B common stock and Series B Preferred Stock as well as holders of interests in BCH which represent noncontrolling interests. For a description of noncontrolling interests, see Item 2 of our Quarterly Report on Form 10-Q for the nine months ended December 31, 2024, and Reconciliation of Business Segment Information Attributable to Ben’s Equity Holders to Net Income Attributable to Ben Common Holders. Such information is computed as the sum of the Ben Liquidity, Ben Custody and Corp/Other segments since it is the operating results of those segments that determine the net income (loss) attributable to Ben’s Equity Holders. See further information in table 5 and Non-GAAP Reconciliations.

    Adjusted Business Segment Information Attributable to Ben’s Equity Holders(2)

    Table 4 below presents unaudited adjusted segment revenue and adjusted segment operating income (loss) for business segments attributable to Ben’s equity holders.

    Adjusted Segment Revenues Attributable to Ben’s Equity Holders(1)(2)
    ($ in thousands)    		 Fiscal 3Q25
    December 31,
    2024    		 Fiscal 2Q25
    September 30,
    2024    		 Fiscal 3Q24
    December 31,
    2023    		 Change %
    vs. Prior
    Quarter    		   YTD Fiscal
     2025    		 YTD Fiscal
     2024    		 Change %
    vs. Prior
    YTD
    Ben Liquidity $ 11,297   $ 11,978   $ 11,275 (5.7)%   $ 34,124   $ 36,303   (6.0)%
    Ben Custody   5,410     5,386     5,897 0.4%     16,178     18,961   (14.7)%
    Corporate & Other   (86 )   (738 )   974 88.3%     (813 )   (205 ) NM
    Total Adjusted Segment Revenues Attributable to Ben’s Equity Holders(1)(2) $ 16,621   $ 16,626   $ 18,146 —%   $ 49,489   $ 55,059   (10.1)%
    Adjusted Segment Operating Income (Loss) Attributable to Ben’s Equity Holders(1)(2)
    ($ in thousands)    		 Fiscal 3Q25
    December 31,
    2024    		 Fiscal 2Q25
    September 30,
    2024    		 Fiscal 3Q24
    December 31,
    2023    		 Change %
    vs. Prior
    Quarter    		   YTD Fiscal
     2025    		 YTD Fiscal
     2024    		 Change %
    vs. Prior
    YTD
    Ben Liquidity $ (2,853 ) $ 2,905   $ 2,525   NM   $ (457 ) $ (11,769 ) 96.1%
    Ben Custody   4,847     4,627     4,835   4.8%     13,890     15,767   (11.9)%
    Corporate & Other   (6,731 )   (9,793 )   (11,954 ) 31.3%     (24,984 )   (41,581 ) 39.9%
    Total Adjusted Segment Operating Income (Loss) Attributable to Ben’s Equity Holders(1)(2) $ (4,737 ) $ (2,261 ) $ (4,594 ) NM   $ (11,551 ) $ (37,583 ) 69.3%

    NM – Not meaningful.

    (1) Adjusted Revenues, Adjusted Operating Income (Loss), Adjusted Segment Revenues attributable to Ben’s Equity Holders and Adjusted Segment Operating Income (Loss) attributable to Ben’s Equity Holders are non-GAAP financial measures. For reconciliations of our non-GAAP measures to the most directly comparable GAAP financial measures and for the reasons we believe the non-GAAP measures provide useful information, see Non-GAAP Reconciliations.
    (2) Segment financial information attributable to Ben’s equity holders is presented to provide users of our financial information an understanding and visual aide of the segment information (revenues, operating income (loss), and adjusted operating income (loss)) that impacts Ben’s Equity Holders. “Ben’s Equity Holders” refers to the holders of Beneficient Class A and Class B common stock and Series B Preferred Stock as well as holders of interests in BCH which represent noncontrolling interests. For a description of noncontrolling interests, see Item 2 of our Quarterly Report on Form 10-Q for the nine months ended December 31, 2024, and Reconciliation of Business Segment Information Attributable to Ben’s Equity Holders to Net Income Attributable to Ben Common Holders. Such information is computed as the sum of the Ben Liquidity, Ben Custody and Corp/Other segments since it is the operating results of those segments that determine the net income (loss) attributable to Ben’s Equity Holders. See further information in table 5 and Non-GAAP Reconciliations.

    Reconciliation of Business Segment Information Attributable to Ben’s Equity Holders to Net Income (Loss) Attributable to Ben Common Shareholders

    Table 5 below presents reconciliation of operating income (loss) by business segment attributable to Ben’s Equity Holders to net income (loss) attributable to Ben common shareholders.

    Reconciliation of Business Segments to Net Income (Loss) to Ben Common Shareholders
    ($ in thousands)    		 Fiscal 3Q25
    December 31,
    2024    		 Fiscal 2Q25
    September 30,
    2024    		 Fiscal 3Q24
    December 31,
    2023    		   YTD Fiscal
     2025    		 YTD Fiscal
     2024
    Ben Liquidity $ (2,853 ) $ 2,905   $ (606,405 )   $ (462 ) $ (1,781,521 )
    Ben Custody   3,507     4,329     (267,995 )     9,123     (538,840 )
    Corporate & Other   (8,935 )   (16,426 )   (20,217 )     18,730     (94,532 )
    Loss on debt extinguishment, net (intersegment elimination)   —     —     (3,940 )     —     (3,940 )
    Gain on liability resolution   —     23,462     —       23,462     —  
    Income tax expense (allocable to Ben and BCH equity holders)   (713 )   —     (75 )     (741 )   (75 )
    Net loss attributable to noncontrolling interests – Ben   4,844     3,067     360,695       15,098     401,985  
    Noncontrolling interest guaranteed payment   (4,489 )   (4,423 )   (4,229 )     (13,268 )   (12,501 )
    Net income (loss) attributable to Ben’s common shareholders $ (8,639 ) $ 12,914   $ (542,166 )   $ 51,942   $ (2,029,424 )


    Earnings Webcast

    Beneficient will host a webcast and conference call to review its third quarter financial results on February 13, 2025, at 8:30 am Eastern Standard Time. The webcast will be available via live webcast from the Investor Relations section of the Company’s website at https://shareholders.trustben.com under Events.

    Replay

    The webcast will be archived on the Company’s website in the investor relations section for replay for at least one year.

    About Beneficent

    Beneficient (Nasdaq: BENF) – Ben, for short – is on a mission to democratize the global alternative asset investment market by providing traditionally underserved investors − mid-to-high net worth individuals, small-to-midsized institutions and General Partners seeking exit options, anchor commitments and valued-added services for their funds− with solutions that could help them unlock the value in their alternative assets. Ben’s AltQuote™ tool provides customers with a range of potential exit options within minutes, while customers can log on to the AltAccess® portal to explore opportunities and receive proposals in a secure online environment.

    Its subsidiary, Beneficient Fiduciary Financial, L.L.C., received its charter under the State of Kansas’ Technology-Enabled Fiduciary Financial Institution (TEFFI) Act and is subject to regulatory oversight by the Office of the State Bank Commissioner.

    For more information, visit www.trustben.com or follow us on LinkedIn.

    Contacts
    Investors:
    Matt Kreps/214-597-8200/mkreps@darrowir.com
    Michael Wetherington/214-284-1199/mwetherington@darrowir.com
    investors@beneficient.com

    Important Information and Where You Can Find It

    This press release may be deemed to be solicitation material in respect of a vote of stockholders to approve an amendment to Ben’s articles of incorporation to increase the authorized shares of Class B Common Stock of Ben and the issuance of securities pursuant to the transactions to revise the liquidation priority of BCH (the “Transactions”). In connection with the requisite stockholder approval, Ben will file with the Securities and Exchange Commission (the “SEC”) a preliminary proxy statement and a definitive proxy statement, which will be sent to the stockholders of Ben, seeking such approvals related to the Transactions.

    INVESTORS AND SECURITY HOLDERS OF BEN AND THEIR RESPECTIVE AFFILIATES ARE URGED TO READ, WHEN AVAILABLE, THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTIONS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT BEN AND THE TRANSACTIONS. Investors and security holders will be able to obtain a free copy of the proxy statement, as well as other relevant documents filed with the SEC containing information about Ben, without charge, at the SEC’s website (http://www.sec.gov). Copies of documents filed with the SEC by Ben can also be obtained, without charge, by directing a request to Investor Relations, Beneficient, 325 North St. Paul Street, Suite 4850, Dallas, Texas 75201, or email investors@beneficient.com.

    Participants in the Solicitation of Proxies in Connection with Transaction

    Ben and certain of its directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the requisite stockholder approvals under the rules of the SEC. Information regarding Ben’s directors and executive officers is available in its annual report on Form 10-K for the fiscal year ended March 31, 2024, which was filed with the SEC on July 9, 2024 and certain current reports on Form 8-K filed by Ben. Other information regarding the participants in the solicitation of proxies with respect to the proposed transaction and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC. Free copies of these documents, when available, may be obtained as described in the preceding paragraph.

    Not an Offer of Securities

    The information in this communication is for informational purposes only and shall not constitute, or form a part of, an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities. The securities that are the subject of the Transactions have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

    Disclaimer and Cautionary Note Regarding Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to, among other things, demand for our solutions in the alternative asset industry, opportunities for market growth, statements regarding the proposed Transactions, including expectations of future plans, strategies, and benefits of the Transactions, statements regarding the proposed Mercantile Bank acquisition and estimates regarding future synergies and benefits, our ability to expand the range of digital asset market solutions, and companion custody clearing and control account fee-based services as a result of the proposed Mercantile Bank acquisition, our ability to identify and negotiate transactions, diversification and size of our loan portfolio and our ability to scale operations and provide shareholder value. These forward-looking statements are generally identified by the use of words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would,” and, in each case, their negative or other various or comparable terminology. These forward-looking statements reflect our views with respect to future events as of the date of this document and are based on our management’s current expectations, estimates, forecasts, projections, assumptions, beliefs and information. Although management believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. All such forward-looking statements are subject to risks and uncertainties, many of which are outside of our control, and could cause future events or results to be materially different from those stated or implied in this document. It is not possible to predict or identify all such risks. These risks include, but are not limited to, the ultimate outcome of the Transactions; the Company’s ability to consummate the Transactions; the ability of the Company to satisfy the closing conditions set forth in the agreement with respect to the Transactions, including obtaining the requisite vote of securityholders; the Company’s ability to meet expectations regarding the timing and completion of the Transactions, the ultimate outcome of the proposed Mercantile Bank acquisition; the Company’s ability to consummate the proposed Mercantile Bank acquisition in a timely manner or at all; the ability of the parties to satisfy the closing conditions to the acquisition; the possibility that the Company may be unable to successfully integrate Mercantile Bank’s operations with those of the Company or realize the expected benefits of the acquisition; the possibility that such integration may be more difficult, time-consuming, or costly than expected; the risk that operating costs, customer loss, and business disruption (including, without limitation, difficulties in maintaining relationships with employees, contractors, and customers) may be greater than expected following the acquisition or the public announcement of the acquisition; the Company’s ability to retain certain key employees of Mercantile Bank; the ability to launch and receive market acceptance for new products and services; risks related to the entry into a new line of business in connection with the proposed Mercantile Bank acquisition, and the risk factors that are described under the section titled “Risk Factors” in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings with the SEC. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this document and in our SEC filings. We expressly disclaim any obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable law.

    Table 6: CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

      Three Months Ended
    December 31,    		   Nine Months Ended
    December 31,
    (Dollars in thousands, except per share amounts)   2024       2023       2024       2023  
    Revenues              
    Investment income, net $ 4,742     $ 7,448     $ 24,311     $ 7,935  
    Loss on financial instruments, net (related party of $(8), $(18,691), $(546) and $(64,217), respectively)   (523 )     (18,024 )     (1,885 )     (64,260 )
    Interest and dividend income   10       118       34       348  
    Trust services and administration revenues (related party of $8, $8, $23 and $23, respectively)   188       158       564       173  
    Other income   2       65       2       65  
    Total revenues   4,419       (10,235 )     23,026       (55,739 )
                   
    Operating expenses              
    Employee compensation and benefits   2,929       7,340       13,914       58,561  
    Interest expense (related party of $3,140, $3,018, $9,330 and $5,843, respectively)   3,240       4,671       11,848       13,569  
    Professional services   5,083       4,970       17,884       22,000  
    Provision for credit losses   —       —       1,000       —  
    Loss on impairment of goodwill   —       883,223       3,692       2,286,212  
    Release of loss contingency related to arbitration award   —       —       (54,973 )     —  
    Other expenses (related party of $723, $2,096, $2,111 and $6,317, respectively)   2,680       5,512       8,551       17,604  
    Total operating expenses   13,932       905,716       1,916       2,397,946  
    Operating income (loss)   (9,513 )     (915,951 )     21,110       (2,453,685 )
    (Gain) loss on liability resolution   —       —       (23,462 )     —  
    Loss on extinguishment of debt, net   —       8,846       —       8,846  
    Net income (loss) before income taxes   (9,513 )     (924,797 )     44,572       (2,462,531 )
    Income tax expense   713       75       741       75  
    Net income (loss)   (10,226 )     (924,872 )     43,831       (2,462,606 )
    Plus: Net loss attributable to noncontrolling interests – Customer ExAlt Trusts   1,232       26,240       6,281       43,698  
    Plus: Net loss attributable to noncontrolling interests – Ben   4,844       360,695       15,098       401,985  
    Less: Noncontrolling interest guaranteed payment   (4,489 )     (4,229 )     (13,268 )     (12,501 )
    Net income (loss) attributable to Beneficient common shareholders $ (8,639 )   $ (542,166 )   $ 51,942     $ (2,029,424 )
    Other comprehensive income (loss):              
    Unrealized (loss) gain on investments in available-for-sale debt securities   (120 )     51       (115 )     4,236  
    Total comprehensive income (loss)   (8,759 )     (542,115 )     51,827       (2,025,188 )
    Less: comprehensive (loss) gain attributable to noncontrolling interests   (120 )     51       (115 )     4,236  
    Total comprehensive income (loss) attributable to Beneficient $ (8,639 )   $ (542,166 )   $ 51,942     $ (2,029,424 )
                   
    Net income (loss) per common share              
    Class A – basic $ (1.32 )   $ (158.36 )   $ 10.30     $ (668.31 )
    Class B – basic $ (1.02 )   $ (156.95 )   $ 13.78     $ (587.49 )
    Net income (loss) per common share              
    Class A – diluted $ (1.32 )   $ (158.36 )   $ 0.12     $ (668.31 )
    Class B – diluted $ (1.02 )   $ (156.95 )   $ 0.12     $ (587.49 )


    Table 7: CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION

      December 31, 2024   March 31, 2024
    (Dollars and shares in thousands) (unaudited)    
    ASSETS      
    Cash and cash equivalents $ 4,149     $ 7,913  
    Restricted cash   52       64  
    Investments, at fair value:      
    Investments held by Customer ExAlt Trusts (related party of $12 and $552)   334,278       329,113  
    Investments held by Ben (related party of nil and $6)   —       6  
    Other assets, net   48,519       14,699  
    Intangible assets   3,100       3,100  
    Goodwill   9,914       13,606  
    Total assets $ 400,012     $ 368,501  
    LIABILITIES, TEMPORARY EQUITY, AND EQUITY (DEFICIT)      
    Accounts payable and accrued expenses (related party of $14,294 and $14,143) $ 149,204     $ 157,157  
    Other liabilities (related party of $16,798 and $9,740)   22,433       31,727  
    Warrants liability   648       178  
    Convertible debt   2,667       —  
    Debt due to related parties   120,274       120,505  
    Total liabilities   295,226       309,567  
    Redeemable noncontrolling interests      
    Preferred Series A Subclass 0 Redeemable Unit Accounts, nonunitized   90,526       251,052  
    Total temporary equity   90,526       251,052  
    Shareholder’s equity (deficit):      
    Preferred stock, par value $0.001 per share, 250,000 shares authorized      
    Series A preferred stock, 0 and 0 shares issued and outstanding as of December 31, 2024 and March 31, 2024   —       —  
    Series B preferred stock, 363 and 227 shares issued and outstanding as of December 31, 2024 and March 31, 2024   —       —  
    Class A common stock, par value $0.001 per share, 5,000,000 and 18,750(1) shares authorized as of December 31, 2024 and March 31, 2024, respectively, 8,246 and 3,348 shares issued as of December 31, 2024 and March 31, 2024, respectively, and 8,237 and 3,339 shares outstanding as of December 31, 2024 and March 31, 2024, respectively   8       3  
    Class B convertible common stock, par value $0.001 per share, 250(1) shares authorized, 239 and 239 shares issued and outstanding as of December 31, 2024 and March 31, 2024   —       —  
    Additional paid-in capital   1,843,911       1,848,068  
    Accumulated deficit   (2,007,272 )     (2,059,214 )
    Stock receivable   —       (20,038 )
    Treasury stock, at cost (9 shares as of December 31, 2024 and March 31, 2024)   (3,444 )     (3,444 )
    Accumulated other comprehensive income   161       276  
    Noncontrolling interests   180,896       42,231  
    Total equity (deficit)   14,260       (192,118 )
    Total liabilities, temporary equity, and equity (deficit) $ 400,012     $ 368,501  

    (1) Number has been adjusted to reflect 1-for-80 reverse stock split on April 18, 2024. See Note 1 – Summary of Significant Accounting Policies – Reverse Stock Split to the consolidated financial statements included in the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on July 9, 2024, for additional information.

    Table 8: Non-GAAP Reconciliations

    (in thousands)   Three Months Ended December 31, 2024
        Ben
    Liquidity    		 Ben
    Custody    		 Customer
    ExAlt Trusts    		 Corporate/
    Other    		 Consolidating
    Eliminations    		 Consolidated
    Total revenues   $ 11,297   $ 5,410 $ 4,317   $ (86 ) $ (16,519 ) $ 4,419  
    Mark to market adjustment on interests in the GWG Wind Down Trust     —     —   8     —     —     8  
    Adjusted revenues   $ 11,297   $ 5,410 $ 4,325   $ (86 ) $ (16,519 ) $ 4,427  
                   
    Operating income (loss)   $ (2,853 ) $ 3,507 $ (35,544 ) $ (8,935 ) $ 34,312   $ (9,513 )
    Mark to market adjustment on interests in the GWG Wind Down Trust     —     —   8     —     —     8  
    Intersegment provision for credit losses on collateral comprised of interests in the GWG Wind Down Trust     —     1,340   —     —     (1,340 )   —  
    Goodwill impairment     —     —   —     —     —     —  
    Release of loss contingency related to arbitration award     —     —   —     —     —     —  
    Share-based compensation expense     —     —   —     804     —     804  
    Legal and professional fees(1)     —     —   —     1,400     —     1,400  
    Adjusted operating income (loss)   $ (2,853 ) $ 4,847 $ (35,536 ) $ (6,731 ) $ 32,972   $ (7,301 )

    (1) Includes legal and professional fees related lawsuits.

    (in thousands)   Three Months Ended September 30, 2024
        Ben
    Liquidity    		 Ben
    Custody    		 Customer
    ExAlt Trusts    		 Corporate/
    Other    		 Consolidating
    Eliminations    		 Consolidated
    Total revenues   $ 11,978 $ 5,386 $ 9,112   $ (738 ) $ (17,177 ) $ 8,561  
    Mark to market adjustment on interests in the GWG Wind Down Trust     —   —   173     —     —     173  
    Adjusted revenues   $ 11,978 $ 5,386 $ 9,285   $ (738 ) $ (17,177 ) $ 8,734  
                   
    Operating income (loss)   $ 2,905 $ 4,329 $ (31,549 ) $ (16,426 ) $ 27,026   $ (13,715 )
    Mark to market adjustment on interests in the GWG Wind Down Trust     —   —   173     —     —     173  
    Intersegment provision for credit losses on collateral comprised of interests in the GWG Wind Down Trust     —   —   —     —     —     —  
    Goodwill impairment     —   298   —     —     —     298  
    Release of loss contingency related to arbitration award     —   —   —     —     —     —  
    Share-based compensation expense     —   —   —     3,364     —     3,364  
    Legal and professional fees(1)     —   —   —     3,269     —     3,269  
    Adjusted operating income (loss)   $ 2,905 $ 4,627 $ (31,376 ) $ (9,793 ) $ 27,026   $ (6,611 )

    (1) Includes legal and professional fees related to lawsuits.

    (in thousands)   Three Months Ended December 31, 2023
        Ben
    Liquidity    		   Ben
    Custody    		   Customer
    ExAlt Trusts    		   Corporate/
    Other    		   Consolidating
    Eliminations    		   Consolidated
    Total revenues   $ 11,275     $ 5,897     $ (11,182 )   $ 789     $ (17,014 )   $ (10,235 )
    Mark to market adjustment on interests in the GWG Wind Down Trust     —       —       18,506       185       —       18,691  
    Adjusted revenues   $ 11,275     $ 5,897     $ 7,324     $ 974     $ (17,014 )   $ 8,456  
                             
    Operating income (loss)   $ (606,405 )   $ (267,995 )   $ (49,363 )   $ (20,217 )   $ 28,029     $ (915,951 )
    Mark to market adjustment on interests in the GWG Wind Down Trust     —       —       18,506       185       —       18,691  
    Intersegment provision for credit losses on collateral comprised of interests in the GWG Wind Down Trust     4,262       —       —       —       (4,262 )     —  
    Goodwill impairment     604,668       272,830       —       5,725       —       883,223  
    Loss on arbitration     —       —       —       —       —       —  
    Share-based compensation expense     —       —       —       2,026       —       2,026  
    Legal and professional fees(1)     —       —       —       327       —       327  
    Adjusted operating income (loss)   $ 2,525     $ 4,835     $ (30,857 )   $ (11,954 )   $ 23,767     $ (11,684 )

    (1) Includes legal and professional fees related to lawsuits.

    (in thousands)   Nine Months Ended December 31, 2024
        Ben
    Liquidity    		   Ben
    Custody    		   Customer
    ExAlt Trusts    		   Corporate/
    Other    		   Consolidating
    Eliminations    		   Consolidated
    Total revenues   $ 34,124     $ 16,178   $ 23,282     $ (820 )   $ (49,738 )   $ 23,026  
    Mark to market adjustment on interests in the GWG Wind Down Trust     —       —     539       7       —       546  
    Adjusted revenues   $ 34,124     $ 16,178   $ 23,821     $ (813 )   $ (49,738 )   $ 23,572  
                             
    Operating income (loss)   $ (462 )   $ 9,123   $ (96,722 )   $ 18,730     $ 90,441     $ 21,110  
    Mark to market adjustment on interests in the GWG Wind Down Trust     —       —     539       7       —       546  
    Intersegment provision for credit losses on collateral comprised of interests in the GWG Wind Down Trust     5       1,340     —       —       (1,345 )     —  
    Goodwill impairment     —       3,427     —       265       —       3,692  
    Release of loss contingency related to arbitration award     —       —     —       (54,973 )     —       (54,973 )
    Share-based compensation expense     —       —     —       5,162       —       5,162  
    Legal and professional fees(1)     —       —     —       5,825       —       5,825  
    Adjusted operating income (loss)   $ (457 )   $ 13,890   $ (96,183 )   $ (24,984 )   $ 89,096     $ (18,638 )

    (1) Includes legal and professional fees related to lawsuits.

    (in thousands)   Nine Months Ended December 31, 2023
        Ben
    Liquidity    		   Ben
    Custody    		   Customer
    ExAlt Trusts    		   Corporate/
    Other    		   Consolidating
    Eliminations    		   Consolidated
    Total revenues   $ 36,303     $ 18,961     $ (54,363 )   $ (1,549 )   $ (55,091 )   $ (55,739 )
    Mark to market adjustment on interests in the GWG Wind Down Trust     —       —       62,873       1,344       —       64,217  
    Adjusted revenues   $ 36,303     $ 18,961     $ 8,510     $ (205 )   $ (55,091 )   $ 8,478  
                             
    Operating income (loss)   $ (1,781,521 )   $ (538,840 )   $ (166,051 )   $ (94,532 )   $ 127,259     $ (2,453,685 )
    Mark to market adjustment on interests in the GWG Wind Down Trust     —       —       62,873       1,344       —       64,217  
    Intersegment provision for credit losses on collateral comprised of interests in the GWG Wind Down Trust     43,872       —       —       —       (43,872 )     —  
    Goodwill impairment     1,725,880       554,607       —       5,725       —       2,286,212  
    Loss on arbitration     —       —       —       —       —       —  
    Share-based compensation expense     —       —       —       37,530       —       37,530  
    Legal and professional fees(1)     —       —       —       8,352       —       8,352  
    Adjusted operating income (loss)   $ (11,769 )   $ 15,767     $ (103,178 )   $ (41,581 )   $ 83,387     $ (57,374 )

    (1) Includes legal and professional fees related to GWG Holdings bankruptcy, lawsuits, public relations, and employee matters.

      Three Months Ended
    December 31,    		   Nine Months Ended
    December 31,
        2024     2023       2024       2023  
    Operating Expenses Non GAAP Reconciliation              
    Operating expenses $ 13,932   $ 905,716     $ 1,916     $ 2,397,946  
    Plus: Release of loss contingency related to arbitration award   —     —       54,973       —  
    Less: Goodwill impairment   —     (883,223 )     (3,692 )     (2,286,212 )
    Operating expenses, excluding goodwill impairment and release of loss contingency related to arbitration award $ 13,932   $ 22,493     $ 53,197     $ 111,734  

    The below table reconciles the non-GAAP financial measures of tangible book value and tangible book value to Ben’s public stockholders to the most comparable GAAP financial measures as of December 31, 2024 on an actual basis and pro forma assuming the transactions described in our Form 8-K filed on December 23, 2024 occurred on December 31, 2024.

      Actual
    and Pro
    Forma     (a)    		       Actual   Pro forma (a)
    Tangible Book Value     Tangible book value attributable to Ben’s public company stockholders        
    Total equity (deficit) $ 14,260     Tangible book value   $ 91,772     $ 91,772  
    Less: Goodwill and intangible assets   (13,014 )   Less: Tangible book value attributable to Beneficient Holdings noncontrolling interest holders     (91,772 )     (82,595 )
    Plus: Total temporary equity   90,526     Tangible book value attributable to Ben’s public company stockholders     —       9,177  
    Tangible book value $ 91,772              

    (a) Assumes the transactions described in our Form 8-K filed on December 23, 2024 closed on December 31, 2024 including that the BCH limited partnership agreement was amended to provide that Beneficient, as the indirect holder of the Class A Units and certain Designated Class S Ordinary Units of BCH, would receive in the event of a liquidation of BCH (i) 10% of the first $100 million of distributions of BCH following the satisfaction of the debts and liabilities of BCH on a consolidated basis and (ii) 33.3333% of the net asset value of the added alternative assets of up to $5 billion in connection with ExAlt Plan liquidity and primary capital transactions entered after December 22, 2024.

    Adjusted Revenues, Adjusted Operating Income (Loss), Adjusted Segment Revenues attributable to Ben’s Equity Holders and Adjusted Segment Operating Income (Loss) attributable to Ben’s Equity Holders are non-GAAP financial measures. We present these non-GAAP financial measures because we believe it helps investors understand underlying trends in our business and facilitates an understanding of our operating performance from period to period because it facilitates a comparison of our recurring core business operating results. Tangible Book Value and Tangible Book Value to Ben’s Public Company Stockholders are also non-GAAP financial measures. We present these non-GAAP financial measures because we believe it help investors in analyzing the intrinsic value of the Company, including the proforma impact of the contemplated transactions more fully described in our Form 8-K filed on December 23, 2024. The non-GAAP financial measures are intended as a supplemental measure of our performance that is neither required by, nor presented in accordance with, U.S. GAAP. Our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Our computation of these non-GAAP financial measures may not be comparable to other similarly titled measures computed by other companies, because all companies may not calculate such items in the same way.

    We define adjusted revenue as revenue adjusted to exclude the effect of mark-to-market adjustments on related party equity securities that were acquired both prior to and during the Collateral Swap, which on August 1, 2023, became interests in the GWG Wind Down Trust. Adjusted Segment Revenues attributable to Ben’s Equity Holders is the same as “adjusted revenues” related to the aggregate of the Ben Liquidity, Ben Custody, and Corporate/Other Business Segments, which are the segments that impact the net income (loss) attributable to all equity holders of Beneficient, including equity holders of Beneficient’s subsidiary, BCH.

    Adjusted operating income (loss) represents GAAP operating income (loss), adjusted to exclude the effect of the adjustments to revenue as described above, credit losses on related party available-for-sale debt securities that were acquired in the Collateral Swap which on August 1, 2023, became interests in the GWG Wind Down Trust, and receivables from a related party that filed for bankruptcy and certain notes receivables originated during our formative transactions, non-cash asset impairment, share-based compensation expense, and legal, professional services, and public relations costs related to the GWG Holdings bankruptcy, lawsuits, a defunct product offering, and certain employee matters, including fees & loss contingency accruals (releases) incurred in arbitration with a former director. Adjusted Segment Operating Income (Loss) attributable to Ben’s Equity Holders is the same as “adjusted operating income (loss)” related to the aggregate of the Ben Liquidity, Ben Custody, and Corporate/Other Business Segments, which are the segments that impact the net income (loss) attributable to all equity holders of Beneficient, including equity holders of Beneficient’s subsidiary, BCH.

    Tangible book value is defined as the sum of total equity (deficit) less goodwill and intangible assets plus total temporary equity. Tangible book value to Ben’s public company stockholders is defined at tangible book value adjusted for the portion of tangible book value that is attributable to Ben’s public company stockholders, which is calculated as tangible book value adjusted for (i) 10% of the first $100 million of distributions of BCH following the satisfaction of the debts and liabilities of BCH on a consolidated basis and (ii) 33.3333% of the net asset value of the added alternative assets of up to $5 billion in connection with ExAlt Plan liquidity and primary capital transactions entered after December 22, 2024.

    These non-GAAP financial measures are not a measure of performance or liquidity calculated in accordance with U.S. GAAP. They are unaudited and should not be considered an alternative to, or more meaningful than, GAAP revenues or GAAP operating income (loss) as an indicator of our operating performance. Uses of cash flows that are not reflected in adjusted operating income (loss) or adjusted segment operating income (loss) attributable to Ben’s Equity Holders include capital expenditures, interest payments, debt principal repayments, and other expenses, which can be significant. As a result, adjusted operating income (loss) and/or adjusted segment operating income (loss) attributable to Ben’s Equity Holders should not be considered as a measure of our liquidity.

    Because of these limitations, Adjusted Revenues, Adjusted Operating Income (Loss), Adjusted Segment Revenues attributable to Ben’s Equity Holders, Adjusted Segment Operating Income (Loss) attributable to Ben’s Equity Holders, Tangible Book Value and Tangible Book Value to Ben’s Public Company Stockholders should not be considered in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP. We compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted Revenues, Adjusted Operating Income (Loss), Adjusted Segment Revenues attributable to Ben’s Equity Holders, Adjusted Segment Operating Income (Loss) attributable to Ben’s Equity Holders, Tangible Book Value and Tangible Book Value to Ben’s Public Company Stockholders on a supplemental basis. You should review the reconciliation of these non-GAAP financial measures set forth above and not rely on any single financial measure to evaluate our business.

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/09d463d7-9883-4bbf-8a05-3c24ea42846e

    The MIL Network –

  • MIL-OSI Economics: Asian Development Blog: A Fork in the Road: Will Asia Prioritize Safety or Suffer Rising Fatalities?

    Source: Asia Development Bank

    While road fatalities in Asia and the Pacific have fallen 11% since 2010, progress remains uneven, with low- and middle-income countries lagging behind. Strengthening infrastructure, enforcing safety regulations, and securing sustainable financing are critical to meeting the UN Decade of Action for Road Safety goal.

    On average, one person dies on Asia’s roads every minute. In 2021 alone, the region recorded over 694,000 road fatalities—nearly 60% of the global total of 1.19 million, according to the World Health Organization. These deaths overwhelmingly occur in Asia’s low- and middle-income countries, which account for 99% of the region’s road fatalities.

    Road crashes in Asia have a particularly severe impact on young people. They are the leading cause of death for those aged 15 to 29, and the second leading cause of death for children aged 5 to 14. Vulnerable road users are disproportionately affected. In 2021, one-third of all road fatalities involved pedestrians and cyclists, while 35% involved motorized two- and three-wheelers.

    The WHO estimates that road traffic deaths have fallen by 5% globally from 2010. In comparison, Asia and the Pacific has outpaced this trend, achieving an overall reduction of 11%. Meanwhile, the overall landscape indicates mixed progress across the region. While 67% of countries in the region have reduced road fatalities, only eight achieved a substantial decrease of 30% or more.

    Most of the decline in road fatalities has occurred in high-income Asian countries, which saw a 46% reduction between 2010 and 2021—an average decrease of 5% per year. In contrast, low- and middle-income countries in the region achieved only a 4% reduction over the same period, with an average annual decline of just 0.3%.
    While progress is being made, accelerated efforts are needed to realize the target. If current trends continue, about two-thirds of countries in the region — accounting for 86% of current road crash fatalities — will not be able to achieve the UN Decade of Action for Road Safety goal of achieving a 50% reduction.  

    While discrepancies exist between the various available datasets, they all paint the same scenario, that the majority of the countries in Asia will fail to meet the 2030 target under current trajectories.

    Regulations in the region focus on users and usage of the roads. For example, 97% of Asian countries have a national law setting speed limits, and 95% have national motorcycle helmet laws.

    With nearly 1.8 billion Asian people lacking access to urban transit and rural roads, countries must invest in safer road infrastructure.

    Targeted steps are needed to establish safe systems — which look beyond individual road behavior and address the underlying environment affecting road user safety, including safe roads and roadsides; safe vehicles; post-crash care; safe speeds and safe road use.

    For example, technical standards for new roads – which affect all road users – are only present in 78% of the countries. Only half have targets to have their streets meet “technical safety standards for all users.”

    There is a dire need to accelerate the improvement of road infrastructure. For example, road user surveys utilizing the IRAP star rating system indicate that the share of roads in Asia with good (3 stars or more) ratings is still quite low. With nearly 1.8 billion Asian people lacking access to urban transit and rural roads, countries must invest in safer road infrastructure.

    On the institutions, while 95% of Asian countries have identified national focal agencies for implementing road safety action plans, more detailed responsibilities also need focal points. Less than half of the countries in the region have identified funds to implement their road safety strategies.    

    Targets and ambitions also need to increase and expand. In the last two decades, Asian countries have added a billion vehicles to the road, and projections suggest that countries will motorize further. However, it is concerning to note that only 68% of the countries in the region have legislation on periodic vehicle technical inspection. 

    Also, considering the import of used vehicles in developing countries, only 56% of the developing countries in the region have high-quality standards for used vehicle imports. 

    Measures—and their implementation—matter. The case of the Republic of Korea, which now leads Asia in terms of progress towards the 2030 target, shows that regulations backed by effective implementation can result in significant impact, saving lives and reducing serious injuries.

    Broader uptake of monitoring mechanisms is also crucial for elevating our collective awareness of road safety, particularly for low- and middle-income countries. 

    The Asian Transport Observatory, for example, has developed road safety profiles for Asian economies. These can support the monitoring of progress towards the implementation of the Global Plan for the Decade of Action for Road Safety 2021-2030.  

    The overall road safety landscape in Asia presents progress but also persistent challenges. We need to turn incremental improvements into transformative actions. This includes boosting investments and standards for safer infrastructure; strengthening and enforcing regulations for ensuring safe vehicles, securing sustainable financing to implement road safety strategies; strengthening institutional capacities and accountability; and enhancing monitoring systems. 

    We are at a turning point, not just a checkpoint, towards achieving the collective goal towards reducing road fatalities. 

    This blog post is related to 4th Global Ministerial Conference on Road Safety, which assesses the progress in implementing the Global Plan for the Decade of Action for Road Safety 2021-2030. The plan aims to achieve a 50% reduction in road traffic fatalities by 2030. Sudhir Gota, Co-Team Lead, Asian Transport Observatory, contributed to this article.

    MIL OSI Economics –

  • MIL-OSI Submissions: Myanmar: Recklessly abrupt US aid stoppage poses existential threat to human rights – Amnesty International

    Source: Amnesty International

    The United States government’s abrupt and sweeping freeze on foreign aid is severely imperiling the human rights of refugees, civilians in armed conflict areas and individuals fleeing persecution in Myanmar, Amnesty International said today.

    The organization warned that lives could be lost unless the decision is urgently reversed, amended or if waivers for life-saving assistance are not immediately granted and swiftly implemented for those working on the ground.

    “The Trump administration’s cruel decision to issue immediate stop work orders on foreign aid is having an instant and devastating impact across the globe, and in Myanmar it is hitting people at a particularly dark hour,” said Amnesty International’s Myanmar Researcher Joe Freeman.

    “The decision has abruptly shut down hospitals in refugee camps, put fleeing human rights defenders at risk of deportation and imperiled programs helping people prevent atrocities, survive in conflict zones and rebuild their lives amid ongoing waves of violence.”

    On 20 January, US President Donald Trump signed a presidential executive order pausing all foreign aid amid a 90-day review of whether it is consistent with American foreign policy. On 24 January, US Secretary of State Marco Rubio issued a stop work order to those delivering assistance worldwide as part of the review, but carved out exemptions to the pause for emergency food assistance, as well as military aid to Israel and Egypt.

    An additional waiver dated 28 January exempted “life-saving humanitarian assistance” from the stoppage, while follow-up clarifications in the first week of February broadened the exemptions for specific activities. However, based on Amnesty’s latest research, implementation of these waivers has yet to trickle down to many organizations working along the Thai-Myanmar border.

    “The US government’s shocking move has had immediate global impacts whose real-life consequences are still being felt and understood. Our findings from Myanmar and Thailand provide just one example of the damage wrought by this heartless decision,” Joe Freeman said.

    In Myanmar, the funding pause has further devastated a civilian population already enduring escalating armed conflict, widespread displacement and severe human rights violations by a military that seized power in a coup more than four years ago. It has also sowed chaos, desperation and anguish among tens of thousands of Myanmar refugees living in Thailand.

    To date, US funding has helped many endure the upheaval by supporting emergency shelter or relocation for activists, delivering food aid, helping create early-warning systems for air strikes, delivering medical treatment in war zones and providing education opportunities to those who have lost all hope of a future.

    From 3-10 February, Amnesty International spoke to 12 Myanmar refugees living in camps along the border in Thailand, along with representatives from 14 organizations with Myanmar-focused activities. They include health workers, human rights researchers and NGOs providing cross-border assistance as well as media and education providers. All warned of severe consequences if the decision was not reversed or amended. Not one had received a communication or confirmation of a waiver from the US government to continue operations.

    ‘The mission is not to die”

    Despite the promise of waivers for life-saving humanitarian assistance, the aid stoppage is posing serious risks to the rights to health of more than 100,000 people living in nine refugee camps on the Thai side of the border with Myanmar. The majority have been there for years, fleeing previous waves of violence in Myanmar, but the camps have grown in size since the coup.

    Amnesty International spoke to refugees living in two separate camps along the border. All said hospitals in the camp, which are run by the International Rescue Committee (IRC) through USAID funding, had abruptly shut down after the stop work order. Though Thai authorities and hospitals have been able to step in and provide services for camp residents, their resources are stretched. As of 11 February, the IRC had still not received a waiver to continue their work.

    The impact of the initial shutdown was felt immediately. In the Umpien camp, for example, residents said at least four people have died as a result of not receiving oxygen provided by the hospitals. Amnesty could not independently confirm the claim. Reuters reported on 7 February that Pe Kha Lau, 71, died four days after she was sent home from a healthcare facility funded by the US through the IRC.

    “It was so scary, they forced everyone to go out of the hospital…and some people died because they lost their oxygen. We were not only sad but also scared of what is coming next,” said U Htan Htun, 62.

    Ma Su Su, a volunteer community medical worker in the Umpien camp, also said that on the day the order was announced people who needed treatment were told to leave the hospital. She said she witnessed staff removing an IV-drip from a patient and described how someone without proper training had to provide stitches to a wounded resident.

    “I told everyone it’s only 90 days. We’ll be okay after 90 days. But I feel hopeless,” she said. “The mission is not to die.”

    Water services at the camps were disrupted, according to residents, while food aid is also at risk of disappearing.

    Maximillian Morch from the Thai Border Consortium (TBC), which provides food and cooking fuel to all the nine camps along the Thai-Myanmar border, said they were trying to get approval for a life-saving waiver from the US government but had no confirmation yet.

    Just over 60% of the Consortium’s funding is from the US through the Bureau of Population, Refugees and Migration (PRM) at the US State Department. The bulk of that is food and cooking assistance. While they have not been told to stop work, they will run out of funds for food in four to six weeks if their funding is discontinued as part of the review of foreign aid.

    “Food is as inoffensive as you can be. And if you stop funding food this is not just a TBC problem, it’s an international humanitarian problem,” Morch said.

    “Very tough days for us”

    Since the Myanmar military took power in a 2021 coup, armed conflict has intensified across the country. Ever-increasing military air strikes have killed civilians and targeted schools, hospitals and monasteries, while elsewhere the military has targeted protesters, activists and journalists. Funded by USAID, civil society organizations across Myanmar help civilians, journalists and human rights defenders find shelter, aid and safety in exile if they have to flee the country.

    Groups in southeastern Myanmar, an area particularly hard-hit by military air strikes, run several US-funded programs which can be considered life-saving. They provide mobile medical units in frontline areas, help pay for hospital referrals for more advanced care and assist civilians in the aftermath of an air strike to find food and shelter.

    “At the same time as all the air strikes, all the bombings…artillery attacks, displacement…the funding has been stopped,” said Saw Diamond Khin, director of the Karen Department of Health and Welfare, which assists seven districts in southeastern Myanmar. “It is very tough days for us.”

    No waivers for life-saving work

    Saw Thar Win, from the Ethnic Health Systems Strengthening Group, said his organization had planned to deliver portable, battery-charged ultrasound and X-ray machines to conflict-affected communities in Myanmar. One set can serve an estimated 50,000 people. But the stop work order meant the machines were just sitting in boxes in his office because the funding for transporting it had been impacted.

    Another community-based health provider said the pause in US funding meant that they can no longer support urgent life-saving treatment inside Myanmar. Their funding had supported costs for emergency surgery to treat wounds from air strikes or other armed conflict injuries, as well as neonatal emergency treatment and surgery for appendicitis and blood transfusions.

    Despite the announcement of waivers at the end of January, medicines for HIV, tuberculosis and malaria, as well as support for mental health services for those traumatized by the armed conflict, have been similarly affected. Not one group Amnesty spoke to said they had been given any communication or confirmation of a waiver for life-saving work, even though their operations, such as helping feed, shelter and treat people in war zones, would clearly qualify.

    All said they lacked clear communication from US agencies such as USAID and their partners on the grounds. The Overseas Irrawaddy Association – which provides emergency relocation for hundreds of activists inside Myanmar, where protesters are routinely imprisoned and tortured by the military – said the freeze has affected their ability to support hundreds of at-risk individuals.

    “By removing the ability of these organizations to protect some of the most vulnerable people inside Myanmar, the US is effectively giving the rights-abusing Myanmar military an invaluable gift in their crackdown on the right to freedom of expression and information,” Freeman said.

    “People are now more vulnerable to arrest, to torture, and for those who have fled to Thailand and rely on funding for shelter, to deportation back to Myanmar. The US must immediately and directly communicate that groups working on life-saving assistance in Myanmar can continue their work.”

    MIL OSI – Submitted News –

  • MIL-OSI NGOs: Uncertainty around PEPFAR programme puts millions of people at risk

    Source: Médecins Sans Frontières –

    • MSF is witnessing the impacts of the US government’s decision to freeze funding to PEPFAR in countries where we work.
    • While clarification on the decision was issued on 6 February, we remain concerned that key areas of HIV prevention are not included in this additional guidance.
    • We urge the US government to immediately resume all funding of critical humanitarian and health aid, including the full range of PEPFAR operations.

    New York/Johannesburg/Brussels — The decision by the United States (US) government to temporarily freeze funding to the President’s Emergency Plan for AIDS Relief (PEPFAR) alongside all other foreign aid for at least a 90-day period has had immediate effects on people living with HIV, said Médecins Sans Frontières (MSF) today. Although the US has since clarified that certain treatment programmes can continue at least until April, we are concerned that critical elements of the PEPFAR programme remain frozen.

    “More than three weeks since the US government froze PEPFAR funding, there is still widespread confusion and uncertainty as to whether this critical lifeline for millions of people has been cut off,” says Avril Benoît, chief executive officer of MSF USA. “Despite a limited waiver covering some activities, what our teams are seeing in many of the countries where we work is that people have already lost access to lifesaving care and have no idea whether or when their treatment will continue.”

    “MSF is calling on the US government to immediately resume funding for the full range of PEPFAR operations as well as other critical health and humanitarian aid,” says Benoît.

    On 1 February, after over a week of chaos and a freeze of activities, the US government issued a limited waiver allowing for the resumption of some programming with specific guidance for HIV. However, that guidance was unclear, and it did not immediately reach PEPFAR country teams. Across our broad network, MSF did not see a single organisation able to resume work as a result of this limited guidance on waivers. On 6 February, the US government issued clarified guidance on HIV care and treatment and prevention of mother to child transmission programmes.

    However, we remain concerned that key areas of HIV prevention, treatment, care, and support are not included in this additional guidance, such as pre-exposure prophylaxis (PrEP) for all vulnerable groups, including LGBTQ+ people and sex workers, specific interventions for adolescent girls and young women in high prevalence countries, and community-led monitoring programmes. These services are essential to ensuring a successful response to the epidemic.

    While MSF does not accept US government funding and will not be directly affected by cuts or freezes to PEPFAR, many of our activities are contingent on the programmes that have been interrupted. In some places we have had to adapt and change our activities, and the indirect effects of these freezes have already been felt in our projects in various parts of the world.

    In sub-Saharan Africa, where MSF runs several HIV/AIDS and related health programmes, we are already witnessing impacts on patients. In South Africa, many clinics providing HIV services, including testing, treatment, and PrEP through PEPFAR-funded organisations have been shuttered, leaving people confused and distressed about where to access their critical medication.

    In Mozambique, a major partner organisation of MSF that provided comprehensive HIV services had to stop activities completely. In Zimbabwe, most organisations providing HIV services have also stopped work, disrupting in particular the DREAMS program aimed at decreasing new HIV infections in adolescent girls and young women.

    “Any interruption to HIV services and treatment is deeply distressing to people in care and an emergency when it comes to HIV treatment,” says Tom Ellman, director of the South Africa Medical Unit at MSF Southern Africa. “HIV medicines must be taken daily or people run the risk of developing resistance or deadly health complications.”

    In Democratic Republic of Congo, the aid freeze was already affecting the most successful model of antiretroviral drug distribution ever implemented in the capital city of Kinshasa: the community-run free distribution and peer support points, known locally as “PODIs”. In a country where stigma against people living with HIV is massive and poverty remains a barrier to care, PODIs have proven to be a medically necessary approach for addressing delays or therapy abandonment. With PEPFAR-supported points of care now closed and other activities frozen, thousands of people were left without support and with a high risk of developing advanced HIV. MSF teams supporting advanced HIV disease care in Kinshasa might not be able to meet the increased demand if disruptions persist.

    In South Sudan, approximately 51 per cent of people living with HIV know their status, and 47 percent are on treatment. A discontinuation of this programme will have devastating effects on thousands of people and their communities. MSF has worked alongside PEPFAR providing essential HIV care in this context and has seen firsthand how this programme saves lives. The support of PEPFAR in this country is critical.

    PEPFAR-supported programming is deeply interconnected with and reliant on other components of the US foreign aid system, specifically implementation support provided by USAID and technical and other assistance provided by the US Centers for Disease Control and Prevention (CDC). Given that the foreign aid freeze and stop-work orders continue to affect these other agencies, and staff from these agencies have been put on immediate leave or recalled, it is unclear when and how even the limited activities now allowed will be able to restart.

    “These disruptions will cost lives and upend years of progress against this virus,” says Benoît. “Every day that passes is an emergency for millions of people for whom PEPFAR is a lifeline.”

    PEPFAR-supported programming has been heavily integrated into key aspects of the broader health systems of partner countries over the last 20 plus years and as a result the consequences of these disruptions have been far-reaching. For this reason, some of the services affected go beyond purely HIV treatment and prevention, such as in Uganda, where PEPFAR-funded aspects of infectious disease surveillance and response, including for Ebola virus, have been stopped.

    “When MSF first started treating people with HIV/AIDS in South Africa 25 years ago, there were no antiretroviral medicines on the shelves, every diagnosis felt like a death sentence, and communities were desperately trying to curb the virus’ spread,” says Ellman.

    Since then, PEPFAR support has helped save more than 25 million lives and encouraged the fight against HIV to be a truly global one. But continued success relies on continued access to the full range of HIV-related programmes, services, and goods including prevention services and treatment, population-specific and targeted programmes, programmes related to gender-based violence, and other critical areas.

    As health care providers, we are deeply concerned by these disruptions to this lifesaving programme.

    “Even temporary interruptions to key components of PEPFAR will harm people at risk of acquiring HIV and people living with HIV,” says Benoît. “We urge the US government to immediately resume all funding of critical humanitarian and health aid, including the full range of PEPFAR operations.”

    MIL OSI NGO –

  • MIL-OSI United Kingdom: Attracting and retaining nurses and midwives

    Source: Scottish Government

    Taskforce report highlights recommended actions.

    A taskforce has published 44 recommended actions on how to improve working conditions for Scotland’s nurses and midwives.

    The Nursing and Midwifery Taskforce was established by the Scottish Government in 2023 to build on efforts to make Scotland the best place for nurses and midwives to work.  Chaired by Health Secretary Neil Gray, it brings together key stakeholders, including the Royal Colleges of Nursing and Midwifery, to engage with nursing and midwifery staff, understand the challenges they face and recommend ways to improve the profession.

    A key part of this work was the Listening Project, which gathered insights from more than 4,000 nurses, midwives, students and academics to shape future improvements. The findings from the Listening Project have led to 44 recommended actions designed to improve recruitment and retention of staff and workplace conditions.

    These actions include:

    • ensuring appropriate staffing levels so that all staff can take the breaks they are entitled to
    • reviewing data-inputting and paperwork requirements to reduce the administrative burden on nurses and midwives
    • developing national guidance on rostering and flexible working to ensure better work-life balance
    • ensuring nurses and midwives can participate in decision making and planning
    • widening entry routes into nursing and midwifery careers

    The next stage of the taskforce will focus on implementation, with a dedicated group developing a detailed work plan and timeline that ensures these recommended actions are delivered effectively.

    Accepting all 44 recommendations, Cabinet Secretary for Health, Neil Gray said:

    “Our nurses and midwives are the backbone of Scotland’s healthcare system and we are committed to ensuring they have the support, flexibility and workplace conditions to thrive.

    “The publication of the Nursing and Midwifery Taskforce report marks an important milestone; we have heard directly from staff about what matters most to them, and this has shaped the recommended actions which will deliver real change for nurses and midwives. I am very grateful to everyone who has taken the time to take part in this important piece of work. The Scottish Government will now work with our partners to deliver the actions contained in the report.”

    Colin Poolman, RCN Scotland Director, said:

    “This is the culmination of two years of collaborative working, and we welcome the recommended actions announced today. We see this as a significant step and, as the implementation board begins its work, the recommendations should provide a strategic roadmap to begin to tackle the nursing retention and recruitment challenges in Scotland.

    “Implementation of the recommendations will take time and investment, we look forward to playing a key role in the Implementation Board to ensure delivery and enable Scottish government to meet its aspiration of making Scotland the best place for nurses and midwives to work.”

    Background 

    The report and recommended actions of the Ministerial Scottish Nursing and Midwifery Taskforce – gov.scot

    Listening Project: You shared, we listened – gov.scot

    Nursing and Midwifery Taskforce – gov.scot

    MIL OSI United Kingdom –

  • MIL-OSI United Kingdom: York furniture charity gets boosted through council-funded scheme

    Source: City of York

    Through a partnership between City of York Council and York Centre for Voluntary Services (CVS), charities across the city can access expert support to maximise their social impact.

    One of the charities that has benefited from the project is York Community Furniture Stores (CFS), which has tackled furniture and digital poverty across North Yorkshire for over three decades by collecting pre-loved home furnishings and selling them back to the community at an affordable price, with additional discounts availble for those on means-tested benefits.

    Through the Organisational Health Check programme, supported by the council through the nationwide UK Shared Prosperity Fund, York charities can access the services of freelance, expert consultants to take a detailed look at all aspects of their organisation and understand which areas could be improved. They then work with the consultants on issues that could include fundraising, HR, structure and governance, and develop strategies to help the charities run more smoothly, become more cost-effective and build future resilience in the face of the challenges currently facing the voluntary sector.

    York CFS initially sought help with a merger process, combining their three branches in York, Selby and Scarborough, but through working with Adrian Ashton, a consultant specialising in voluntary sector governance, developed a broader plan for the organisation’s future.

    Speaking in a new video celebrating the project, Katy Ridsdill-Smith, CEO of York CFS, explained:

    What I thought would be a relatively straightforward project – merging the three charities into one – has transformed into a larger organisational change programme which will include a rebrand, the launch of a bold anti-poverty strategy and a new organisational structure.

    “The support has enabled to us to think critically about the level of support we provide to our local communities and how we can be more effective in our work. It’s a really exciting time for CFS!”

    Alison Semmence, Chief Executive of York CVS, said:

    Our work with York Community Furniture Store provides an excellent example of how the partnership has enabled us to connect voluntary, community and social enterprise (VCSE) sector organisations in York with specialist expertise, to not only support the sector’s ability to navigate challenges, but so that organisations can seize opportunities, grow their impact, and continue to deliver meaningful change across our city.

    Cllr Pete Kilbane, Executive Member for Economy and Culture at City of York Council, said:

    Like so many of York’s voluntary organisations, York Community Furniture Store plays a vital role in supporting the whole community, especially those who need great quality furniture at an affordable price.

    “Through this partnership with York CVS, who are experts in our city’s voluntary sector, we’re delighted to have helped organisations like York CFS become more resilient and run more efficiently, meaning they’ll be better able to support our communities for years to come.”

    To find out more about how York CFS benefited from the scheme, watch our video about supporting York charities.

    MIL OSI United Kingdom –

  • MIL-OSI Canada: Refocusing continuing care for the future | Recentrer les soins continus pour l’avenir

    [. As their needs evolve, it is important that older adults and vulnerable populations have access to the support they need to maintain their quality of life and independence so they can age with dignity. Over the next 10 years, the demand for continuing care in Alberta is projected to grow by 80 per cent, increasing even faster as people live longer and with more complex needs.

    Alberta’s government is establishing Assisted Living Alberta – the new provincial continuing care agency – as part of the province’s health refocusing. This will ensure the province is well-positioned to meet the future needs that are anticipated with Alberta’s both growing and aging population. Assisted Living Alberta will provide Albertans access to a comprehensive system of continuing care with a full range of wraparound services, including medical and non-medical supports, home care, community care and social services. This transition will allow the province to place a holistic social service lens on assisted living services to deliver care more effectively and consistently throughout the province. By taking this approach, individuals and families will have more options when they need care and as their needs evolve, helping older adults and vulnerable populations maintain their quality of life and independence.

    “As the need for continuing care services in Alberta grows, I am committed to working with health, social services and continuing care professionals to transform the system and ensure the new provincial agency, Assisted Living Alberta, meets all Albertans’ needs. This change ensures Albertans have access to a full range of wraparound supports to meet their evolving needs and maintain their independence and quality of life as they age or require more support.”

    Jason Nixon, Minister of Seniors, Community and Social Services

    Assisted Living Alberta is on track to be established and become an entity by April 1, and will be fully operational by fall 2025. The new agency will align medical and non-medical supports and services, increase continuing care spaces, reduce wait times, and provide comprehensive wraparound supports for Albertans who require different levels and types of care. This includes both seniors in long-term care and those who want to continue aging at home but need supports to do so, as well as people with disabilities, individuals experiencing homelessness and other vulnerable Albertans who require temporary or long-term care. Refocusing Alberta’s health care system ensures all Albertans have access to the services and support they need, when and where they need it.

    “Improving health care services is a top priority for our government. We are committed to addressing the urgent need for enhanced assisted living services across our growing province. I look forward to working alongside the Ministry of Seniors, Community and Social Services to bring Albertans more options and the high quality of care they need close to home.”

    Adriana LaGrange, Minister of Health

    Albertans currently receiving care, and those who need care, will continue to have access to the services they need. A transition committee led by Dr. Sayeh Zielke, author, cardiologist and medical director of Chinook Cardiology, along with leaders from health care, continuing care, social services and other local organizations, will provide the minister with advice to support this transformation. Committee members were chosen based on their experience, diverse perspectives, leadership and background in the continuing care and social services space. The committee’s work will be essential to ensuring a smooth and seamless transition with no disruptions.

    “It is an honour to be playing a role in helping transform Alberta’s continuing care system. Our goal is to put patients and clients first and give our front-line workers the support they need, which is why it is so important that we are taking the time to gets things right and consulting directly with Albertans.” 

    Dr. Zielke, cardiologist and medical director of Chinook Cardiology and chair of the Assisted Living Transition Committee

    Albertans are invited to share their feedback, support the stand up of Assisted Living Alberta and help shape the future of continuing care through online engagement that will be open from Jan. 30 to March 3 at Alberta.ca/lead-the-way. Continuing care providers and health care and continuing care workers will also have an opportunity to provide feedback through targeted engagement that will be open at the same time. Albertans’ insights and perspectives will help lead the way in improving the system to ensure it meets Alberta’s needs today and for generations to come.  

    Alberta’s government is making significant strides in its efforts to refocus the health care system. Assisted Living Alberta will be the fourth and final new provincial health agency to be established and operational. Recovery Alberta officially began operations on Sept. 1, 2024, with Primary Care Alberta ready to follow suit and become operational on Feb. 1, 2025. On the same date, Acute Care Alberta is set to become a legal entity. By creating four provincial health agencies to oversee the priority sectors of primary care, acute care, continuing care, and mental health and addiction, the province is putting patients first in every health care decision and giving front-line experts the support they need to properly care for Albertans.

    “The Alberta Continuing Care Association welcomes this transformational move by the Alberta government. By bringing social services, medical and non-medical supports, and continuing care together under one health agency, patients will be able to access wraparound supports for the care and services they need.”

    Feisal Keshavjee, chair, Alberta Continuing Care Association

    “Integrated health and social care enhances outcomes, aligns with the preferences of older adults, caregivers and practitioners, and underpins leading continuing care models. Healthy Aging Alberta and the United Way of Calgary congratulate the ministry on this exciting transition and look forward to supporting an integrated wraparound model of continuing care in Alberta.”

    Karen McDonald, provincial director, Healthy Aging Alberta 

    Transition committee members

    • Dr. Sayeh Zielke, committee chair – cardiologist and medical director of Chinook Cardiology
    • MLA Brandon Lunty, deputy chair – MLA for Leduc-Beaumont
    • Dr. David Stewart, member – physician, Family Medical Centre
    • David Weyant, member – president and CEO, Alberta Lawyers Indemnity Association
    • Robin James, member – chief administrative officer, Lethbridge Housing Authority
    • Feisal Keshavjee, member – board chair, Alberta Continuing Care Association
    • Karen McDonald, member – provincial director, Healthy Aging Alberta (and executive director, Sage)
    • Andrea Hesse, member – CEO, Alberta Council of Disability Services
    • Joyce Wicks, member – former nurse and seniors advocate
    • Ruben Breaker, member – councillor, Siksika First Nation
    • Arlene Adamson, member – former CEO, Silvera for Seniors
    • Salimah Walji-Shivji, member – KC, CEO, AgeCare
    • Irene Martin-Lindsay – member, executive director, Alberta Seniors and Community Housing Association

    Related news

    • Continuing care: Ministers LaGrange and Nixon (Oct 16, 2024)

    Related information

    • Refocusing health care in Alberta
    • Continuing Care Transformation
    • Online survey for feedback on Alberta’s continuing care system

    Multimedia

    • Watch the news conference
    • Listen to the news conference

    Dans le cadre du recentrage des soins de santé, le gouvernement de l’Alberta procède à l’établissement d’Assisted Living Alberta, l’organisme provincial des soins continus.

    D’ici 2046, un Albertain sur cinq aura 65 ans ou plus. À mesure que les besoins évoluent, il est important que les adultes plus âgés et les populations vulnérables aient accès au soutien nécessaire pour maintenir leur qualité de vie et leur indépendance afin de vieillir avec dignité. Au cours des 10 prochaines années, on prévoit que la demande de soins continus en Alberta augmentera de 80 %, puis encore plus rapidement à mesure que les gens vivent plus longtemps et avec des besoins plus complexes.

    Le gouvernement de l’Alberta établit Assisted Living Alberta, le nouvel organisme provincial des soins continus, dans le cadre du recentrage des soins de santé. Cette initiative a pour but de s’assurer que la province est bien placée pour répondre aux besoins futurs prévus en raison de la population croissante et vieillissante de l’Alberta. Assisted Living Alberta fournira l’accès à un système global de soins continus doté d’une gamme complète de services intégrés, notamment des soutiens médicaux et autres, des soins à domicile, des soins communautaires et des services sociaux. Cette transition permettra à la province de mettre en place des services d’aide à l’autonomie sous l’angle holistique des services sociaux afin de fournir des soins de manière plus efficace et plus cohérente partout en Alberta. En adoptant cette approche, les personnes et les familles auront plus de choix lorsqu’elles auront besoin de soins et à mesure que leurs besoins évolueront, ce qui aidera les adultes plus âgés et les populations vulnérables à conserver leur qualité de vie et leur indépendance.

    « À mesure que les besoins en soins continus augmentent en Alberta, je suis résolu à travailler avec les professionnels de la santé, des services sociaux et des soins continus pour transformer le système et veiller à ce que le nouvel organisme, Assisted Living Alberta, satisfasse à tous les besoins des Albertaines et des Albertains. Grâce à ce changement, la population aura accès à une gamme complète de soins intégrés pour répondre à ses besoins en évolution constante et conserver son indépendance et sa qualité de vie à mesure qu’elle vieillit et exige davantage de soutien. »

    Jason Nixon, ministre des Personnes âgées et des Services communautaires et sociaux

    Assisted Living Alberta est en bonne voie d’être établi d’ici le 1er avril, et sera entièrement opérationnel d’ici l’automne 2025. Ce nouvel organisme harmonisera les soutiens et les services, médicaux et autres, augmentera les espaces de soins continus, réduira les temps d’attente et fournira des soutiens intégrés complets aux Albertaines et aux Albertains qui exigent différents niveaux et types de soins. Ceci comprend les personnes âgées dans des établissements de soins de longue durée et celles qui veulent continuer de vieillir chez elles, mais ont besoin de soutiens pour ce faire, ainsi que les personnes handicapées, les personnes en situation d’itinérance et d’autres personnes vulnérables nécessitant des soins temporaires ou de longue durée. Le recentrage des soins de santé en Alberta permet aux Albertaines et aux Albertains d’avoir accès aux services et au soutien nécessaires, au moment et à l’endroit où ils en ont besoin.

    « L’amélioration des services de soins de santé est une priorité absolue pour notre gouvernement. Nous sommes déterminés à satisfaire au besoin urgent de services d’aide à la vie autonome améliorés partout dans notre province, dont la population augmente continuellement. Je me réjouis de travailler aux côtés du ministre des Personnes âgées et des Services communautaires et sociaux pour offrir aux Albertaines et aux Albertains un plus grand choix et la grande qualité de soins pour rester près de chez eux. »

    Adriana LaGrange, ministre de la Santé

    Les Albertains qui reçoivent actuellement des soins, et ceux qui exigent des soins continueront d’avoir accès aux services nécessaires. Un comité de transition dirigé par la Dre Sayeh Zielke, autrice, cardiologue et directrice médicale de Chinook Cardiology, ainsi que des chefs de fils des soins de santé, des soins continus, des services sociaux et d’autres organisations locales, conseilleront la ministre à l’appui de cette transformation. Les membres du comité ont été choisis en fonction de leur expérience, de leurs divers points de vue et de leurs antécédents dans le domaine des soins continus et des services sociaux. Le travail du comité sera essentiel pour ce qui est d’assurer une transition sans heurt et sans interruption.

    « C’est un honneur de contribuer à transformer le système de soins continus en Alberta. Notre objectif est de donner la priorité aux patients et aux clients et d’apporter à nos travailleurs de première ligne le soutien nécessaire. C’est pourquoi il est si important que nous prenions le temps de bien faire les choses et de consulter directement les Albertaines et les Albertains. » 

    Dre Zielke, cardiologue et directrice médicale de Chinook Cardiology, et présidente du comité de transition d’aide à la vie autonome

    Les Albertains sont invités à faire part de leur rétroaction, à soutenir l’établissement d’Assisted Living Alberta et à contribuer à façonner l’avenir des soins continus par l’intermédiaire de l’engagement en ligne qui sera accessible du 30 janvier au 3 mars à Alberta.ca/lead-the-way. Les fournisseurs de soins continus et les travailleurs de la santé et des soins continus auront également l’occasion de donner leur opinion dans le cadre d’un engagement ciblé pendant la même période. Les idées et les points de vue de la population albertaine aideront à ouvrir la voie vers l’amélioration du système en veillant à ce qu’il réponde aux besoins actuels et des générations à venir.  

    Le gouvernement de l’Alberta fait des progrès considérables dans le recentrage des soins de santé. Assisted Living Alberta sera le quatrième et dernier organisme de santé provincial à être établi et opérationnel. Recovery Alberta a officiellement lancé ses activités le 1er septembre 2024. Primary Care Alberta lui emboîte le pas et entrera en fonction le 1er février 2025. Acute Care Alberta deviendra une entité juridique à la même date. En créant quatre organismes de santé provinciaux pour superviser les secteurs prioritaires des soins primaires, des soins actifs, des soins continus et de la santé mentale et des dépendances, la province accorde la priorité aux patients dans chaque décision en matière de santé et donne aux experts de première ligne le soutien nécessaire pour s’occuper des Albertains comme il se doit.

    « L’Alberta Continuing Care Association se réjouit de cette transformation effectuée par le gouvernement de l’Alberta. En réunissant sous un même organisme les services sociaux, les soutiens médicaux et autres et les soins continus, les patients pourront avoir accès aux soutiens intégrés dont ils ont besoin sur le plan des soins et des services. »

    Feisal Keshavjee, président, Alberta Continuing Care Association

    « L’intégration des soins de santé et des services sociaux améliore les résultats, correspond aux préférences des adultes plus âgés, des soignants et des praticiens, et sous-tend des modèles de soins continus de pointe. Healthy Aging Alberta et Centraide Calgary félicitent le ministère de cette transition emballante, et ont hâte d’appuyer un modèle intégré de soins continus en Alberta. »

    Karen McDonald, directrice provinciale, Healthy Aging Alberta

    Membres du comité de transition

    • Dre Sayeh Zielke, présidente du comité – cardiologue et directrice médicale de Chinook Cardiology
    • Brandon Lunty, député provincial et vice-président – député de Leduc-Beaumont
    • Dr David Stewart, membre – médecin, Family Medical Centre
    • David Weyant, membre – PDG, Alberta Lawyers Indemnity Association
    • Robin James, membre – directeur municipal, Lethbridge Housing Authority
    • Feisal Keshavjee, membre – président du conseil, Alberta Continuing Care Association
    • Karen McDonald, membre – directrice, Healthy Aging Alberta (et directrice générale, Sage)
    • Andrea Hesse, membre – directrice générale, Alberta Council for Disability Services
    • Joyce Wicks, membre – ancienne infirmière et défenseure des personnes âgées
    • Ruben Breaker, membre – conseiller, Première Nation Siksika
    • Arlene Adamson, membre – ancienne chef de la direction, Silvera for Seniors
    • Salimah Walji-Shivji, membre – chef de la direction, AgeCare
    • Irene Martin-Lindsay – membre, directrice générale, Alberta Seniors and Community Housing Association

    Nouvelles connexes

    • Continuing care: Ministers LaGrange and Nixon (Soins continus : ministre LaGrange et Nixon (16 octobre 2024)

    Renseignements connexes

    • Refocusing health care in Alberta (Recentrer les soins de santé en Alberta)
    • Continuing Care Transformation (Transformation des soins continus)
    • Online survey for feedback on Alberta’s continuing care system (Sondage en ligne pour obtenir de la rétroaction au sujet du système de soins continus)

    Multimédia

    • Regarder la conférence de presse

    Translations

    • Arabic
    • Simplified Chinese
    • Traditional Chinese
    • Punjabi
    • Spanish
    • Ukrainian

    MIL OSI Canada News –

  • MIL-OSI Russia: Vice-Rector of SPbGASU presented a medal and books to the Library of the Russian Academy of Sciences

    Translartion. Region: Russians Fedetion –

    Source: Saint Petersburg State University of Architecture and Civil Engineering – Evgeny Korolev (center) and employees of the Library of the Russian Academy of Sciences: Elena Ermoshina, head of the collections and services department; Olga Skvortsova, director; Natalia Kolpakova, deputy director for research, and Natalia Volkova, head of the spr

    Vice-Rector for Research, Professor, Head of the Department of Construction Materials Technology and Metrology at SPbGASU, Academician of the Russian Engineering Academy Evgeny Korolev presented the Library of the Russian Academy of Sciences with a medal “For outstanding achievements in the field of popularization of engineering knowledge” and a set of rare books.

    “The Library of the Russian Academy of Sciences in St. Petersburg was founded in 1714 by Peter the Great and is the oldest in Russia. Today, it is one of the largest libraries in our country and the world. Its collections contain millions of storage units and many unique literary monuments. The library staff supports scientific and research activities, provides a wide range of services, thereby contributing to the popularization of science in general and engineering knowledge in particular. In gratitude, the Presidium of the Russian Engineering Academy decided to award the institution a medal. This award is our appreciation for the work of all library employees,” noted Evgeny Korolev.

    On behalf of SPbGASU, the vice-rector donated rare editions to the library: “Brick Outfit of Nevsky Prospect” and “Brick Saint Petersburg in the 18th–19th Centuries”. Their author is Vsevolod Inchik, Doctor of Technical Sciences, Advisor to the Russian Academy of Architecture and Construction Sciences, Full Member of the Petrovskaya Academy of Sciences and Arts, and the creator of the unique Museum of Saint Petersburg Brick at SPbGASU.

    The library management and staff thanked the Russian Engineering Academy for the high assessment of their work, and SPbGASU for valuable publications. They expressed hope for further fruitful cooperation for the benefit of Russian science and education.

    Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.

    MIL OSI Russia News –

  • MIL-OSI USA: In Senate Budget Committee, Republicans Block Murray Amendments for Bipartisan Approach to Spending, Affirming Congressional Spending Authority, Reversing NIH Cuts, Transparency & Accountability for DOGE, and More

    US Senate News:

    Source: United States Senator for Washington State Patty Murray
    ICYMI: Senator Murray Remarks at Senate Budget Resolution Markup: Blasts Roadmap to Devastating Cuts, Calls for Budget Hearing with Musk – MORE HERE
    Washington, D.C. — Today, at the Senate Budget Committee’s mark up of Senate Republicans’ budget resolution, U.S. Senator Patty Murray (D-WA), Vice Chair of the Senate Appropriations Committee and a senior member and former Chair of the Senate Budget Committee, put forward six amendments to steer Republicans toward a bipartisan approach to spending, affirm Congress’ power of the purse, reverse massive arbitrary cuts to NIH, deliver transparency into the so-called Department of Government Efficiency (DOGE), and more. Republicans unanimously opposed every amendment Murray and other Democrats offered.
    MURRAY AMENDMENT 01: Senator Murray first proposed an amendment to address defense and nondefense needs equally—tackling national security concerns and challenges at the border alongside priorities like supporting our veterans, biomedical research, child care, agriculture, and more—noting that such investments should be a part of ongoing bipartisan topline negotiations between appropriators. Rather than the $342 billion Republicans are proposing in mandatory funding through the partisan reconciliation process, Murray’s amendment would have provided $171 billion in discretionary funding for defense and $171 in discretionary funding for non-defense needs.  Unlike the partisan approach taken by Republicans, the funding under the Murray amendment would be available to address a range of critical needs, including but not limited to national security and the border.
    “Democrats share many of your concerns about investing in our national security, providing more resources to address the challenges at the border, and making sure we counter China,” said Senator Murray of her amendment to equally divide the proposed spending toward defense and non-defense priorities. “While also wanting to make sure we address critical areas like supporting veterans, agriculture, wildfires, disaster response, biomedical research, child care, and much more. So, the approach in my amendment is to say we should work together on a bipartisan basis – and really this should be part of the topline conversations we are having now as we hurtle toward the March 14th funding deadline. I want to make clear Democrats remain at the table on the FY 2025 topline – but it is getting pretty lonely for us when we see Republicans assume a trillion dollars for this year alone in unilateral DOGE cuts, remain quiet as Russ Vought and the administration continues to unlawfully impound funds, and now propose to jam through $342 billion in funding for your priorities on a partisan basis—while I am trying to negotiate in good faith a bipartisan, four-corner topline deal for fiscal year 2025. I would urge my Republican colleagues to get serious and keep your eye on the ball regarding the funding lapse on March 14th, not to mention the sequester cuts at the end of April.”
    MURRAY AMENDMENT 06: Senator Murray pressed her colleagues to pass an amendment to stand up to the Trump Administration and affirm Congress’ power of the purse which Republicans all unanimously opposed.
    “This is not a partisan issue—it is about upholding our laws and Congress’s constitutional authority over federal spending,” said Senator Murray of her amendment to affirm Congressional spending authority. “The Constitution grants Congress—not the President—the power of the purse. This has been affirmed time and again—by: The Supreme Court, Congress, The Government Accountability Office, and others. And yet, Trump, Elon Musk, and Russ Vought have been holding up huge chunks of funding that Congress passed—often on a bipartisan basis. When Presidents ignore our spending laws and the power of the purse our Constitution gives Congress—not the president—it doesn’t just block funding for the American people, it erodes the trust necessary for bipartisan negotiations in Congress. As I have emphasized, Members of Congress—on both sides—must know a deal is a deal. This amendment is about protecting the integrity of our democratic process—our most fundamental checks and balances. Every Senator—Republican or Democrat—should support this amendment to preserve Congress’s authority and maintain the trust necessary for effective governance.”
    MURRAY AMENDMENT 17: Senator Murray also offered an amendment to reverse the Trump Administration’s indiscriminate cut to biomedical research and the lifesaving work supported by the National Institutes of Health (NIH) at research institutions across the country—which no Republican spoke in opposition to during debate, but every Republican voted in opposition.  
    “On Friday night the Trump Administration announced it was implementing a policy to arbitrarily cut National Institutes of Health funding that supports biomedical research at institutions across the country,” said Senator Murray of her amendment to reverse Trump’s proposed policy on indirect costs. “In capping indirect cost rates at 15 percent for NIH-funded grants, this policy would cut funding that is essential to conducting research – such as operating and maintaining labs and research facilities. That is in clear violation of our annual appropriations bills, which have included an explicit prohibition on NIH implementing a policy exactly like this since fiscal year 2018. Fortunately, a court has temporarily paused the policy, but let’s be clear, if the Trump administration were to be successful in gutting NIH funding in this way, it would be absolutely catastrophic for lifesaving research patients and families are counting on, including lifesaving cancer research at Fred Hutch in my home state of Washington, and at so many other institutions in Red and Blue states nationwide.”
    “Research would come to a halt, sick kids would not get the treatment they need, and clinical trials would shut down abruptly,” Murray continued. “Our commitment to supporting basic research infrastructure—which this policy does—is what helped make the American research enterprise the best in the world.  This is funding that helps produce medical breakthroughs and change patients’ lives and ensure that the U.S. continues to be the global leader in biomedical research. NIH is an important economic driver in just about every single one of our states—creating jobs and spurring innovation.”
    MURRAY AMENDMENT 05: Senator Murray pushed for passage of an amendment to have the Senate request the Government Accountability Office (GAO) to review, audit and report back within 90 days on DOGE, including the appropriateness of the authorities and finances under which it is operating; internal controls and compliance with appropriations, data privacy, and other laws; the hiring, vetting, and security clearance of its employees, special government employees, and volunteers; appropriateness of actions taken to cancel contracts, reassign or otherwise change the status of federal employees; and any other areas deemed appropriate by the Comptroller General. Every Republican voted no.
    “My amendment requests the Government Accountability Office to review, audit and report back within 90 days on the so called Department of Government Efficiency so that we can understand its role, authorities, and impacts,” said Senator Murray of her amendment to provide some level of transparency into DOGE. “Mr. Chairman, your Mark assumes $1 trillion in savings over the remaining seven to eight months in 2025. That is an astronomical amount of savings to achieve in a very short amount of time and with absolutely no detail provided to us. Those savings would appear largely to come from DOGE, which is operating throughout the government without any authorization from Congress, without any normal disclosure of people, processes, or conflicts, and really with no accountability whatsoever. Whether you support some actions of DOGE or not, you should support transparency and accountability to Congress and the American public. Elon Musk and DOGE have already tried to shut down USAID, the Consumer Financial Protection Bureau, and we are told it is now targeting the Department of Education, with the President saying he wants Musk over at the Pentagon next. None of this is normal – not DOGE, the involvement of an unelected billionaire, the vast influence it has, or the actions they have taken to date with little or no input from Congress.”
    “Let’s be clear—no one voted to let an unelected billionaire decide what bills the federal government would or wouldn’t pay or whether our elementary schools and hospitals get funding, but President Trump is giving Elon the keys to the Treasury,” continued Senator Murray. “And, again, the lack of transparency into its people, processes, and potential conflicts should concern every one of us. So, my hope is with this amendment we can agree to some oversight of DOGE and ask Congress’s independent, nonpartisan watchdog, the GAO, to review DOGE and report back to us within 90 days. And if you are not supportive of this—I have to ask, what are you scared of finding out?”
    MURRAY AMENDMENT 15: Murray also put forward an amendment to prevent federal disaster assistance from being included in the highly partisan budget reconciliation process and ensure that federal disaster relief funds go to the communities that need them when they need them.
    MURRAY AMENDMENT 14: Murray also pressed to pass an amendment, modeled off her Veteran Families Health Services Act, to provide additional funding for improving the reproductive assistance provided by the Department of Defense and the Department of Veterans Affairs to members of the Armed Forces, veterans, and their spouses or partners—particularly for IVF. Every Republican also opposed these amendments, notwithstanding their intention to significantly increase the size of our military through their reconciliation plan, which will result in even more servicemembers and veterans needing reproductive assistance.
    Prior to consideration of amendments, Senator Murray underscored in her opening comments that the resolution Senate Republicans have put forth is a roadmap to devastating cuts to programs families count on every day—from Medicaid to SNAP to veterans benefits—so that Republicans can later pass more tax breaks for the ultra-rich. Senator Murray emphasized that right now Congress’ focus should be on addressing the fast-approaching March 14 funding deadline and addressing President Trump and Elon Musk’s sweeping, illegal funding freeze—not a partisan measure to gut investments in working people. She also called for Elon Musk to come before the Committee to discuss his already in-motion efforts to decimate programs people count on.

    MIL OSI USA News –

  • MIL-OSI USA: WATCH: Padilla Slams RFK Jr. Nomination to Lead Health and Human Services

    US Senate News:

    Source: United States Senator Alex Padilla (D-Calif.)

    WATCH: Padilla Slams RFK Jr. Nomination to Lead Health and Human Services

    WATCH: Padilla calls RFK, Jr. “unfit and unprepared” to serve as HHS Secretary

    WASHINGTON, D.C. — Today, U.S. Senator Alex Padilla (D-Calif.) delivered remarks on the Senate floor to oppose the nomination of Robert F. Kennedy, Jr. to lead the Department of Health and Human Services (HHS), raising the alarm on the disastrous public health implications if he is confirmed. Padilla called out RFK, Jr. for his severe lack of qualifications and his record of peddling dangerous public health misinformation.

    • “I oppose this nomination for his wildly misinformed beliefs and his utter lack of experience. I believe he is fundamentally unfit and unprepared — and Americans will be less healthy if he is confirmed.”

    RFK, Jr. has repeatedly spread dangerous conspiracy theories — for his own financial gain — even going as far as to say that “there’s no vaccine that is safe and effective.” Padilla called him out for making false accusations that vaccines cause autism, lying that the COVID-19 virus targeted specific racial and ethnic groups, founding his own anti-vaccine organization, authoring several books pushing public health conspiracies, and making millions off anti-vaccination lawsuits.

    • “In the face of all the proven science, proven again and again science, Mr. Kennedy has chosen to profit off fear. And countless parents are being misled into making dangerous decisions for their children.
    • “Look — I get the fear. I’m proud to represent California in the Senate. I’m proud to have an engineering background. But I too am a parent of three boys. And I remember what it was like to hold a baby in your arms, and to worry every time there was a sniffle and a cough. I’d do anything to protect my children, just as you would do anything to protect yours.
    • “But where families have reasonable questions on everything from doctors to diets, Mr. Kennedy simply sees dollar signs.”

    Padilla, a co-founder of the bipartisan Senate Mental Health Caucus, also highlighted the dangers RFK, Jr. poses to mental health care access and Medicaid benefits. He slammed RFK, Jr. for his dangerous lack of knowledge regarding Medicaid funding and benefits. 

    • “At a time when Republicans are looking to cut funding for lifesaving services, I’d rather see a fierce defender of Medicaid at HHS. Yet, during his confirmation hearings, Mr. Kennedy failed to show even a basic understanding of Medicaid. Not the sources of funding, not the benefits, and at one point, he even seemed to conflate or confuse Medicaid and Medicare.
    • “Colleagues, I shouldn’t have to say this: This is not a ‘learn on the job’ nomination.”

    As Republicans threaten major cuts to Medicaid, Padilla underscored the importance of confirming a nominee with the necessary qualifications and experience to protect public health. He urged his colleagues to vote against RFK, Jr.’s confirmation.

    • “Republicans are already floating cuts to Medicaid to pay for even more tax breaks for the rich. In the White House, President Trump and his Shadow President Musk have proven they’ll shutter any agency that stands in their way.
    • “And today, we’re left wondering who will speak up to protect the health of millions of Americans. Unfortunately, Mr. Kennedy has already shown he is not up to the task. So colleagues, I urge you to join me in fighting to protect the health of our constituents and oppose the confirmation of Mr. Kennedy.”

    Video of Senator Padilla’s full remarks is available here.

    MIL OSI USA News –

  • MIL-OSI Video: We’ll stop climate change, but ‘how soon’ is the life-and-death question – Al Gore

    Source: World Economic Forum (video statements)

     

    As the world record’s it’s highest ever average global temperatures, and the US, once again, quits the UN climate change pact, Al Gore is surprisingly upbeat on humanity’s ability to tackle global warming.

    He spoke to Radio Davos at the Annual Meeting, where he presented a new system that tracks greenhouse gas emissions around the world, Climate TRACE.

     

    Links:

    Global Risks Report 2025: https://www.weforum.org/publications/global-risks-report-2025/

    Climate TRACE: www.climatetrace.org/explore (https://www.climatetrace.org/explore)

    Climate and Health Initiative: https://initiatives.weforum.org/climate-and-health/home

    Centre for Nature and Climate: https://centres.weforum.org/centre-nature-and-climate/home

     

    Related podcasts:

    Can climate action survive geopolitical upheaval?: https://www.weforum.org/podcasts/radio-davos/episodes/gfc-geopolitics-climate-global-south/

    Breathe! The cities working together on air pollution and climate change (https://www.weforum.org/podcasts/radio-davos/episodes/breathe-cities-air-pollution-jaime-pumarejo/) : https://www.weforum.org/podcasts/radio-davos/episodes/breathe-cities-air-pollution-jaime-pumarejo/

    What are the ‘positive tipping points’ that could help us accelerate out of climate disaster? (https://www.weforum.org/podcasts/radio-davos/episodes/climate-change-positive-tipping-points-tim-lenton/) : https://www.weforum.org/podcasts/radio-davos/episodes/climate-change-positive-tipping-points-tim-lenton/

    Al Gore on leadership skills, climate action and the ‘tipping point’ ahead (https://www.weforum.org/podcasts/meet-the-leader/episodes/al-gore-on-leadership-skills-climate-action-and-the-tipping-point-ahead/) : https://www.weforum.org/podcasts/meet-the-leader/episodes/al-gore-on-leadership-skills-climate-action-and-the-tipping-point-ahead/

    Check out all our podcasts on wef.ch/podcasts: 

    YouTube: – https://www.youtube.com/@wef/podcasts

    Radio Davos – subscribe: https://pod.link/1504682164

    Meet the Leader – subscribe: https://pod.link/1534915560

    Agenda Dialogues – subscribe: https://pod.link/1574956552

    Join the World Economic Forum Podcast Club: https://www.facebook.com/groups/wefpodcastclub

     

    https://www.youtube.com/watch?v=4OGQ38GkbRE

    MIL OSI Video –

  • MIL-OSI China: US stocks close mixed after hot inflation data

    Source: China State Council Information Office

    U.S. stocks ended mixed on Wednesday, as the unexpected rise in inflation led to speculation that the Federal Reserve may delay interest rate cuts to manage the economy’s overheating.

    The Dow Jones Industrial Average declined by 225.09 points, or 0.50 percent, ending at 44,368.56. The S&P 500 decreased by 16.53 points, or 0.27 percent, to close at 6,051.97. In contrast, the Nasdaq Composite Index edged up by 6.09 points, or 0.03 percent, finishing at 19,649.95.

    Within the S&P 500’s 11 primary sectors, nine closed in negative territory. Energy and real estate sectors led the declines, losing 2.69 percent and 0.91 percent, respectively. Conversely, consumer staples and communication services sectors posted gains, rising 0.23 percent and 0.04 percent, respectively.

    The U.S. Bureau of Labor Statistics reported Wednesday that the consumer price index (CPI), a comprehensive measure of the costs of goods and services across the U.S. economy, accelerated by 0.5 percent on a seasonally adjusted basis for the month, pushing the annual inflation rate to 3 percent. This outcome surpassed the estimates, which had predicted a 0.3 percent monthly increase and a 2.9 percent annual rate, with the annual rate rising by 0.1 percentage point compared to December.

    Excluding volatile food and energy prices, the CPI advanced by 0.4 percent for the month, resulting in a 12-month inflation rate of 3.3 percent — again beating the respective forecasts of 0.3 percent and 3.1 percent — and the annual core rate was up by 0.1 percentage point from December.

    “Shelter costs continue to be the main driver of core inflation as higher mortgage rates push more Americans into a rental market in which vacancy rates are near record lows,” said Erik Norland, chief economist at CME Group. “Traders appear to believe that today’s data make additional Fed cuts less likely than they had expected previously.”

    “The ‘wait and see’ Fed is going to be waiting longer than anticipated after a red-hot January CPI inflation report,” wrote Josh Jamner, investment strategy analyst at ClearBridge Investments. “This report puts the final nail in the coffin for the rate cut cycle, which we believe is over.”

    Market expectations have shifted, with traders now pricing the next rate cut to occur no earlier than September, even as Fed Chair Jerome Powell cautioned against reading too much into the latest CPI report. “We don’t get excited about one or two good readings and we don’t get excited about one or two bad readings,” Powell said in testimony before the House Financial Services Committee.

    Powell reiterated Wednesday that while the Fed has made “great progress” in bringing inflation closer to its 2 percent target, it is “not quite there yet.” He emphasized the need to keep monetary policy restrictive for now.

    Meanwhile, a new round of earnings has provided insight into the resilience of Corporate America. Kraft Heinz shares slipped after the company’s 2025 profit outlook fell short of expectations, whereas CVS Health enjoyed a boost as its quarterly profit drop was smaller than anticipated.

    In after-hours trading, Reddit’s upcoming results are drawing significant attention amid lofty Wall Street expectations, and Robinhood’s report is also in the spotlight following a three-year high in its stock price.

    MIL OSI China News –

  • MIL-OSI USA: “He’s a Danger,” King Warns in Floor Speech Against RFK Jr. Nomination

    US Senate News:

    Source: United States Senator for Maine Angus King

    WASHINGTON, D.C. — U.S. Senator Angus King (I-ME) tonight took to the floor of the Senate to share his concern over President Trump’s nomination of Robert F. Kennedy, Jr. to serve as the Secretary of Health and Human Services (HHS). In the speech, Senator King began his remarks by outlining the roles of Congress and the Presidency as America’s Founders envisioned: to make laws and to execute laws, respectively.  He then turned to the HHS candidate, speaking to Kennedy’s lack of experience and qualifications needed to run a large-scale health organization, and pointed out Kennedy’s long held public opinions as hostile toward the mission of the agency. He also warned of Kennedy’s dangerous skepticism toward proven, life-saving vaccines, sharing a childhood memory of a classmate who had polio.

    “Mr. President, I’d like to begin my remarks this afternoon by talking a little bit about the Constitution. I spent some time last week talking about the Constitution and our failure to observe that the Constitutional, fundamental structure of the division of power between the Congress and the Executive is being violated and the Congress is allowing it to happen. Another provision of the Constitution is the provision in Article I about advise and consent. It’s a fundamental check and balance built into the Constitution by the framers for a reason. It wasn’t a throw-away line or a few sentences that were put in because they wanted to fill the paragraph out. Again, it’s part of the structure that was designed to protect us from tyranny. And the structure involved the division of power, the separation of power because the framers knew that if all power was concentrated in a single individual or single institution, that institution or that individual would inevitably abuse our people. That’s human nature. That’s 1,000 years of human nature. All power corrupts and absolute power corrupts absolutely. So, the advise and consent provision was in the Constitution for a reason. It was in there for a reason, in order to provide a check on the executive and the people who were going to be put in charge of running the administration. 

    “By the way, I want to stop for a minute and focus on the word administration and the word executive, because it really goes to the discussion we’re having in this country right now about how our government is supposed to work. The executive comes from the word execute, and the word execute means put into action. It doesn’t mean initiate the action. It means put it into action. The same for the term administration. There’s a reason we call it the administration. They are to administer the laws. In fact, the obligation on the president in Article II is to see that the laws are faithfully executed. And it does not give the president the power to ignore laws or to decide which laws he or she thinks are okay, to ignore the responsibility and constitutional authority of the congress to define spending. It does not give the president that power. Although, the fellow we approved for Office of Management and Budget last week thinks he has that power. Or this President or any president has that power. That’s absolutely antithetical to the Constitution, as established by the framers. So, administration means administer the laws, executive means execute the laws, not make them. We make the laws here and the administration is to faithfully execute those laws. 

    “Now, let’s talk about advise and consent. Advise and consent means we have a responsibility — a Constitutional responsibility to consider each of the president’s nominees for these important jobs. This isn’t something that we may do or occasionally do. This is a fundamental part of our job. We take an oath when we come here to defend the Constitution against all enemies, foreign and domestic. I think it’s interesting — they knew in 1787 that there was a potential for domestic enemies to the Constitution. So we have an obligation to take advise and consent seriously. 

    “Now, I’m a former governor, as is the presiding officer. And as a former executive, I believe the executive should have the ability to choose the team that they want, to choose their advisors. To choose the people they will work with, with some limitations. In other words, I start with the premise of the person elected should perhaps get the benefit of the doubt is a little too strong, but I start with the premise that they were elected and they should be able to choose the team that they are going to be working with. However, I think there are two qualifications. This has been my stated position on this since I entered the Senate. Benefit of the doubt to the executive, however, the nominee must be manifestly qualified and not hostile to the mission of the agency to which they’ve had been appointed. Two criteria that for me give life to the idea of advise and consent. 

    “Okay, let’s talk about Robert F. Kennedy, Jr. He, unfortunately, checks both of the boxes as to being disqualified. Number one, he’s not remotely qualified to run an organization. He has no experience running anything remotely like the scope and scale of the Department of Health and Human Services. No executive experience in that sense. So that’s number one. Is he qualified? No. He’s grossly unqualified. But the second box is he hostile to the mission of the agency? And if the mission of the agency, HHS, is to protect the health of the American people, I would argue he is manifestly hostile to that mission. There’s been a lot of discussion here today and I think it’s interesting. I haven’t heard too many people come up on the floor and support this nominee and tell us why he should be approved because, you know what, Mr. President? If this were a secret ballot, this man wouldn’t get 20 votes. Everybody in this body knows he’s not qualified. Everybody in this body knows he has no business anywhere near this position. But here we are. We’re going to take a vote. Unfortunately, it will probably be on a party-line basis. 

    “But let me focus on just one little piece. On January 29, barely a week ago, before the Senate Finance Committee, here’s what Mr. Kennedy said. Quote, “news reports have claimed that I’m antivaccine or anti-industry. I am neither. I am pro-safety. All of my kids are vaccinated.” I bet that came as news to all of the folks he’s been leading astray over the last 25-30 years. I believe vaccines have a critical role in health care. I am reminded of Saul on the road to Damascus. A miraculous conversion. A bright light was shown and suddenly the scales fell from his eyes in his confirmation hearing. Okay, let’s go back a little over a year, July 6, 2023, this is a quote, a direct quote, “there is no vaccine that is safe and effective.” He later said, on the same podcast, ‘vaccines are inherently unsafe.’ Mr. President, this man shouldn’t be confirmed because he told the committee and the Senate something diametrically opposed to the position he’s taken the last 30 years, all of his adult life. 

    “Maya Angelou said, “If somebody tells you who they are, you should believe them.” And he’s told us repeatedly. And he has acted on his vaccine skepticism. This wasn’t something that was rumbling around in his head. He’s traveled the world. He’s written articles, gone on podcasts, gone on TV and he’s discouraged people from being vaccinated. And now he has this miraculous conversion 10 days ago. ‘All my kids are vaccinated. I believe vaccines have a critical role in health care.’ The same thing during COVID. He said, ‘it is criminal medical malpractice to give a child one of these vaccines.’ Wow, criminal malpractice. And of course it’s been discussed. He said I do believe that autism does come from vaccines. July of 2023 there was one study in England — I think it was in 1998 — that showed that — purported to show a tenuous convection between vaccines and — connection between vaccines and autism. I’m reasonably confident that one of the authors recanted. It was withdrawn and it’s been debunked over and over and over again, but this man has been peddling this lie for 20 years, and who knows how many parents have fallen for that on the one hand who knows how many children have paid the price. Just to talk about vaccines, at one point during the pandemic, there was a survey — July of 2021 — remember, that was the height of it — they surveyed 50 hospitals in 17 states. 94% of the patients hospitalized in July of 2021 were unvaccinated. What does that tell you? Vaccinations worked. And people who were unvaccinated were at enormously higher risk. 94% of the people were unvaccinated.

    “In addition to the vaccination issue, this guy — this man doesn’t respect the FDA, the agency that was put in place to protect our health, to regulate us, to be sure that we’re getting safe medications, to deal with some of the awful problems of the potential of harmful medications literally getting into America’s bloodstream. In December of 2024, barely a couple months ago, he said he would fire officials at the FDA. And in October 2024 he said on X, ‘FDA’s war on public health is about to end. If you work for the FDA and are part of this corrupt work, two messages for you: prepare your records and pack your bags.’ He didn’t say a certain office in the FDA or a certain part of the FDA or maybe there was one provision, a part that he didn’t think was helpful. He said, if you work for the FDA, that’s everybody, preserve your records and pack your bags. 

    “This man is not only unqualified, he’s anti-qualified. He’s a danger. We have physicians in the Senate — I believe that the Hippocratic oath, do no harm, should apply to Senate votes. You should not be voting for somebody who you know is going to do harm to the public health. So this is really a kind of surreal debate because everybody in this chamber knows this man should not be Secretary of Health and Human Services. 

    “Now, I want to end with a personal story. One of the few advantages of being older is that you have a long memory. And in 1952 I was entering the third grade at Macarthur School in Alexander, Virginia. In my class was a kid named Butch. And he was horribly twisted into a wheelchair. I don’t think I’d ever seen a wheelchair when I was going into the third grade. He was there, and I’m not even going to say how many years later, but I can close my eyes and see Butch in that chair. Polio was what he had. He was in pain daily. He could barely make himself understood. His arms were crossed. His legs were bent grotesquely in the wheelchair. And three years later the Salk Vaccine began what turned out to be the elimination of Polio. Where would we be as a country if this man had been the head at that time it was HEW and somehow put a stop to this vaccine, which I believe he has said even the Polio vaccine should be rescinded, which has saved millions of lives around the world. Where would we be? I can’t escape the memory of that boy in that wheelchair. I can’t forget the memory of my parents not letting me go to the public swimming pool because of the fear of Polio. Not being able to go out in the summer and play because of the fear of Polio that stalked the land. The former Republican leader was a victim of Polio. Former President Franklin D. Roosevelt was a victim of Polio. It was the vaccine. And, Mr. President, I hope this place comes to its senses and rejects this surreal nomination. It would be probably be hard to find somebody less qualified to serve in this position. I believe that it will lead to damage to our country, to our health, to our children, and I urge my colleagues to vote no. If you vote yes, you’ll regret it. Thank you, Mr. President. I yield the floor.”

    Senator King has been continuously sounding the alarm on President Donald Trump’s existential threat to the Constitution: he declared that the proposal to halt all federal grant and loan disbursement was illegal and a direct assault on the Constitution. More recently, he joined 36 Senators in a letter to Secretary of State Marco Rubio, sharing the detrimental effects of  the Trump Administration’s dismantling of the U.S. Agency for International Development (USAID). He also joined fellow Senate Select Committee on Intelligence (SSCI) colleagues in writing a letter to the White House about the risks to national security by allowing unvetted Department of Government Efficiency (DOGE) staff and representatives to access classified and sensitive government materials. Last week, he spoke on the Senate floor to share his growing concerns over the Trump Administration’s largely unconstitutional and unprecedented overreach; in the speech he cited the Founding Fathers to add historical perspective to the decision facing the Senate, including the importance of the separation of powers.

    MIL OSI USA News –

  • MIL-OSI USA: February 12th, 2025 Heinrich Delivers Floor Speech Opposing the Nomination of Robert F. Kennedy, Jr. for Health Secretary

    US Senate News:

    Source: United States Senator for New Mexico Martin Heinrich

    VIDEO

    WASHINGTON — This afternoon, U.S. Senator Martin Heinrich (D-N.M.) delivered remarks on the Senate floor amplifying the voices of New Mexicans opposing the nomination of Robert F. Kennedy, Jr. to be the U.S. Secretary for Health and Human Services.

    “I hope all of my colleagues take seriously what it would mean to confirm this anti-vaccine, anti-science snake oil salesman as our next Secretary of Health and Human Services,” said Heinrich.

    VIDEO: U.S. Senator Martin Heinrich (D-N.M.) delivers remarks on the Senator floor opposing the nomination of Robert F. Kennedy, Jr. for Health Secretary, February 12, 2025.

    Heinrich began his remarks by recounting how Mr. Kennedy’s 2019 trip to the Pacific island of Samoa intensified vaccine skepticism and contributed to a deadly measles outbreak that killed 83 people, mostly children under five. Heinrich said: “As someone with a background in science, but more importantly, as a father of two, I am horrified by this story. Thanks to incredible scientific research and medical advances, we now have a vaccine that has proven to be safe and effective at protecting our kids and largely eradicated the measles outbreaks that used to result in the devastating loss of babies and young children. That is until anti-vaccine crusaders like Mr. Kennedy started promoting phony science and conspiracy theories in places like Samoa.”

    Heinrich condemned Mr. Kennedy’s long track record of spreading fear, peddling misinformation, and promoting conspiracy theories: “Mr. Kennedy has repeatedly and falsely alleged that safe and effective vaccines for tetanus, the flu, COVID, and HPV are dangerous to human health. Mr. Kennedy has promoted the completely discredited conspiracy theory that vaccines lead to autism. At the height of the COVID-19 pandemic that led to more than one million deaths in the United States alone, Mr. Kennedy campaigned to end the nationwide vaccination effort that helped us save millions more lives. Mr. Kennedy has — again without any sound evidence — also pushed conspiracy theories claiming that antidepressant medications cause mass shootings and chemicals in our water make children gay. If those claims sound ludicrous, it’s because they are.”

    Heinrich warned that, if he is confirmed to lead the U.S. Department of Health and Human Services, Mr. Kennedy has committed to following President Trump’s orders to further roll back women’s reproductive rights: “During his confirmation process, Mr. Kennedy also reportedly made commitments to my Republican colleagues to support restrictions on mifepristone, a medication abortion and miscarriage management drug. Mr. Kennedy has also signaled to Republican senators that he will go along with whatever President Trump wants to further roll back women’s reproductive rights.”

    Heinrich also cautioned that Mr. Kennedy would help to enact President Trump and Elon Musk’s dangerous agenda to drastically cut federal funding for everything from New Mexicans’ Medicaid health coverage to medical research at the University of New Mexico. Heinrich warned: “The Department of Health and Human Services oversees health coverage programs that serve half of all Americans, including Medicare, Medicaid, and the Affordable Care Act. HHS also supports the medical research that helps us develop the next vaccines, prevent the next pandemic, and find cures to cancer and chronic diseases like diabetes. We have also already seen President Trump, Elon Musk, and his DOGE minions target scientific and medical research at agencies like the National Institutes of Health (NIH). Just last week, we saw them announce an estimated $4 billion cut for NIH health research at universities all across our country—including an estimated $17 million impact at the University of New Mexico alone.”

    Heinrich finished his remarks by amplifying the concerns of New Mexicans who have written or called into his office expressing concern over Mr. Kennedy’s nomination. Watch a video of Heinrich uplifting New Mexicans’ voices here.

    “I agree with these New Mexicans that Mr. Kennedy is unprepared, unqualified, and dangerously unfit to be confirmed as our next Health Secretary,” Heinrich concluded. “To protect our kids’ health from debunked conspiracy theories, to defend women’s reproductive rights, to safeguard the future of Medicare and Medicaid, and to continue lifesaving medical research and medical care in my state and across the country, I urge all of my colleagues to join me in voting NO on confirming Robert F. Kennedy Jr.”

    Heinrich has been amplifying the voices of New Mexicans who have written or called into his office expressing concern over President Trump’s harmful actions and unqualified nominees.

    Last night on the Senate floor, Heinrich uplifted New Mexicans’ concerns over Tulsi Gabbard’s nomination for the Director of National Intelligence. In his remarks, Heinrich emphasized the risk Gabbard’s nomination poses to our national security and discussed Ms. Gabbard’s lack of qualifications and judgment, particularly relating to her 2017 trip to Bashar al-Assad’s Syria. Heinrich zeroed in on Ms. Gabbard’s false denial during her confirmation hearing before the Senate Intelligence Committee about meeting with Ahmad Badreddin Hassoun, Syria’s most senior Sunni Muslim cleric during the Assad regime who made threats to conduct suicide bomb attacks in the United States.

    Last week, Heinrich delivered remarks on the Senate floor amplifying the voices of New Mexicans opposing the nomination of Russell Vought to lead the Office of Management and Budget (OMB). Mr. Vought is the lead architect of the Heritage Foundation’s Project 2025, the policy blueprint for Donald Trump’s harmful agenda to throw the government into chaos and harm working families.

    Last month, Heinrich delivered the longest speech of his career, where he slammed President Trump’s unlawful unilateral blockade of all federal grant funding. In his remarks, Heinrich uplifted stories from New Mexicans on how Trump’s federal funding freeze endangered New Mexicans and threatened communities across the state. Find the video of Heinrich sharing letters from New Mexicans on the Senate floor here.

    Heinrich is leading Senate Democrats in sounding the alarm on Elon Musk and Donald Trump’s destructive actions that are wreaking havoc on Americans, weakening our economy, and threatening the livelihoods of New Mexicans.

    Last week, in an interview with Jim Sciutto on CNN’s The Situation Room, Heinrich vocalized the concerns of his constituents who continue to write-in and call his office opposing Trump’s harmful actions, which are impacting New Mexico families and their financial security. Watch the full video of that interview here.

    Since Trump took office in 2025, Heinrich:

    • Introduced a resolution condemning Trump’s pardons of people found guilty of assaulting police officers on January 6.
    • Led Senate Democrats in sounding the alarm on Elon Musk and Donald Trump’s destructive actions that are wreaking havoc on Americans, weakening our economy, and threatening the livelihoods of New Mexicans.

    MIL OSI USA News –

  • MIL-OSI USA: ICYMI: Delaying RFK Jr. Confirmation Vote on Senate Floor, Warren Highlights Kennedy’s Egregious Conflicts of Interest, “Long History of Promoting Anti-Science Conspiracy Theories”

    US Senate News:

    Source: United States Senator for Massachusetts – Elizabeth Warren

    February 12, 2025

    Warren, Democrats hold Senate floor for 30 hours to oppose “dangerous” RFK Jr. confirmation 

    “Kennedy’s actions speak louder than his latest words, and time and time again, Kennedy has shown us who he is: An anti-science conspiracy peddler who is willing to gamble with American lives. We know who he is, we need to pay attention.”

    “(W)hile you and your family are forced to deal with the grave consequences of Kennedy’s conspiracy-driven health care decisions, Kennedy could set himself up to make millions of dollars off his anti-vaccine crusade – just like he’s been doing for decades. ” 

    Video of Remarks (YouTube)

    Washington, D.C. – On the floor of the United States Senate, Senator Elizabeth Warren, a member of the Senate Finance Committee, joined Democrats in delaying a final vote to confirm Robert F. Kennedy Jr. for Secretary of the Department of Health and Human Services. Senator Warren warned that American families and children would pay the price for Mr. Kennedy’s “conspiracy-driven health care decisions,” while his serious ethics conflicts remain unresolved. 

    Senator Warren called on her colleagues to oppose his nomination. The Senate is scheduled to vote on Mr. Kennedy’s confirmation on the morning of February 13, 2025. 

    Transcript: Floor Speech Opposing the Confirmation of Robert F. Kennedy Jr., Nominee for Secretary of Health and Human Services
    U.S. Senate Floor
    February 12, 2025 
    As Delivered

    Senator Elizabeth Warren: Thank you, Mr. President. And I want to say thanks to the Senator from Minnesota for her leadership on this point. I know that the great research institutions in Minnesota that count on her support are out there fighting thanks to Donald Trump, as they are in Massachusetts. And the people all around this country that rely on those research institutions, who are looking for those cures, for those better treatments, for those opportunities in their lives that right now Donald Trump and his co-president, Elon Musk, seem to want to cut off. So we will stay in this fight. We will indeed. 

    I am here today because Americans didn’t vote to bring back measles.

    Americans didn’t vote to bring back polio.

    Americans didn’t vote to bring back dangerous diseases that we thought we had wiped out decades ago. 

    Americans didn’t vote to get rid of critical vaccines that we know — based on science — we know save lives.

    But that is what Robert F. Kennedy Jr.’s vision would mean for Americans. That is the vision Donald Trump will empower him to carry out.

    Kennedy not only worked to undercut vaccines at home and abroad, he’s made a lot of money doing it. In fact, Kennedy has made millions off of peddling harmful conspiracy theories that hurt real people. He opposed the life-saving Covid vaccine just six months into the pandemic. And he’s set himself up so that he and his family could make millions more from putting Americans’ health at risk.

    One thing is very clear: We cannot trust Robert Kennedy to make health care decisions that will affect every person in this country.

    Right now, millions of Americans are sitting down for dinner with their kids. And I hope we just think for a minute about what RFK Jr.’s plans would mean for them.

    Will their teeth decay because Kennedy took fluoride out of our water based on some conspiracy theory? 

    Will they have to worry about getting measles at school because Kennedy is spreading anti-vax conspiracies on government letterhead? 

    Will parents have to risk their kids getting polio—and maybe dying—by sending them to daycare because Kennedy used HHS rules to open the door to a flood of bogus lawsuits that forced manufacturers to pull the vaccines?

    Look, here’s the thing: Robert Kennedy has spent years on an anti-vaccine crusade, spreading baseless conspiracy theories under the guise of protecting children, so we don’t need to guess the level of harm he will cause; his past already tells us everything we need to know.   

    In July 2018, two children died immediately after receiving a measles vaccine that nurses had incorrectly mixed with a muscle relaxant. Within weeks, the Samoan Health Ministry publicly confirmed the nursing error and charged the nurses with manslaughter. Nevertheless, leading anti-vaccine groups, including Kennedy’s own organization, Children’s Health Defense, exploited public fears to question the reports and spread baseless claims.

    On August 5th, 2018, Kennedy’s organization, Children’s Health Defense, posted on Facebook, and I will quote the post. “Were these once-healthy children the only two to receive MMR that day? If not, why were they the only ones to die? Research needs to determine susceptibility so that no child is ever injured.” Del Bigtree, Kennedy’s partner and former campaign manager, also released a video linking the tragedy to false claims about measles, and telling his followers to “share it with everyone you know. This is how we are changing the world.” 

    Now, amidst public distrust and a paused vaccine program in Samoa, the vaccination rates plummeted. About 10 months later, once the Samoan government had finally stood up against the disinformation and resumed the vaccine program, Kennedy visited the island to meet with the Prime Minister.

    Later, recognizing the blowback that comes with how much went wrong when a conspiracy theory cost people their lives, Kennedy has since denied that his visit had anything to do with vaccines and said that anything suggesting otherwise was an “industry propaganda trope.” In other words, totally false. “Industry propaganda trope.” 

    Kennedy lied. A blog post that Kennedy himself wrote in 2021 admits he went to Samoa to meet with the Prime Minister, who wanted to discuss the possibility of “measur(ing) health outcomes following the ‘natural experiment’ created by the nation’s respite from vaccines.” 

    Think about what that means. Another way to say it is that Kennedy was interested in taking advantage of how the vaccination rate had plummeted, caused by misinformation, so that they could conduct uncontrolled trials on whether unvaccinated kids were healthier than vaccinated kids, a conspiracy theory he has spread widely. You see, at the time, one of his traveling partners was working on a similar study with two anti-vaccine activists, which was ultimately retracted following an investigation that “raised several methodological issues and confirmed that the conclusions were not supported by strong scientific data.” 

    Now, there’s no surprise here. The Prime Minister declined Kennedy’s outrageous proposal – he didn’t want his country to be Kennedy’s guinea pig. He didn’t want unvaccinated children to be studied to see what happened to them when measles or other diseases broke out. But that didn’t stop him from spreading his message. On this trip to Samoa, he met with various anti-vaccine influencers, one of whom said the meeting was “profoundly monumental for (the) movement.” A few months after Kennedy left, in October 2019, the vaccination rate in Samoa hit an historic low of 31%, down from 74% the prior year – and no surprise, a massive measles outbreak erupted. So here is Kennedy telling us now he had nothing, nothing to do with this, his trip to Samoa had nothing to do with the measles vaccine and calling any claim “industry propaganda trope.” And yet, he himself posted a blog about meeting with the Prime Minister and talking about a study to measure health outcomes following a natural experiment of studying children–some with no vaccination and some that were vaccinated. And the anti-vax groups that he met with talked about how profoundly important it is, then Mr. Kennedy leaves, vaccination rates drop down to 31%.

    The measles outbreak was truly tragic. In total, more than 70 children died, right up until a door-to-door vaccination campaign brought the disaster to an end.

    As HHS Secretary, Kennedy would be responsible for whether we keep our children vaccinated or subject them to, in his words, the same “natural experiment” he was interested in testing in Samoa.

    Is that what we want for our kids? Is that what we want for our elderly parents? That is a living nightmare — and it could truly be our reality with Kennedy heading up the Department of Health and Human Services. And all the while that this is going on, while Kennedy is promoting this anti-vax theory, he and his family are profiting off of the plan.

    Now, I’ve been sounding the alarm about Kennedy since the minute Donald Trump announced that he would nominate him for HHS Secretary. It’s not just that he’s unqualified — his long history of promoting anti-science conspiracy theories make him disqualified.

    This is a man who claimed “there is no vaccine that is safe and effective.” “No vaccine.” 

    He said that the polio vaccine “killed many, many more people” than polio ever did. Now, Kennedy came to our committee and said don’t worry, he swears anti-vaccine. But he’s spent his entire career on an anti-vaccine crusade, spreading baseless conspiracy theories under the guise of protecting children and making millions in the process.

    And when, in Senate hearings, he was confronted with his own words, he simply denied saying them.  Denied saying them— despite the videotapes, the transcripts, the blog posts, and the people who heard them. Kennedy thinks he knows what he needs to say to try to get the job that will put him in charge of our vaccine program, so he says he didn’t say exactly what he said.

    Kennedy’s actions speak louder than his latest words, and time and time again, Kennedy has shown us who he is: An anti-science conspiracy peddler who is willing to gamble with American lives. We know who he is, we need to pay attention.

    Let’s do a quick count of some of the ways that, as HHS Secretary, Kennedy could make the anti-vaccine lawsuits — and his own payouts — even bigger. What could Kennedy do? Well, as Secretary of HHS: 

    • He could publish his anti-vaccine conspiracies, but this time on U.S. government letterhead — something that might impress a jury in a subsequent trial. 
    • He could appoint people to the CDC vaccine panel who share his anti-vax views and let them do his dirty work.
    • He could tell the CDC vaccine panel to remove a particular vaccine from the vaccination schedule. 
    • He could remove vaccines from a special compensation program, which would “open up manufacturers to mass torts (lawsuits).” 
    • He could “make more injuries eligible for compensation even if there’s no causal evidence.” 
    • He could change vaccine court processes to make it easier to bring junk lawsuits that could get vaccines pulled from the market.
    • He could turn over FDA (data) to his friends at the law firm, and they could use it however benefits their lawsuits. 

    In short, as HHS Secretary, Kennedy would have the power to make health care decisions that would affect millions of Americans — for working Americans, kids, seniors — on everything from vaccines to abortion to life-saving drugs. Kennedy would have the capacity, as head of HHS, to make it easier to sue vaccine manufacturers. And in an area where the profit margins on vaccines are quite modest, if those lawsuits mount up, vaccines could simply disappear from the market altogether. Manufacturers could decide, “you know, it’s just not worth the lawsuits. We’ll go produce other drugs.” 

    Those kinds of decisions are critically important, and the consequences are grave. For many Americans, they may be the difference between life and death. And they can change lives forever.

    So, while you and your family are forced to deal with the grave consequences of Kennedy’s conspiracy-driven health care decisions, Kennedy could set himself up to make millions of dollars off his anti-vaccine crusade – just like he’s been doing for decades. 

    Remember, the very first ethics agreement that Kennedy submitted to us on the Senate Finance Committee, he said that even while serving as HHS Secretary, he planned to keep his financial stake in ongoing litigation — including vaccine-related litigation. That means that from the jump, Kennedy’s plan was to keep making money off the backs of lawsuits against vaccine manufacturers, some of which directly related to the very products he would have the power to regulate as Secretary of HHS. So, there he is. He has the power to regulate these drugs. He has the power to make life a little better or a little worse for the vaccine manufacturers. He has the power to make it more likely that lawsuits against vaccine manufacturers would succeed. And his initial plan was even while he sat there as Secretary of HHS, he was going to keep on making money from that. 

    This was a damning conflict of interest, so we called it out. Kennedy told us okay, okay, he would submit an updated ethics agreement. Sounds good? What was his update?

    Well, he said instead of personally keeping the millions he’d make off these ongoing lawsuits… he would hand that money directly to his son. Later, he confirmed that the son he’s handing his interests off to is the one who works at Wisner Baum—the same law firm that Kennedy has maintained his very lucrative arrangement with over years, so far netting him a reported $2.5 million just in the last few years. And Kennedy has made clear that he can use his tools as HHS Secretary to open up the door for more anti-vax litigation, and once he’s through as Secretary of HHS, go right back to Wisner Baum and cash in on the new flood of cases that Kennedy himself has unleashed.

    So that is Kennedy’s idea of “fixing” an ethics issue.

    And beyond that, Kennedy has flip-flopped countless times in his answers to the Finance Committee. He is untrustworthy. He has made so many contradictory statements that it’s come to the point it is hard to believe anything he says is true.

    For example, Kennedy originally said he was not an attorney of record in any of these vaccine-related lawsuits. But we did a little homework and we found at least five cases related to the vaccine litigation that hadn’t been disclosed where Kennedy seems to be an attorney of record. That is important because what it means is that Kennedy is a lot closer to these cases than he’s revealing — cases that he and his family will be able to make bank off even as he serves as HHS Secretary. 

    The importance of this litigation can’t be overstated. Just 20 years ago, we watched vaccine makers pull their products off the market because they didn’t have protection from these kinds of lawsuits. The consequence of Kennedy’s ability to make those lawsuits easier is also the ability to shut down access and manufacturing for vaccines for every one of us. And I think that is a terrible mistake.

    Kennedy claims that he is taking on Big Pharma, but that is the lie he is peddling to hide his conflicts. I pressed him on real ways to take on the industry, including using marching-in on Big Pharma’s patents when they use taxpayer funds to bring drugs to market and then turn around and jack up prices on hardworking Americans, and by having the government negotiate prices directly with Big Pharma on behalf of Medicare beneficiaries. But Kennedy, after talking a big game about taking on Big Pharma, said no, he doesn’t support march-in rights and no, he didn’t want to commit to defending Medicare price negotiations, two proven methods to take on the drug industry and put money back into Americans’ pockets. So whose side is he on? 

    Well, one thing is for sure: RKF Jr. is on the side of his own bottom line. He has also refused to share a list of cases that he stands to benefit from. Now, I told you. He said nope, he was not attorney of record on any cases. We dug around and we found five. How many more are there? Well, here’s what Kennedy said when we said, just give us a list of the cases that you’re participating in so we can take a look at the possible conflicts. His answer? The list is so long and the conflicts so clear that, evidently, it would be more damning than what we already know. 

    Kennedy’s list of ethics issues and financial issues are a mile long—and there’s still too much that he refuses to reveal. Think about this. He’s already told us enough about his conflicts, about how he plans to keep making money, even while he was Secretary of HHS. He revealed all that right upfront. He said “Yep, I’m going to make money while I’m Secretary of HHS.” 

    And yet on basic questions like can you just give us a list of the cases that you participated in? He says, “No, I can’t do that,” which really makes you ask what on Earth is he hiding? He is dodging questions from the Senate, he is contradicting himself, and he keeps changing his answers in order to muddy the waters and really make it hard to understand what’s going on.

    Look, no one is fooled about what is happening here. Kennedy has said he’ll, “slam shut the revolving door,” between government agencies and the companies they regulate. But what he won’t agree to is cut off his own family’s steady stream of money flowing in from lawsuits that he personally can directly affect while he is Secretary of HHS. 

    Kennedy knows that these conflicts are serious. And that’s why he scrambled to update his ethics agreement and hand off his interests to his son in a desperate attempt to “fix” things.

    Video of Senator Warren’s full remarks can be found here. 

    MIL OSI USA News –